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ABSTRACT 
In the present study, the benefits of integrating acceptance and commitment training (ACT) into 
an educational workshop for parents of children with autism spectrum disorder (ASD) were 
investigated.  A sample of 23 parents (18 mothers and 5 fathers) of children with ASD aged 4 to 
26 years were randomly assigned to participate in either the ACT workshop (i.e., treatment-
related information supplemented with ACT) or the Support workshop (i.e., treatment-related 
information with supplemented general parent support). Parents’ knowledge of ASD treatment 
selection, acceptance of ASD-related thoughts and emotions, ASD-related cognitive fusion, and 
willingness to select evidence-based treatments were measured at preworkshop, postworkshop, 
and three-month follow-up time points. Parents’ feedback regarding their experiences was also 
gathered via open-ended items embedded within questionnaires completed by participants at 
postworkshop and follow-up. Repeated measures analyses of variance revealed increases in 
treatment selection knowledge from preworkshop to postworkshop for both groups and these 
gains were maintained at follow-up. Trajectories of change in parents’ acceptance and cognitive 
fusion differed significantly by group over time, with ACT workshop participants showing 
increases in acceptance and decreases in cognitive fusion over time. However, the differences in 
acceptance and cognitive fusion between groups failed to reach statistical significance at 
postworkshop and follow-up time points. Unexpectedly, participants’ willingness to select 
evidence-based treatments decreased over time in both groups. Although acceptance and 
cognitive fusion were not found to moderate the relation between participants’ treatment 
selection knowledge and their willingness to select evidence-based treatments, evidence for a 
positive relation between increases in parents’ acceptance from postworkshop to follow-up and 
their willingness to select evidence-based treatments at follow-up was found. Participants in both 
TREATMENT SELECTION                                                                                        v 
 
groups identified treatment information as the most important thing they learned in the 
workshop. Support workshop participants revealed that they most liked the treatment 
information, while ACT workshop participants revealed that they most liked the ACT-specific 
content. Participant satisfaction ratings were high for both workshops and participants reported 
feeling more knowledgeable and confident in their ability to effectively select treatments for 
their children at follow-up. Results of the study demonstrate the feasibility of incorporating ACT 
into educational community workshops for parents of children with ASD. Although neither 
workshop was associated with increased willingness to select evidence-based treatments, 
increases in treatment selection knowledge were observed in both groups, with preliminary 
support for additional benefits of increased acceptance and decreased cognitive fusion in the 
ACT workshop group. Further implications are discussed, as well as strengths and limitations of 
the present study and suggestions for future research.  
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INTRODUCTION  
Study Overview  
Treatment selection is a complex and, at times, overwhelming process for many parents 
of children with Autism Spectrum Disorder (ASD).  Many treatments are available, with widely 
varying rationales, methods, goals, and levels of empirical support (National Autism Center, 
2015).  Few supports are currently available to assist parents in selecting treatments for their 
children with ASD and the resources most commonly used by parents often contain 
misinformation (Drouillard, 2012; Green, 2007).  Despite widespread availability of high-
quality, evidence-based treatments, many parents of children with ASD use non-evidence-based 
treatments with their children (Wong & Smith, 2006).  These parents report believing that every 
treatment works in some way and that there is no harm in trying a treatment (Drouillard, 2009). 
However, consequences of using non-evidence-based treatments include potentially harmful side 
effects, inefficient use of time and financial resources, and possible delayed or prevented access 
to evidence-based treatments.  Research investigating promotion of evidence-based treatment 
selection among parents of children with ASD is necessary to help ensure that the wealth of 
research devoted to identifying methods of early identification and developing efficacious 
treatments translates to tangible benefits for children with ASD. 
Previous research investigating the promotion of evidence-based treatment use has 
demonstrated that information alone often does not lead to lasting changes in attitudes or 
behaviours (Varra, Hayes, Roget, & Fischer, 2008).  Emotional factors are often more influential 
in parents’ treatment selection for their children with ASD than the evidence supporting each 
treatment (Drouillard, 2009; Green et al., 2006; Hodgson, 2012).  Specifically, lower levels of 
acceptance of children’s ASD diagnoses and related thoughts and emotions in parents of children 
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with ASD has been associated with selection of a greater number of treatments, regardless of 
empirical support (Drouillard, 2012).   
Acceptance of the ASD diagnosis and related thoughts and emotions appears to be a 
particularly complex process for parents of children with ASD (Zembat & Yildiz, 2010).  
Acceptance and Commitment Therapy (ACT) is an evidence-based therapy which has been 
demonstrated to significantly increase this acceptance among parents of children with ASD 
(Blackledge & Hayes, 2006; Fung, Lake, Steel, Bryce, & Lunsky, 2018), as well as 
professionals’ willingness to use evidence-based interventions with clients (Luoma et al., 2007; 
Varra, Hayes, Roget, & Fisher, 2008).  
ACT has also been demonstrated to significantly decrease cognitive fusion (i.e., the 
tendency to react to thoughts as literal truths; Luoma, Hayes, & Walser, 2007) in parents of 
children with ASD (Fung et al., 2018). This is particularly relevant given that, for professionals, 
decreases in cognitive fusion have been associated with increases in willingness to use evidence-
based interventions with clients (Varra et al., 2008). 
In the present randomized pilot feasibility trial, the benefits of incorporating elements of 
Acceptance and Commitment Therapy (ACT) into a parent educational workshop on selecting 
treatments for children with ASD were examined. The purpose of the study was to investigate 
ways to increase willingness to select evidence-based treatments in parents of children with 
ASD. Participants were 23 parents of children with ASD who were randomly assigned to 
participate in either the ACT workshop (comprised of information about selecting treatments and 
ACT) or the Support workshop (comprised of information about selecting treatments and general 
parent support). Participants’ knowledge of ASD treatment selection, levels of ACT process 
variables (i.e., acceptance, cognitive fusion), and willingness to select evidence-based treatments 
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were measured at preworkshop, postworkshop, and three-month follow-up time points. This 
study represents a possible practical solution to a significant gap between current research and 
the lives of children with ASD and their families.  Results of the investigation have the potential 
to improve early access to evidence-based intervention among children with ASD, as well as to 
promote relevant knowledge and psychological wellbeing among parents of these children.  
In the following sections, a review of the literature related to parents’ treatment selection 
for their children with ASD is presented. The benefits of evidence-based treatments are 
discussed, as well as the popularity of non-evidence-based treatments in ASD. Factors which 
influence parents’ treatment-related decisions for their children with ASD are reviewed, with 
particular attention given to the impact of psychological processes. 
Autism Spectrum Disorder 
Autism Spectrum Disorder is a neurodevelopmental disorder characterized by ongoing 
impairments in social communication and social interaction across several contexts, as well as 
restricted or repetitive behaviours or interests (American Psychiatric Association, 2013).  The 
term ‘spectrum’ denotes the widely varying profiles of skills, symptoms, and supports required 
among individuals sharing this designation (National Institute of Mental Health, 2015).  In the 
latest Diagnostic and Statistical Manual of Mental Disorders (DSM-5; American Psychiatric 
Association, 2013), a dimensional view of autism has been adopted in which previously distinct 
disorders such as Autistic Disorder and Asperger’s Disorder are now conceptualized as falling 
along a continuum under the single label of Autism Spectrum Disorder (ASD).     
Prevalence.  Recent studies estimate that ASD now affects approximately 1 in every 59 
children (Baio et al., 2018; Christensen et al., 2019).  This prevalence rate has increased 15% 
since the previous estimate in 2014 (Wingate et al., 2014), highlighting the growing number of 
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individuals being diagnosed with ASD each year.  ASD is diagnosed four times more often in 
males than in females, affecting 1 in every 37 males, although it should be noted that the gender 
gap in ASD diagnoses has begun to decrease in recent years (Baio et al., 2018). Although 
increased awareness of the early signs of ASD and the importance of early intervention has 
contributed to earlier diagnoses for many children with ASD, most children in the U.S. are 
diagnosed after the age of four (CDC, 2018). The average age of diagnosis in Ontario is 5.5 years 
(Canadian Autism Spectrum Disorders Alliance, 2014). 
Etiology.  There is no single known cause for ASD. Many researchers agree that the 
etiology of ASD is complex and likely involves genetic, biological, and environmental factors 
(CDC, 2014).  Genetic factors have been demonstrated to be particularly significant in the 
etiology of ASD, with an approximate heritability rate of 90% (Sandin, Lichtenstein, Kuja-
Halkola, Hultman, Larsson, & Reichenberg, 2017). However, evidence points to many possible 
genetic pathways to ASD rather than a single ‘autism gene’ (Andrews et al., 2018; Geschwind, 
2011). Furthermore, a combination of genetic susceptibility and exposure to environmental risk 
factors may also increase the risk for ASD (Rubenstein et al., 2018; Schanen, 2006; Windham et 
al., 2018).  
Despite popular opinion, several large-scale scientific studies have demonstrated that 
vaccines do not cause ASD (e.g., Destefano, Price, & Weintraub, 2013; Institute of Medicine, 
2004).  The original paper by Wakefield and colleagues (1998) which introduced the purported 
link between the measles, mumps, and rubella (MMR) vaccine and ASD was subsequently 
retracted due to serious ethical and methodological concerns in the study (Editors of the Lancet, 
2010).  Previous beliefs that parental practices are related to the onset of ASD in children have 
also been widely criticized (e.g., NIMH, 2014). 
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Development and course.  Children typically manifest the first signs of ASD during the 
second year of life (i.e., between 12 and 24 months), although symptoms have also been noted in 
younger children (APA, 2013).  Often, parents first become concerned about delayed language 
development (Herlihy, Knoch, Vibert, & Fein, 2013). Other early signs of ASD include limited 
social interest, unusual interaction patterns (e.g., leading individuals by the hand but failing to 
make eye contact), and odd styles of play (e.g., lying on the floor to look at car wheels).  
Repetitive behaviours and restricted interests typically begin to develop beyond 24 months of 
age (APA, 2013).  A small subgroup of children with ASD appear to experience significant 
developmental regression in the first two years (i.e., the loss of previously attained skills and/or 
language), as opposed to general developmental delays (APA, 2013). 
Prognosis.  ASD is widely regarded as a lifelong condition (CDC, 2018; NIMH, 2014).  
In a large-scale longitudinal study, over 95% of individuals maintained an ASD diagnosis 13 to 
22 years after initial diagnosis (Billstedt, Gillberg, & Gillberg, 2005).  Previous research has 
demonstrated that most individuals with ASD continue to rely on family members or other 
caregivers for lifetime support (CASDA, 2014; Howlin, Goode, Hutton, & Rutter, 2004).  With 
earlier access to high quality, evidence-based intervention and appropriate supports, however, 
research has demonstrated that some individuals with ASD do achieve independence in 
adulthood (Gray et al., 2014; Eaves & Ho, 2008; Howlin, 2000).  These individuals tend to have 
higher intellectual abilities and language skills and can access employment which capitalizes on 
their special skills and interests (APA, 2013; Gray et al., 2014).  It is now well established that 
early access to evidence-based treatment is consistently associated with the most positive 
outcomes for individuals with ASD (e.g., Children’s Mental Health Ontario, 2003; NAC, 2015; 
Ornstein et al., 2014). 
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Evidence-Based Treatments 
Evidence-based treatments, also referred to as ‘empirically-supported’ treatments, are 
defined as specific psychological interventions which have demonstrated efficacy in controlled 
clinical trials (APA Presidential Task Force on Evidence-Based Practice, 2005).  The term 
‘evidence-based’ is used throughout this document rather than the term ‘empirically-supported’, 
as this latter term is thought by some to denote a sense of finality, mischaracterizing the complex 
and evolving nature of treatment research.   
In a seminal article on the topic, Chambless and Hollon (1998) outlined criteria for 
determining the conditions which must be met for a given treatment or intervention with a 
specific population to be considered evidence-based.  These criteria included: (a) a randomized 
controlled trial or equivalent in which the treatment is demonstrated to be statistically superior to 
a no-treatment, alternative treatment, or placebo control group, with adequate power; (b) 
treatment administered according to a manual or its equivalent, with a sample selected using 
reliable and valid inclusion criteria, using reliable and valid assessment measures, and 
appropriate statistical analyses; and (c) studies conducted in at least two independent research 
sites demonstrating the treatment superiority over control.  Chambless and Hollon (1998) also 
distinguished between the designations of ‘efficacious’ (i.e., treatments meeting the previously 
described criteria) and ‘possibly efficacious’ (i.e., superiority of the treatment demonstrated in 
only one study or by only one team of researchers), representing the complex nature of the term 
‘evidence-based’, rather than representing a simple dichotomy.     
 Several arguments against the movement toward evidence-based treatments have been 
documented in the literature.  With the emphasis on highly controlled randomized clinical trials 
as the ‘gold standard’ for establishing efficacy, some researchers have questioned the 
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generalizability of these findings to community mental health settings (e.g., Reichow & 
Volkmar, 2011).  Similarly, the appropriateness of the emphasis on randomized controlled trials 
has been questioned within social science research, where it is often difficult to obtain the 
necessary sample sizes for testing hypotheses with such strict inclusion criteria (Chorpita, 2003).  
Indeed, Chambless and Hollon (1998) have asserted that, although efficacy trials are an 
important first step, research on ‘real world’ effectiveness and cost-effectiveness are equally 
important next steps.  Overall, the benefits of the movement toward the use of evidence-based 
treatments appear to far outweigh the strength of arguments against the movement, particularly 
when viewed in terms of the ethical responsibility to provide clients with treatments which have 
been demonstrated to be associated with positive outcomes and minimal risks. 
Importance of evidence-based treatments for children with ASD.  Given the rapid 
development of new interventions within the field of ASD, it is important for professionals to 
understand the current state of empirical support for common interventions, as well as which 
questions should be asked when evaluating particular treatments (Perry & Weiss, 2007). In ASD, 
time is of the essence as the benefits of early intervention, beginning before age four (Miriam 
Foundation, 2008), for maximizing progress in children with ASD are now well established 
(Children’s Mental Health Ontario, 2003; Koegel, Koegel, Ashbaugh, & Bradshaw, 2014; NAC, 
2015; Ornstein et al., 2014; Rogers, 1996).  Research suggests that children with ASD are 
particularly receptive to intervention during these early years, with several studies demonstrating 
that children with ASD make significantly greater gains through intensive early intervention than 
do children with other developmental disabilities (Guralnick, 2005; Rogers, 1996).  Furthermore, 
among children with ASD, those who receive intensive intervention at earlier ages make greater 
gains than those who receive intensive intervention at older ages (e.g., Rogers & Vismara, 2008).  
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With the established impact of these formative years on children’s developmental trajectories, it 
has been suggested that parents employ evidence-based interventions with their children with 
ASD as early as possible in order to increase the odds of their children maximizing their progress 
during this time (e.g., Children’s Mental Health Ontario, 2003; NAC, 2015).  Utilizing evidence-
based interventions affords children with ASD the best chances of benefitting during this ‘critical 
period’ and throughout the lifespan (Rogers, 1996), as evidence-based interventions are those 
which have been demonstrated to be efficacious within the specific population.   
There is no ‘quick fix’ for ASD. Research has demonstrated that the most effective 
interventions for children with ASD often require great amounts of time and effort for both 
children with ASD and their parents.  More specifically, participation in intensive (i.e., minimum 
of 25 hours/week [National Research Council, 2011]) evidence-based behavioural intervention 
has been consistently shown to be associated with the most positive outcomes in children with 
ASD (e.g., Green, 1996; Ornstein et al., 2014; Weiss, 1999; Wong et al., 2014).  Longer duration 
(i.e., years rather than months) of evidence-based behavioural interventions has also been 
associated with more positive long-term outcomes in children with ASD (e.g., Luiselli, O’Malley 
Cannon, Ellis, & Sisson, 2000).  Finally, higher levels of parental involvement in evidence-based 
intervention have been associated with greater gains in children with ASD, with researchers 
hypothesizing that parental involvement enhances treatment intensity and promotes 
generalization of skills to new environments (Burrell & Borrego, 2012; Ingersoll & Dvortcsak, 
2006).   
Evidence-based treatments for ASD.  One of the greatest triumphs of ASD research 
thus far is the number of high-quality interventions which have been developed and 
demonstrated to be efficacious for children with ASD.  Overall, there is broad agreement within 
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the ASD research community on the effectiveness of these evidence-based treatments, as well as 
on the types of ASD treatments deemed to be evidence-based, many of which are based on 
behavioural principles (e.g., Applied Behaviour Analysis [ABA]).  For instance, the National 
Research Council (2001) reviewed the body of literature and identified several common features 
of effective treatments for ASD, including: (a) intensive programming, (b) active engagement, 
(c) individualized goals, and (d) one-on-one or small group instruction.  More recently, 
Schreibman and colleagues (2015) reviewed available treatment research and noted common 
features of many evidence-based treatments for ASD, including: (a) use of behavioural strategies 
to teach developmentally-appropriate skills, (b) natural contingencies, (c) naturalistic settings, 
and (d) collaboration between children and treatment providers.  These researchers introduced 
the term ‘naturalistic developmental behavioural interventions’ to capture interventions sharing 
these features, reflecting the intervention aspects consistently supported by scientific 
investigation for ASD.  Similarly, Wong and colleagues (2014) conducted a large-scale review 
of interventions used with children with ASD and identified 27 practices meeting their criteria 
for being evidence-based.  These researchers noted that the evidence-based interventions they 
identified tended to consist of similar elements, including: (a) fundamental behavioural 
techniques (e.g., reinforcement, prompting), (b) behavioural assessment and analytic techniques 
(e.g., task analysis), and (c) combinations of behavioural techniques to form replicable 
interventions (e.g., pivotal response training). 
One of the most comprehensive reviews of ASD treatments, The National Standards 
Report, was published by the National Autism Center (2009).  In this systematic review, experts 
rated the empirical support for 37 popular intervention strategies for children with ASD from 0 
to 5 on the Scientific Merit Rating Scale (SMRS).  This scale, developed specifically for the 
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purpose of this review, includes five dimensions of methodological rigor: (a) research design, (b) 
measurement of the dependent variable, (c) measurement of the independent variable/procedural 
fidelity, (d) participant ascertainment, and (e) generalization.  On the basis of expert ratings on 
the SMRS, 11 intervention strategies for ASD were classified as ‘established’ (e.g., 
comprehensive behavioural treatment for young children, pivotal response treatment).  Most of 
these ‘established’ intervention strategies were behaviourally-based.  Experts also classified 21 
intervention strategies as ‘emerging’ (e.g., social skills package, cognitive-behavioural 
intervention package) and 5 intervention strategies as ‘unestablished’ (e.g., gluten/casein-free 
diet, auditory integration training).   
More recently, the National Autism Center (2015) updated the original National 
Standards Report to include findings from intervention studies published as recently as February 
of 2012.  On the basis of this updated literature review, 13 intervention strategies were classified 
as ‘established’ (e.g., behavioural interventions, parent training).  Similar to their previous 
review (NAC, 2009), these ‘established’ intervention strategies were largely behaviourally-based 
(see Table 1 for a complete list of the empirical classifications of each treatment reviewed).  
Experts also classified 18 intervention strategies as ‘emerging’ (e.g., augmentative and 
alternative communication devices, music therapy) and 13 intervention strategies as 
‘unestablished’ (e.g., gluten/casein-free diet, animal-assisted therapy).   
Non-evidence-based treatments for ASD.  Selection of non-evidence-based treatments 
is common among parents of children with ASD, despite availability of high-quality evidence-
based treatments.  Results of one study indicated that 52% of parents of children with ASD 
reported using non-evidence-based treatments with their children (Salamone et al., 2015; Wong 
& Smith, 2006). It is important to note that non-evidence-based treatments for ASD often aim to 
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‘cure’ ASD by addressing its hypothesized underlying causes (e.g., heavy metals in the 
bloodstream), rather than aiming to slowly build skills in affected areas (e.g., social-
communication; Levy & Hyman, 2008). Parents may believe that if these underlying causes are 
addressed, their children may be cured or no longer show any symptoms of ASD. Without 
support to scrutinize the legitimacy of claims made by promoters of non-evidence-based 
treatments, the widespread selection of these treatments by parents of children with ASD is 
understandable.  
The gluten/casein-free diet is a widely used non-evidence-based treatment for children 
with ASD (Drouillard, 2012; Green, Pituch, Itchon, Choi, O’Reilly, & Sigafoos, 2006; NAC, 
2015; Wong & Smith, 2006).  Thanks in large part to anecdotal reports from celebrity mother 
Jenny McCarthy (e.g., McCarthy & Katzinel, 2009), this diet became a treatment of choice for 
many parents of children with ASD despite lacking empirical support.  Unfortunately, the 
gluten/casein-free diet is associated with significant risks, including reduced levels of essential 
amino acids and disruptions in bone development (Arnold, Hyman, Mooney, & Kirby, 2003; 
Hediger, England, Molloy, Yu, Manning-Courtney, & Mills, 2008; Mulloy, Lang, O’Reilly, 
Sigafoos, Lancioni, & Rispoli, 2009).   
Facilitated communication is another non-evidence-based treatment which has received a 
great deal of media attention (Hemsley et al., 2018; Montee, Miltenberger, Wittrock, Watkins, 
Rheinberger, & Stackhaus, 1995). Scientific investigations have consistently demonstrated that, 
despite claims that facilitated communication helps individuals with ASD overcome 
communication barriers to reveal their ‘true’ selves (e.g., Bilken, 1990), it is most often the 
assistant, not the individual with ASD, controlling the content resulting from facilitated   
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Table 1                    
Empirical Classifications of Intervention Strategies Reviewed by NAC (2015) 
Established Emerging Unestablished 
Behavioural Interventions Augmentative and 
   Alternative Communication 
   Devices 
Animal-assisted Therapy 
Cognitive Behavioural 
   Intervention Package 
Developmental Relationship- 
   based Treatment 
Auditory Integration Training 
Comprehensive Behavioural 
   Treatment for Young 
   Children 
Exercise Concept Mapping 
Language Training 
   (Production) 
Exposure Package DIR/Floor Time 
Modeling Functional Communication 
   Training 
Facilitated Communication 
Natural Teaching Strategies Imitation-based Intervention Gluten-free/Casein-free diet 
Parent Training Initiation Training Movement-based 
Intervention 
Peer Training Package Language Training 
   (Production & 
   Understanding) 
SENSE Theatre Intervention 
Pivotal Response Training Massage Therapy Sensory Intervention Package 
Schedules Multi-component Package Shock Therapy 
Scripting Music Therapy Social Behavioral Learning 
   Strategy 
Self-Management Picture Exchange 
   Communication System 
Social Cognition Intervention 
Social Skills Package Reductive Package Social Thinking Intervention 
Story-based Intervention 
   Package 
Sign Instruction  
 Social Communication 
   Intervention 
 
 Structured Teaching  
 Technology-based 
   Intervention 
 
 Theory of Mind Training  
*Note. Classifications based on the Scientific Merit Rating Scale. NAC = National Autism 
Center 
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communication (Hemsley et al., 2018; NAC, 2015).  For example, research has demonstrated 
that individuals with ASD tend to become more passive in communication when using facilitated 
communication and rely more heavily on the aid of assistants (Bebko, Perry, & Bryson, 1996).  
This finding has been corroborated by other studies which have demonstrated that individuals 
with ASD using facilitated communication are unable to describe objects hidden from their 
assistants (Jacobson, Mulick, & Schwartz, 1995).  In detracting from the agency of individuals 
with ASD and making false promises to family members, this treatment is also associated with 
serious risks to the psychological wellbeing of individuals with ASD and their families 
(Children’s Mental Health Ontario, 2003).    
Use of psychotropic medications (e.g., haloperidol, risperidone, clomipramine, 
aripiprazole, methylphenidate, selective serotonin reuptake inhibitors) to treat ASD is also quite 
common, despite little empirical support for their efficacy (Children’s Mental Health Ontario, 
2003; McPheeters et al., 2011; Parr, 2010).  For example, results from one study indicated that 
64% of children with ASD have used at least one psychotropic medication and 35% have used 
more than one simultaneously (Spencer et al., 2013).  Similar rates of psychotropic 
polypharmacy in ASD are reported in Canada, with one study finding that approximately 25% of 
youth with ASD were receiving at least two psychotropic medications concurrently (Lake, 
Weiss, Dergal, & Lunsky, 2014). Risperidone and aripiprazole are currently the only medication-
based treatments which are FDA-approved for use with children with ASD, and they are 
indicated only for reducing irritability and aggression (Spencer et al., 2013).  Due to the 
significant risk of adverse effects such as social withdrawal, irritability, sedation, weight gain, 
tremors, and seizures (Children’s Mental Health Ontario, 2003; McPheeters et al., 2011; Parr, 
2010), however, these medications are generally not recommended for children with ASD except 
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in children with significant risk of injury or severe functional impairments (Bryson, Rogers, & 
Fombonne, 2003; desPortes, Hagerman, & Hendren, 2003; Mandell, Morales, Marcus, Stahmer, 
Dashi, & Polsky, 2008; McPheeters et al., 2011).   
 Countless other non-evidence-based treatments are used with children with ASD, many 
of which are associated with significant risks.  One of these non-evidence-based treatments is 
chelation therapy (Brent, 2013; Davis et al., 2013), which was reportedly used by 7% of children 
with ASD (Green et al., 2006) despite being associated with serious side effects including 
vomiting, diarrhea, hypotension, and cardiac arrhythmia (Moel & Kumar, 1982), as well as risk 
of hypocalcemia, cardiac arrest (Brown, Willis, Omalu, & Leiker, 2006), and even death (CDC, 
2006).  Hyperbaric oxygen therapy has also been proposed to treat ASD, with little empirical 
evidence of its efficacy (e.g., Granpeesheha, Tarboxa, Dixona, Wilkea, Allena, & Bradstreet, 
2010).  In addition to the high financial cost, several risks of this treatment have been outlined, 
including possible paralysis, air embolism (i.e., artery or vein blockage caused by pockets of air), 
and risk of fire (FDA, 2013).  Thousands of children with ASD also received secretin injections 
(NIH, 1999) following early anecdotal reports of symptom reduction which subsequent studies 
overwhelmingly failed to support (e.g., Esch & Carr, 2004; Williams, Wray, & Wheeler, 2012).  
This treatment has been shown to be associated with several side effects, including rash, fever, 
tachycardia (i.e., rapid heart rate), vomiting, photosensitivity, and increased irritability (Roberts 
et al., 2001). 
Some non-evidence-based treatments such as vitamin supplements (Li, Ou, Li, & Xiang, 
2017), dolphin-assisted therapy (Fiksdal, Houlihan, & Barnes, 2012), and therapeutic horseback 
riding (Rolandelli & Dunst, 2003) may appear to hold no risks for children with ASD. However, 
use of these treatments may be associated with great investments in time and financial resources 
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or may lead to delayed receipt of evidence-based treatments.  As previously discussed, this poses 
a significant risk to children with ASD, for whom early, evidence-based intervention is 
particularly beneficial (Children’s Mental Health Ontario, 2003; Koegel, Koegel, Ashbaugh, & 
Bradshaw, 2014; NAC, 2015; Ornstein et al., 2014; Rogers, 1996).  Overall, the widespread use 
of non-evidence-based interventions with children with ASD despite the availability of evidence-
based interventions speaks to a significant gap between research findings and decisions made by 
“real world” parents, who are most often responsible for selecting treatments for their children 
with ASD.   
Factors Influencing Parents’ Treatment Selection for their Children with ASD 
The question of which factors influence parents’ treatment selection for their children 
with ASD is of particular interest to researchers due to the significant benefits associated with 
evidence-based treatments and risks associated with non-evidence-based treatments (e.g., 
Koegel, Koegel, Ashbaugh, & Bradshaw, 2014; Miriam Foundation, 2008). Empirical support 
does not appear to be a major influence on parents’ treatment selection for their children with 
ASD, despite these high stakes.  For example, Green, Pituch, Itchon, Choi, O’Reilly, and 
Sigafoos (2006) found use of non-evidence-based treatments among children with ASD to be 
common, with 52% of parents reporting using at least one medication with their children, 43% 
reporting use of vitamin supplements, and 27% reporting use of special diets.  These researchers 
also noted varying levels of empirical support for the most popularly used treatments, with visual 
schedules and applied behaviour analysis considered ‘empirically established’, speech therapy 
considered ‘empirically emerging’, and sensory integration considered ‘empirically unsupported’ 
(CMHO, 2003; NAC, 2015).   
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Similarly, results of a more recent study revealed that, of the five most commonly 
selected treatments by parents of children with ASD, three treatments (i.e., antecedent package, 
behavioural package, and visual schedules) were classified as ‘empirically established,’ while 
two treatments (i.e., academic interventions and the gluten/casein-free diet) were classified as 
‘empirically unestablished’ (Drouillard, 2012).  Notably, these parents reported selecting an 
average of 16 treatments each for their children with ASD, with most treatments selected being 
classified as ‘empirically emerging’.  This ‘multi-treatment approach’ is consistent with findings 
from Goin-Kochel, Myers, and Mackintosh (2007) that parents select an average of seven to nine 
treatments for their children with ASD and use an average of four to six treatments 
simultaneously. 
More parents of children with ASD than parents of children with other health-related 
concerns may select non-evidence-based treatments. Wong and Smith (2006) found that 52% of 
parents of children with ASD have used at least one non-evidence-based treatment (e.g., 
gluten/casein-free diet, sensory integration training, homeopathic remedies, therapeutic 
horseback riding) with their children, compared to 28% of parents of children with other mental 
health diagnoses.  Accordingly, as qualitative research has demonstrated that empirical support is 
not the most important factor in parents’ treatment selection for their children with ASD (e.g., 
Green et al., 2006), the focus has shifted to identifying which factors are more influential in these 
decisions. 
Many parents of children with ASD learn about ASD treatments through unverifiable 
sources, rather than from scientific literature.  Through interviewing parents of children with 
ASD, Green (2007) found that parents most commonly reported that their information about 
ASD treatments came from other parents of children with ASD (22%) and the Internet (20%), 
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with only 7% of parents citing scientific literature.  Similarly, Drouillard (2009) found that 
parents’ most common sources of ASD treatment information, in order of frequency, were 
reportedly healthcare professionals, the Internet, ASD community organizations, and other 
parents of children with ASD.  Parents’ reliance on information from professionals, ASD-related 
books, and other parents of children with ASD when selecting treatments for their children was 
demonstrated in another study (Hodgson, 2012). Unfortunately, information from these sources 
may be confusing for parents, as their recommendations are often not based on the empirical 
support for each intervention (e.g., Chowdhury, Drummond, Fleming, & Neufeld, 2002; Matson 
& Williams, 2015). 
Parents of children with ASD commonly report relying on professionals for information 
about available treatment options.  Clinicians typically communicate ASD diagnoses in person to 
parents after an in-depth assessment of their children’s developmental history and current 
functioning through clinical interviews, parent report questionnaires, and structured observation 
using a standardized assessment tool such as the Autism Diagnostic Observation Schedule, 
Second Edition (ADOS-2; Lord, Rutter, DiLavore, Risi, Gotham, & Bishop, 2012).  During this 
meeting, many professionals provide parents with their first information about various treatment 
options available to their children.  In Ontario, ASD is typically diagnosed by pediatricians 
(39%), psychologists (32%), and psychiatrists (19%; CASDA, 2014).  Unfortunately, many of 
these professionals admit being unaware of relevant research findings outside of their own 
discipline, despite calls for increased interdisciplinary collaboration in client care (Upton & 
Upton, 2006).  Thus, professionals providing parents with treatment information may lack a 
comprehensive understanding of evidence-based treatments for ASD, many of which are most 
commonly reported in the psychological literature, rather than the medical literature.   
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Parents’ relationships with professionals and treatment providers have also been 
demonstrated to influence their treatment selection.  For example, parents’ trust in the treatment 
provider and the perceived “fit” between the treatment provider and the family are commonly 
reported as influential factors in parents’ treatment selection for their children with ASD 
(Drouillard, 2009; Golnick, Maccabee-Ryaboy, Scal, Wey, & Gaillard, 2012; Shyu, Tsai, & Tsai, 
2010).  Similarly, parents who receive greater levels of professional guidance regarding 
controversial treatment issues and who engage in collaborative decision-making with 
professionals during treatment selection report higher levels of satisfaction with their children’s 
treatments (Golnick et al., 2012). 
Practical considerations also significantly impact parents’ treatment selection for their 
children with ASD.  Cost, availability (e.g., in rural or remote communities), and ease of 
implementation all influence the types of treatment these parents select for their children (Carlon, 
Carter, & Stephenson, 2013; Green, 2007; Hodgson, 2012; Mandell & Novak, 2005).  For 
example, although many parents are interested in evidence-based behavioural therapies (e.g., 
Applied Behaviour Analysis [ABA]) for their children with ASD (Green, 2007), these therapies 
are often quite costly to administer due to the time intensity (e.g., $80,000 annually). 
Furthermore, there is currently a long waitlist for government funding to access ASD treatments 
in Ontario. As of September 2019 there were 23,312 children awaiting funding or services in 
Ontario alone, with only 11,300 currently receiving services (Ministry of Children, Community, 
and Social Services, 2019). Due to decreases in government funding for many children with 
ASD associated with recent changes to the Ontario Autism Program (Ministry of Children, 
Community, and Social Services, 2019), several ASD service organizations have had to reduce 
their staff, limiting availability of evidence-based interventions, particularly in rural areas (e.g., 
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Alphonso, 2019). As such, the political and social context in which parents make treatment-
related decisions on behalf of their children also has a notable impact on their decision-making.  
Parents’ beliefs about the causes of their children’s ASD have also been found to impact 
their treatment selection.  For example, parental beliefs in external causes for their children’s 
ASD (e.g., vaccine injury, food allergies, toxic metals in the bloodstream) have been found to be 
associated with selection of detoxification, diet, and vitamin-based treatments (Al Anbar, 
Dardennes, Prado-Netto, Kaye, & Contejean, 2010; Dardennes, Al Anbar, Prado-Netto, Kaye, 
Contejean, &  Al Anbar, 2011; Drouillard, 2012; Shyu, Tsai, & Tsai, 2010), despite wide 
scientific discreditation of claims linking these factors to the development of ASD (e.g., Editors 
of the Lancet, 2010).  Parental beliefs in supernatural causes for their children’s ASD have been 
found to be associated with selection of faith-based treatments such as prayer or changing the 
names of affected children (Shyu et al., 2010).   
Parents have identified their emotional reactions as an additional factor which impacts 
their treatment selection for their children with ASD.  For example, parents often report selecting 
several treatments for their children to assuage their fears that their children may ‘miss out’ on a 
particular treatment which may have been effective (Hodgson, 2012).  Many parents report that 
their ‘parental intuition’ and ‘gut reactions’ to various treatments for ASD often significantly 
impact their treatment selection (Drouillard, 2012; Hodgson, 2012).  Finally, parents commonly 
report that their experiences of grief and denial were significant challenges while selecting 
treatments for their children with ASD (Drouillard, 2012).  In the words of one parent, “When 
you take on the responsibility for helping your child and they aren’t getting better as fast as you 
want them to, there’s really no one to point a finger at but you” (Drouillard, 2012; p. 74).  
 Acceptance and parents of children with ASD.  Acceptance of the ASD diagnosis and 
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related thoughts and emotions appears to be a particularly complex process among parents of 
children with ASD, who report significantly lower levels of acceptance than parents of children 
with developmental disabilities such as Down Syndrome (Zembat & Yildiz, 2010).  In an early 
study which sought to define acceptance of children’s ASD diagnoses, Pianta, Marvin, Britner, 
and Borowitz (1996) conducted in-depth interviews with parents of children with ASD and 
outlined characteristics of parents deemed to have high levels of acceptance as well as 
characteristics of parents deemed to have low levels of acceptance.  The authors concluded that 
parents with high levels of acceptance tended to: (a) openly discuss both the positive and 
negative aspects of parenting children with ASD, (b) focus less on the past and what caused their 
children’s ASD, and (c) demonstrate accurate understandings of their children’s strengths and 
limitations.  Conversely, parents with low levels of acceptance tended to: (a) attempt to avoid or 
detach from their emotional responses to the diagnoses and (b) lack energy and motivation to 
take action in support of their children.   
Few studies have specifically examined the impact of parents’ acceptance on their 
treatment selection for their children with ASD.  Nonetheless, some researchers have 
extrapolated from their results to hypothesize about possible relations between acceptance and 
treatment selection among these parents.  Mandell and Novak (2005), for example, interpreted 
their finding that parents’ causal beliefs influence their treatment selection for their children with 
ASD to suggest that parents who believe false claims that ASD can be easily cured may be more 
likely to select non-evidence-based treatments promising this result.  Similarly, Siegel (1997) 
hypothesized that parents with lower acceptance of their children’s diagnoses and their 
associated thoughts and emotions may be particularly vulnerable to non-evidence-based 
proposed “quick fixes” for ASD (e.g., chelation therapy).  More specifically, it has been 
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hypothesized that parents who allow themselves to experience both the negative and positive 
thoughts and emotions associated with raising children with ASD (i.e., parents with higher levels 
of acceptance) may be more likely to select evidence-based treatments for their children, which 
often require greater investments of time and active engagement with their children (MacDonald, 
Hastings, & Fitzsimons, 2010).   
In the only known study to empirically examine the relations between parents’ 
acceptance of their children’s ASD and their treatment selection, low levels of acceptance were 
found to be significantly associated with selection of a greater number of ASD treatments, 
regardless of empirical support (Drouillard, 2012).  This treatment selection strategy was termed 
the ‘shotgun approach’ (Drouillard, 2012) and was exemplified by a parent in an earlier study, 
who explained that, “As a parent, you feel so worried… whatever you can get, you use it right 
away… you want to try every single thing…every method works in some way” (Drouillard, 
2009, pp. 16). Taken together, these findings seem to suggest that interventions aimed at 
increasing acceptance among parents of children with ASD may also serve to promote the 
selection of evidence-based treatments within this population.       
Acceptance and Commitment Therapy 
Acceptance and Commitment Therapy (ACT, said as one word) is a therapeutic approach 
which posits that it is individuals’ relations to their distressing emotions, thoughts, and 
experiences (e.g., avoidance, preoccupation, surrender) which lead to suffering and dysfunction, 
not simply the presence of these distressing emotions, thoughts, and experiences (Hayes, 2004).  
The ACT model asserts that pain is an important and universal aspect of the human experience 
and that, as such, the goal of treatment should not be to eliminate or reduce pain, but instead to 
simply recognize and accept distressing thoughts, emotions, and experiences as they arise, 
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without attempting to avoid or struggle with them, and to act consistently with one’s values in 
the face of pain (Hayes, Strosahl, & Wilson, 2003).      
Theoretical underpinnings of ACT. ACT is regarded as a ‘third wave’ behavioural 
therapy, with the ‘first wave’ representing Behaviour Therapy and the ‘second wave’ 
representing Cognitive-Behaviour Therapy (Hayes, 2004).  The theoretical basis for ACT both 
rests and builds upon each of these models. The originator of ACT, Steven Hayes, was trained as 
a behaviourist (S. Hayes, personal communication, April 10, 2014) and was heavily influenced 
by Skinnerian behavioural theory’s assertion that learning and behaviour are affected by external 
contingencies (e.g., rewards). Skinner used the term ‘operant’ to describe behaviours that 
‘operate’ on the environment (e.g., when a pigeon raises its head above a certain height, it 
immediately receives food; Skinner, 1953). However, behaviour theory failed to take cognition 
into consideration, limiting its applicability to directly observable phenomena. According to 
Hayes (2004), cognitive behaviour theory addressed this gap by asserting that behavioural and 
emotional reactions are often caused by individuals’ interpretations of events, rather than the 
events themselves. Hayes has asserted that cognitive behaviour theory, despite this important 
contribution, downplayed some elements of basic behaviour theory and failed to address 
situations in which distressing thoughts are not based on cognitive distortions (Hayes, 2004). 
Based on these theories and their limitations, Hayes proposed Relational Frame Theory.  
This theory asserts that language and cognition are dependent on the ability to derive relations 
between events (Hayes, Bames-Holmes, & Roche, 2001). Relational framing involves deriving 
implicit relations between events which are indirectly associated (e.g., an object and a thought). 
These derived relations are applied systematically in similar contexts moving forward. Hayes 
(2004) applied this theory to thoughts and emotions as well (in line with cognitive-behavioural 
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theory), such that the memory of a painful event can evoke more distress than the event itself, 
and that even imaginary events which have not been directly experienced can cause distress. As 
people make these associations automatically, attempting to avoid situations, thoughts, or 
emotions associated with a stressor (or attempting to dispute the association through examining 
evidence for/against its validity) typically only serves to further expand these negative relational 
networks and increase distress (Barnes-Holmes, Barnes-Holmes, McHugh, & Hayes, 2004). This 
all called for a new therapeutic stance which focused on altering the context of these relational 
frames, rather than their content. Based on Relational Frame Theory, in the Acceptance and 
Commitment Therapy framework, people’s relations to distressing thoughts, emotions, and 
experiences (e.g., avoidance) are emphasized and targeted, rather than targeting their form, 
frequency, or intensity.   
As with other third wave behaviour therapies such as Dialectical Behaviour Therapy 
(Linehan, 1993), Functional Analytic Psychotherapy (Kohlenberg & Tsai, 1991), and 
Mindfulness-Based Cognitive Therapy (Segal, Williams, & Teasdale, 2002), ACT builds upon 
behavioural and cognitive-behavioural therapies by incorporating elements such as acceptance, 
mindfulness, experiential exercises, and an emphasis on contextual factors (Hayes, 2004).   
The ACT model.  The six core processes of the ACT model include: (a) acceptance, (b) 
cognitive defusion, (c) contact with the present moment, (d) self as context, (e) values, and (f) 
committed action (Hayes, Strosahl, & Wilson, 2003).  These processes are said to represent 
positive psychological skills, rather than tools for minimizing or avoiding distressing internal 
experiences (Hayes, Luoma, & Walser, 2007), and they are conceptualized as being 
interconnected and mutually influencing (Hayes et al., 2003).  Together, these skills help to 
improve clients’ psychological flexibility, defined as “the ability to contact the present moment 
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more fully as a conscious human being, and based on what the situation affords, to change or 
persist in behaviour in order to serve valued ends” (Luoma, Hayes, & Walser, 2007, pp. 17).  
Each of these six core components of ACT is described in greater detail below. 
 Acceptance.  Acceptance, within the ACT framework, is conceptualized as the process of 
fully and actively embracing one’s thoughts, emotions, and bodily sensations (both pleasant and 
unpleasant), without attempting to escape them or to reduce their frequency or intensity (Luoma 
et al., 2007).  As acceptance is conceptualized as an alternative to experiential avoidance, 
acceptance work in ACT shares some features with exposure techniques in behavioural and 
cognitive-behavioural therapies (Hayes, 2004).  In ACT, however, acceptance is thought of as a 
valued process, not merely as a means by which to gradually reduce the frequency or intensity of 
clients’ unpleasant internal experiences (Hayes, 2004).  Experiential exercises are utilized in 
ACT to encourage clients to confront previously avoided internal experiences, combined with 
mindfulness techniques to encourage flexibility and willingness in the face of these often 
distressing experiences (Luoma et al., 2007).   
 Cognitive defusion.  Cognitive defusion is an ACT term which literally means to ‘undo 
fusion’, referring to the process of separating from one’s thoughts in order to look at them, rather 
than from them (Luoma et al., 2007).  Within the ACT model, cognitive fusion occurs when 
clients mistake thoughts as being literal and use thoughts as reasons for behaviours (Luoma et 
al., 2007).  The ACT model differs from the cognitive-behavioural model in that clients are 
asked to evaluate the workability of their thoughts, rather than their validity (Luoma et al., 2007).  
In ACT, the emphasis is placed on changing the context of distressing thoughts, rather than their 
content (Luoma et al., 2007).  Clients are encouraged to be mindful of their thoughts and the 
context in which they occur, without ‘buying into’ them.  For example, a client with the thought 
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“I am bad” is not asked to examine evidence contrary to that conclusion, but is instead 
encouraged to simply be mindful that, in that moment, he/she is experiencing the thought “I am 
bad” (Hayes, 2004).  Clients may be encouraged to engage in exercises such as verbally 
repeating a thought over and over until the original meaning of the thought is altered (e.g., 
Hayes, Strosahl, & Wilson, 2003). 
Contact with the present moment.  The goal of this core ACT component is increased 
awareness of and connection with internal and external experiences as they occur (Luoma et al., 
2007).  Clients are encouraged to focus on the present moment as a means of combatting both 
cognitive fusion and experiential avoidance, as well as enhancing their awareness of 
opportunities for values-based action (Luoma et al., 2007).  Mindfulness exercises such as 
imagining one’s thoughts as leaves floating by on a stream are used to rehearse this process of 
noticing present thoughts, emotions, and bodily sensations from a nonjudgmental, defused, and 
accepting stance (Hayes, 2004). 
 Self-as-context.  Self-as-context in ACT refers to a heightened understanding of a stable 
and transcendent sense of self from which internal and external events are experienced (Hayes, 
2004).  It is a reconceptualization of the self as an ongoing process of self-awareness (e.g., 
“Right now, I am seeing this”; Hayes & Smith, 2005).  This concept is closely tied to defusion as 
its goal is to increase awareness of the continuous and enduring self which experiences various 
events, but which exists independent of those events (Luoma et al., 2007).  Through fostering 
awareness of experiences and decreased attachment to them, the development of a sense of self-
as-context also encourages acceptance (Luoma et al., 2007).   
 Values.  Values, within the ACT model, represent ‘big picture’ desired qualities of life 
which answer the question “What do you want your life to stand for?” (Hayes, 2004).  Values 
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(e.g., family closeness) are distinct from goals in that they are more aspirational than concrete 
and, as such, can never be fully obtained or achieved (Luoma et al., 2007).  Instead, values are 
used to inform the identification of discrete goals, concrete steps toward these goals, and 
potential barriers to taking these steps (Hayes, 2004).  Within this framework, other core 
components of ACT (e.g., acceptance) are important in their relations to one’s capacity for 
values-consistent action (Luoma et al., 2007).   
 Committed action.  Committed action involves engaging in behaviours consistent with 
one’s identified values and working toward achieving one’s self-set goals toward this end 
(Hayes, 2004).  Through values work, clients identify discrete goals, concrete steps toward the 
goals, and potential barriers to taking those steps, which form the basis of behavioural 
experiments and other experiential exercises comprising committed action (Luoma et al., 2007).  
These values-based actions (e.g., choosing a treatment for your child’s serious condition) 
frequently lead to the experience of unpleasant thoughts, emotions, and bodily sensations, which 
in turn require the use of other core processes such as acceptance and defusion (Luoma et al., 
2007).  In committed action, clients must be willing to experience distressing internal states in 
the service of taking action to achieve concrete goals consistent with their larger values systems 
(Ciarrochi, 2012).    
Empirical support for ACT.  ACT appears to be largely unique within the various ‘third 
wave’ therapies which have been proposed in recent decades in terms of both the depth of 
research demonstrating its efficacy and the breadth of clinical concerns found to be significantly 
improved through its use.   
 Group format.  Several studies have demonstrated the efficacy of ACT when 
administered in group format.  ACT with groups generally takes the form of workshops focusing 
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on increasing individuals’ psychological flexibility through introducing and rehearsing the six 
core components of ACT (i.e., acceptance, cognitive defusion, contact with the present moment, 
self as context, values, and committed action; Luoma et al., 2007).  This workshop format of 
ACT is often referred to as Acceptance and Commitment Training, as opposed to Acceptance 
and Commitment Therapy, highlighting the distinction between this more general, brief form of 
ACT intervention and the standard more intensive ongoing, individualized ACT intervention 
(e.g., Blackledge & Hayes, 2006).   
 Group ACT has been demonstrated to result in significantly lower levels of depressive 
symptoms and significantly higher levels of general health among parents of children with ASD, 
which were maintained at three-month follow-up (Blackledge & Hayes, 2006).  In this study, 20 
parents of children with ASD participated in a 2-day (14-hour) ACT workshop aimed at 
increasing parents’ psychological flexibility through focusing on the six core components of 
ACT and how they relate to being parents of children with ASD.  Parents completed measures of 
depression, general health, and self-efficacy, as well as measures of ACT processes such as 
acceptance and cognitive fusion, at four time points.  Results revealed significant improvements 
among the participants from first assessment to one week after the workshop in terms of 
depressive symptoms and general psychological functioning.  These changes remained 
significant at three-month follow-up, at which time even greater improvements were noted. 
Parents’ scores on ACT process measures also demonstrated evidence of increased acceptance 
and decreased cognitive fusion at follow-up. 
 Building upon the work of Blackledge and Hayes (2006), Kowalkowski (2013) 
demonstrated that an 8-week group ACT intervention resulted in significantly decreased 
parenting stress and more positive attitudes toward caregiving for 13 parents of children with 
TREATMENT SELECTION                                                                                        28 
 
ASD.  Kowalkowski’s (2013) ACT intervention was largely based on that developed by 
Blackledge and Hayes (2006) and targeted processes including values, mindfulness, acceptance, 
and committed action through experiential exercises and use of metaphors.  Participants 
completed measures of psychological functioning and ACT processes (i.e., acceptance, cognitive 
fusion, mindfulness) at three time points.  Changes in parenting-related stress and attitudes 
toward caregiving were largely maintained at three-month follow-up.  Unfortunately, changes in 
participants’ acceptance, mindfulness, and cognitive fusion were not statistically significant at 
post-intervention or follow-up, likely due to insufficient power afforded by the small sample 
size.   
 In a recent Canadian study, Lunsky, Fung, Lake, Steel, and Bryce (2018) examined the 
mental health benefits of a 3-session parent-led ACT group for 29 mothers of children with ASD. 
Participants completed measures of psychological functioning a week before participating in the 
group, one month after the final session, and eight weeks after the final session. Results revealed 
significant reductions in depressive symptoms and social isolation, as well as significant 
improvement in physical health scores which were maintained at follow-up. In a follow-up 
study, Fung, Lake, Steel, Bryce, and Lunsky (2018) found significant improvement in ACT 
process variables such as psychological flexibility, cognitive fusion, and value-consistent 
activities in mothers of children with ASD who completed the ACT workshop. They concluded 
that even brief ACT-based groups facilitated by other parents of children with ASD may have a 
long-lasting positive impact on parents of children with ASD.  
 Similarly, ACT in group format has been demonstrated to lead to reduced distress and 
enhanced psychological protective factors in a sample of 5 parents of children with obsessive-
compulsive disorder (Donnelly, 2011), as well as in a sample of 34 parents with continued 
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involvement with Child Protective Services (O’Brien, 2013).  Group ACT has also been 
associated with positive outcomes in the treatment of social phobia in a sample  of 12 adults 
(Ossman, Wilson, Storaasli, & McNeill, 2006), chronic pain in a sample of 56 adults 
(McCracken & Gutierrez-Martinez, 2011; McCracken, Sato, & Taylor, 2013), borderline 
personality disorder in a sample of 41 adults (Morton, Snowdon, Gopold, & Guymer, 2012), and 
chronic headaches in a sample of 26 women (Mo’tamedi, Rezaiemaram, & Tavallaie, 2012), in 
addition to enhanced coping skills in a sample of 45 ‘treatment resistant’ clients with diverse 
psychological diagnoses (Clarke, Kingston, Wilson, Bolderston, & Remington, 2012). 
 ACT has also been used to supplement educational workshops to enhance behavioural 
change in attendees.  Gregg, Callaghan, Hayes, and Glenn-Lawson (2007) evaluated the 
effectiveness of supplementing an educational workshop on diabetes self-management skills with 
ACT for increasing individuals’ adoption of these techniques.  These researchers randomly 
assigned 81 participants to either a one-day (7 hour) diabetes education workshop with ACT 
components or a one-day diabetes education-only workshop.  In the diabetes education with 
ACT workshop, participants were taught cognitive defusion techniques in order to accept 
negative diabetes-related thoughts and emotions and reframe them as simply negative thoughts 
and emotions, identify their life values, and take committed actions in terms of their diabetes 
self-management which were consistent with these life values.  At three-month follow-up, 
participants in the diabetes education with ACT workshop had significantly higher reported 
adherence to the diabetes self-management techniques taught in the workshop, as well as 
significantly lower glucose levels, than did participants in the education-only workshop.  There 
were no differences in understanding of diabetes self-management strategies between 
participants in the two workshop conditions, suggesting that the addition of ACT strategies in the 
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diabetes education with ACT group was responsible for the improvements in adherence and 
glucose levels in that group.  Furthermore, changes in participants’ acceptance of diabetes-
related thoughts and emotions significantly mediated the impact of the workshop condition on 
participants’ glucose levels at follow-up.    
 Professionals’ willingness to adhere to guidelines regarding the use of evidence-based 
treatments with their clients has also been a target of group intervention in ACT.  Luoma and 
colleagues (2007), for example, randomly assigned 30 professional addictions counselors who 
had participated in a one-day continuing education workshop on a specific evidence-based 
intervention for individuals with substance abuse issues (i.e., group drug counseling) to either an 
8-week group-format ACT intervention (12 hours in total) or to a no contact control group.  The 
focus of the ACT intervention was on acceptance of negative thoughts and emotions associated 
with trying a new treatment in their practice and willingness to take committed action by 
implementing the new, evidence-based treatment in service of the value of optimal care for their 
clients.  Results indicated that the professionals who had participated in the ACT intervention 
following the educational workshop reported significantly higher use of the evidence-based 
treatment in their professional practice than did professionals in the no contact control condition.  
These group differences were maintained at 2-month and 4-month follow-up assessments, with 
professionals in the ACT condition also reporting significantly higher levels of personal 
accomplishment at the 4-month follow-up.  Remarkably, participation in the ACT intervention 
accounted for approximately 35% of the variance in self-reported use of the evidence-based 
treatment at 4-month follow-up.  This study provides preliminary support for the usefulness of 
ACT with education in increasing individuals’ willingness to use evidence-based treatments.    
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 In a related study by Varra, Hayes, Roget, and Fischer (2008), 59 professional addictions 
counselors were randomly assigned to attend either a 1-day (6 hour) ACT workshop or a 1-day 
educational control workshop before attending a 2-day workshop on evidence-based treatments 
for substance abuse in order to examine the usefulness of ACT for increasing professionals’ 
willingness to use evidence-based treatments with clients.  This 2-day workshop focused heavily 
on evidence-based agonist and antagonist pharmacological interventions for substance abuse.  In 
the ACT workshop, participants were taught cognitive defusion techniques in order to assist in 
separating themselves from thoughts acting as barriers to using these evidence-based treatments 
with their clients.  They were also taught techniques for accepting negative thoughts and 
emotions associated with trying new treatments with their clients and were helped through 
various values-based exercises designed to assist them in clarifying their commitment to their 
clients and values as therapists.  The educational control workshop consisted of presentations 
describing the current empirical literature on substance abuse prevention and practical strategies 
for substance abuse prevention and was equivalent to the ACT workshop in terms of time, 
attention, and support given. 
Varra and colleagues (2008) found that education on evidence-based treatments and their 
importance as a standalone intervention did not have a positive impact on professionals’ 
adoption of evidence-based treatments in their clinical work.  When combined with ACT, 
however, this educational workshop resulted in professionals being significantly more likely to 
use evidence-based agonist/antagonist pharmacological treatments with their clients and 
significantly less likely to report experiencing barriers to using these treatments.  These group 
differences were maintained at three-month follow-up and the magnitude of the effect size for 
the workshop was larger at follow-up than at post-workshop in terms of increasing professionals’ 
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willingness to use evidence-based treatments.  Through mediational analyses, the authors also 
demonstrated that increases in acceptance and decreases in the believability of barriers to 
implementation (i.e., decreased cognitive fusion) largely accounted for the differences in use of 
evidence-based treatments between the groups.   
 Individual format.  ACT has been most commonly used and researched in individual 
format and has been shown to be associated with positive outcomes in individuals from both 
clinical populations and nonclinical populations, as well as in both laboratory and community 
settings.  As ACT has been studied in ‘real world’ community settings in addition to highly 
controlled laboratory settings, there is growing evidence for its effectiveness (i.e., association 
with positive outcomes in community settings), as well as its efficacy (i.e., association with 
positive outcomes in highly controlled settings).  In individual format, ACT has been 
demonstrated to be effective in improving outcomes among nonclinical individuals in the general 
population, through reducing work-related stress (Bond & Bunce, 2000; Hayes et al., 2004), 
marital distress (Peterson, Eifert, Feingold, & Davidson, 2009), and stigma toward individuals 
with mental health concerns (Masuda et al., 2007).   
ACT has also been demonstrated through numerous randomized controlled trials to be 
efficacious in the treatment of several psychological disorders, including: major depressive 
disorder (Zettle & Hayes, 1986; Zettle & Rains, 1989), panic disorder (Meuret, Twohig, 
Rosenfield, Hayes, & Craske, 2012), substance abuse (Batten & Hayes, 2005), obsessive-
compulsive disorder (Twohig, 2009; Twohig, Hayes, & Masuda, 2006), social phobia (Block, 
2002), and generalized anxiety disorder (Roemer & Orsillo, 2007; Roemer, Orsillo, & Salters-
Pedneault, 2008).  ACT  has also been associated with significantly improved functioning among 
individuals with various medical conditions such as chronic pain (Dahl, Wilson, & Nilsson, 
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2004; McCracken, MacKichan, & Eccleston, 2007; Vowles & McCracken, 2008), cancer (Feros, 
Lane, Ciarrocchi, & Blackledge, 2013), epilepsy (Lundgren, Dahl, Melin, & Kees, 2006; 
Lundren, Dahl, Yardi, & Melin, 2008), and tinnitus (i.e., chronic ringing in the ears; Hesser, 
Westin, Hayes, & Anderson, 2009).  
Recently, Gould, Tarbox, and Coyne (2018) examined the effectiveness of individual 
ACT for increasing values-consistent behaviours in parents of children with ASD. Within this 
study, ACT content was delivered to three mothers of children with ASD over the course of six 
90-minute individual sessions held in the participants’ homes. Although each of the six sessions 
covered a different component of ACT (i.e., valuing, mindfulness, defusion, the ACT matrix, 
committed action, acceptance and self-compassion), session content was individualized 
according to the values identified by the participant at the onset of the intervention (e.g., child 
autonomy, self-care, quality family time). Frequency of values-consistent behaviours (e.g., 
asking child to collect an item from a different aisle in the supermarket, taking an exercise class, 
eating dinner together as a family) was tracked by parents via journals and data sheets which 
were verified by a third party (e.g., significant other, friend, therapeutic instructor). Results 
indicated that all three mothers increased their values-consistent behaviours throughout the 
intervention, with further increases noted at six-month follow-up. Increases in parents’ 
acceptance and self-compassion were also noted.  
ACT with parents of children with ASD.  Theoretically, the overall goal and core 
components of ACT seem particularly appropriate for use with parents of children with ASD.  
As previously discussed, Pianta et al.’s (1996) conceptualization of parent acceptance of ASD 
diagnoses in their children (i.e., open discussion of both the positive and negative aspects of 
parenting a child with ASD, not preoccupied with focusing on the past, motivation to take action 
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in support of their child) corresponds closely to the ACT principles of acceptance, defusion, 
contact with the present moment, and committed action.  Parenting children with ASD involves 
both accepting the negative thoughts and emotions which sometimes occur, as well as 
committing to taking action and working toward values-consistent goals to help the children 
reach their fullest potential.   
Busch (2007) proposed that the ACT core process of defusion may be particularly useful 
to parents of children with ASD, who, largely due to their children’s symptoms, commonly 
report experiencing thoughts such as “my child does not love me”.  If parents are ‘fused’ with 
these types of thoughts, they believe in their literal meaning and are likely to experience 
overwhelming sadness and to doubt their parenting abilities.  Parents of children with ASD may 
also internalize negative societal messages and begin to believe thoughts such as “No matter 
what I do, it will never make a difference for my child” (Busch, 2007).  If parents become fused 
with these unhelpful thoughts instead of recognizing them as merely passing thoughts, they may 
begin to doubt their abilities to support their children, as well as the likelihood that their 
children’s treatments will be effective (Busch, 2007).   
 Many parents of children with ASD demonstrate experiential avoidance when confronted 
with distressing internal or external experiences related to their children (Busch, 2007).  This 
avoidance may represent a maladaptive attempt to cope with the effects of the cognitive fusion 
they experience (Busch, 2007).  For example, many parents of children with ASD have reported 
purposely avoiding bringing their children on public outings such as to the grocery store, 
restaurants, or on play dates due to their own doubts in their parenting abilities and fears that 
their children will be negatively judged by members of the public (Busch, 2007).  In this way, 
parents may allow their own internal experiences (i.e., distressing thoughts, anxiety) to 
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overwhelm them and prevent them from acting in a manner consistent with their values (e.g., 
social inclusion).  The ACT model recommends that instead, parents ‘step back’ and examine 
their thoughts and feelings instead of looking ‘through’ them.  Doing so would allow parents to 
accept their distressing thoughts and feelings and to move forward with values-consistent action 
(e.g., taking their children with ASD for playdates) in the presence of these distressing internal 
experiences. 
 In an empirical examination of the role of acceptance in parents of children with ASD, 
Weiss, Cappadocia, MacMullin, Vieceli, and Lunsky (2012) found that parents’ acceptance of 
their thoughts and emotions related to their children’s ASD was a significant mediator of the 
path between children’s ‘problem behaviours’ (i.e., conduct problems, hyperactivity, self-injury, 
anxiety, ritualistic, and oversensitivity) and parent mental health problems. Specifically, these 
researchers found that as child problem behaviours increased, parents’ acceptance decreased, 
leading to increased psychological distress in parents. It seems that when parents are faced with 
challenging behaviours which cause them to experience distressing thoughts and emotions, some 
may turn to experiential avoidance (i.e., the opposite of acceptance) in an attempt to minimize 
their own distress. However, this avoidance may reduce parents’ openness to experiencing 
positive thoughts and emotions related to their children’s ASD in addition to reducing their 
openness to experiencing negative thoughts and emotions. According to the ACT model, 
decreased acceptance in these parents will also be associated with decreased capacity for 
engaging in values-consistent behaviours (Luoma et al., 2007) to support themselves and their 
children.   
The tendency of some parents to use multiple treatments for their children regardless of 
empirical support (i.e., the ‘shotgun’ approach; Drouillard, 2012) may represent an alternative 
TREATMENT SELECTION                                                                                        36 
 
form of experiential avoidance.  In this case, these parents may use many treatments with their 
children in order to avoid the difficult emotions associated with making decisions about their 
children’s treatment, and in recognizing ASD as an enduring aspect of their children’s lives 
(Busch, 2007).  Furthermore, the ACT concept of values may also have implications for 
treatment selection among parents of children with ASD in that values are ‘big picture’ life 
directions which can never be fully attained (e.g., improving potential).  In this regard, parents of 
children with ASD may hold the value of improving their children’s potential, which could lead 
to more discrete goals for values-consistent committed action (e.g., selecting evidence-based 
treatments, actively participating in their children’s treatments). 
Limitations of Previous Studies 
 The studies reviewed above represent significant contributions to the body of literature 
examining feasible methods of promoting positive outcomes in individuals and groups through 
ACT.  Furthermore, results from these studies provide preliminary support for supplementing 
psychoeducation with ACT as an effective means of increasing willingness to use evidence-
based treatments among parents of children with ASD.    
These studies have limitations which should be addressed in future research, despite their 
important contributions.  In Blackledge and Hayes’ (2006) study of ACT with parents of children 
with ASD, it may have been more difficult to determine whether ACT-specific processes were 
responsible for the noted improvements due to the small sample size (i.e., 20 participants) and 
lack of a control group for comparison. Similarly, the overall small sample size in 
Kowalkowski’s (2013) study (i.e., 13 parents in the ACT condition), high number of measures, 
and high attrition rate in the support group resulted in significantly decreased statistical power 
and prevented between-groups comparisons.  Direct comparison between groups may also have 
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been difficult in this study as the ACT groups and control support groups were led by different 
facilitators. Participants in this study missed an average of one out of eight sessions over the 
course of treatment, leading to heterogeneity of experiences even within treatment conditions, as 
well as difficulty obtaining data at post-treatment and follow-up (Kowalkowski, 2013). Further, 
in Gould et al.’s (2018) study, the sample size of only three mothers and failure to monitor 
treatment integrity make it difficult to determine the extent to which results may generalize to the 
broader population of parents of children with ASD and the extent to which observed changes 
were due to the treatment protocol developed.  
 With respect to demonstrating the applicability of ACT to increasing willingness to use 
evidence-based practices, studies by Luoma and colleagues (2007) and Varra and colleagues 
(2008) also have important limitations.  These include the lack of comparable control group 
(Luoma et al., 2007), control for facilitator skills (Varra et al., 2008), and measure of knowledge 
retained (Varra et al., 2008).  Preliminary evidence from these studies that ACT has the potential 
to increase individuals’ willingness to select evidence-based treatments through increasing 
acceptance and decreasing cognitive fusion would be greatly strengthened by addressing these 
limitations in future research.   
The Present Study 
 The purpose of the present randomized pilot feasibility trial was to investigate the 
potential benefits of incorporating ACT components into a standard one-day educational 
workshop on selecting treatments for children with ASD for increasing parents’ willingness to 
use evidence-based treatments with their children with ASD.  Participants were randomized to 
either the ACT workshop group or the Support workshop group. Measures of treatment selection 
knowledge, willingness to select evidence-based treatments, and ACT processes (i.e., 
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acceptance, cognitive fusion) were completed at preworkshop, postworkshop, and three-month 
follow-up. Parent feedback was also collected at postworkshop and follow-up via open-ended 
items embedded in study measures (Creswell, Plano Clark, Gutmann, & Hanson, 2003) in order 
to allow for a richer understanding of the study results by generating additional insights from 
parents’ responses (Creswell et al., 2003; Hammarberg, Kirkman, & de Lacey, 2016).  
Two parents of children with ASD acted as Parent Advisors in planning the study, 
recruiting participants, interpreting quantitative and qualitative results, identifying study 
implications and limitations, and making recommendations for future research. ASD research 
has a proud history of parent involvement (e.g., Wiener, 2016) and Parent Advisors continue to 
have an important voice in ASD research currently being conducted at highly regarded 
organizations such as the Autism Research Centre (Holland Bloorview Kids Rehabilitation 
Hospital, 2017). Involvement of Parent Advisors in research is consistent with calls for increased 
patient and public stakeholder involvement in health and social services research (e.g., Borup, 
Friis Bach, Schmiegelow, Wallach-Hildemoes, Jannik Bjerrum, & Westergaard, 2015).  
Parent Advisors for the present study contributed unique and critical perspectives. In 
addition to having children with ASD, they were also employed in the ASD field, actively 
involved in the local ASD community, and known as ‘champions for ASD’ in their respective 
communities. Furthermore, the Parent Advisor for the Toronto workshops had previous training 
and experience in facilitating ACT groups with parents of children with ASD. Including Parent 
Advisors represents an approach to research in which stakeholders actively collaborate in 
research to maximize the validity and utility of the results obtained for the population of interest 
(Whyte, Greenwood, & Lazes, 1989). These methods also lead to improved knowledge 
translation and implementation of recommendations (Fletcher-Watson et al., 2018).    
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Research Questions and Hypotheses  
Research question 1: How will acceptance, cognitive fusion, and willingness to select 
evidence-based treatments change over time within and between the workshop groups? The 
primary purpose of the present study was to examine the potential benefits of the ACT workshop 
in terms of increasing acceptance (i.e., parents’ willingness to experience both positive and 
negative thoughts and emotions related to their children’s diagnoses of ASD), decreasing 
cognitive fusion (i.e., parents’ tendency to buy into and get stuck on particular thoughts about 
their children’s diagnoses of ASD), and increasing willingness to select evidence-based 
treatments in a community sample of parents of children with ASD, compared to the Support 
workshop. In previous studies with parents of children with ASD, group ACT interventions have 
been associated with increased acceptance and decreased cognitive fusion in participants 
(Blackledge & Hayes, 2006; Fung et al., 2018). Therefore, it was of interest to study whether 
embedding ACT exercises within an educational workshop would be associated with similar 
increases in acceptance and decreases in cognitive fusion over time, compared to a workshop 
embedding general parent support and discussion within the same treatment-related information. 
Limitations of previous studies were addressed by evaluating the ACT workshop against a 
similar workshop without ACT content, having the same facilitators lead both types of 
workshop, randomizing participants to workshop groups, and measuring fidelity within each 
workshop.  
Hypothesis 1a. Acceptance was expected to differ significantly over time by workshop 
group, with ACT group participants showing greater increases in acceptance over time than 
Support group participants.  
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Hypothesis 1b. Cognitive fusion was expected to differ significantly over time by 
workshop group, with ACT group participants showing greater decreases in cognitive fusion 
over time than Support group participants.  
Previous studies have further demonstrated that workshops comprised of both education 
and ACT training for addictions counsellors have been associated with increased willingness to 
use evidence-based treatments with their clients (Luoma et al., 2007; Varra et al., 2008). 
Combining ACT training with information about evidence-based diabetes self-management 
techniques has also been shown to be associated with greater adoption of these practices by 
adults with type II diabetes (Gregg, Callaghan, Hayes, & Glenn-Lawson, 2007). In each of these 
studies, participants’ reported willingness to use evidence-based treatments and their adoption of 
evidence-based treatments did not increase in the information-only control groups (Gregg et al., 
2007; Luoma et al., 2007; Varra et al., 2008).  Therefore, the present study sought to investigate 
whether a workshop specifically targeting acceptance and cognitive fusion while simultaneously 
presenting parents with information about ASD treatment selection would be associated with 
increased willingness to select evidence-based treatments over time, compared to an intervention 
presenting the same treatment-related information with general parent support and discussion.  
Hypothesis 1c. Willingness to select evidence-based treatments was expected to differ 
significantly over time by workshop group, with ACT group participants showing greater 
increases in willingness to select evidence-based treatments over time than Support group 
participants.  
Research question 2: How will acceptance and cognitive fusion change between 
postworkshop and follow-up? In a previous study by Varra and colleagues (2008), changes in 
ACT process variables such as acceptance and cognitive fusion were found to continue in 
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expected directions even months after completion of an ACT workshop by addictions 
counsellors. In participants who completed an educational workshop, however, acceptance and 
cognitive fusion were not found to significantly change over time (Varra et al., 2008). The 
present study sought to examine whether ACT workshop participants would demonstrate 
continued increases in acceptance and decreases in cognitive fusion three months following 
completion of the workshop.  
Hypothesis 2a. Acceptance was expected to continue to increase between postworkshop 
and follow-up within the ACT workshop group.  
Hypothesis 2b. Acceptance was not expected to change significantly between 
postworkshop and follow-up within the Support workshop group.  
Hypothesis 2c. Cognitive fusion was expected to continue to decrease between 
postworkshop and follow-up within the ACT workshop group.    
Hypothesis 2d. Cognitive fusion was not expected to change significantly between 
postworkshop and follow-up within the Support workshop group. 
Research question 3: Will the workshops result in greater knowledge of ASD 
treatment selection? Educational workshops supplemented with ACT exercises have been 
associated with significant increases in knowledge (Gregg et al., 2007). Furthermore, Gregg and 
colleagues (2007) found that the gains observed in participants who completed an educational 
workshop with ACT were comparable to gains observed in participants who completed an 
education-only workshop. Therefore, the present study investigated whether parents’ treatment 
selection knowledge increased significantly from preworkshop to postworkshop, as well as 
whether these gains were maintained at three-month follow-up.  
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Hypothesis 3a. Treatment selection knowledge was expected to increase significantly 
from preworkshop to postworkshop in both the ACT group and the Support group.  
Hypothesis 3b. Increases in treatment selection knowledge were expected to be 
maintained from postworkshop to follow-up in both the ACT group and the Support group.  
Research question 4: Will acceptance and cognitive fusion moderate the relation 
between participants’ treatment selection knowledge and their willingness to select 
evidence-based treatments? Acceptance and cognitive fusion are thought to be two primary 
mechanisms of change in the ACT model (e.g., Hayes, Strosahl, & Wilson, 2003). Previous 
research investigating ACT groups with parents of children with ASD has suggested that 
changes in acceptance and cognitive fusion appear to predict improvement in parents’ mental 
health (Blackledge & Hayes, 2006; Fung et al., 2018). Studies have also found that changes in 
acceptance and cognitive fusion predict the impact of combined ACT with education workshops 
on changes in both reported willingness to use evidence-based treatments and actual use of 
evidence-based treatments (Gregg et al., 2007; Varra et al., 2008). The present study examined 
the potential role of acceptance and cognitive fusion in moderating the relation between parents’ 
treatment selection knowledge and their willingness to select evidence-based treatments for their 
children with ASD at postworkshop and follow-up time points.  
Hypothesis 4a. Acceptance was expected to significantly moderate the relation between 
treatment selection knowledge and willingness to select evidence-based treatments at 
postworkshop, such that the relation between parents’ treatment selection knowledge and their 
willingness to select evidence-based treatments would vary depending on their levels of 
acceptance. 
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Hypothesis 4b. Acceptance was expected to significantly moderate the relation between 
treatment selection knowledge and willingness to select evidence-based treatments at follow-up, 
such that the relation between parents’ treatment selection knowledge and their willingness to 
select evidence-based treatments would vary depending on their levels of acceptance.  
 Hypothesis 4c. Cognitive fusion was expected to significantly moderate the relation 
between treatment selection knowledge and willingness to select evidence-based treatments at 
postworkshop, such that the relation between parents’ treatment selection knowledge and their 
willingness to select evidence-based treatments would vary depending on their levels of 
cognitive fusion. 
 Hypothesis 4d. Cognitive fusion was expected to significantly moderate the relation 
between treatment selection knowledge and willingness to select evidence-based treatments at 
follow-up, such that the relation between parents’ treatment selection knowledge and their 
willingness to select evidence-based treatments would vary depending on their levels of 
cognitive fusion.  
Research question 5: What feedback do parents have regarding their experiences 
during the workshop? A qualitative research question was also developed to further explore 
parents’ experiences during the workshop in terms of their most liked aspects, least liked aspects, 
suggestions for future changes, and any additional feedback they wanted to share. As both the 
ACT and Support workshops were designed for the purposes of the present study and have not 
previously been studied, participants’ qualitative feedback was elicited through the Workshop 
Satisfaction Survey. The intention of these research questions was to inform future research on 
these types of workshops. Thus, although no specific hypotheses existed due to the novel nature 
of the workshops, parents’ qualitative responses to these questions were of interest, as well as 
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whether parent feedback were similar or distinct between the ACT workshop and the Support 
workshop.  
Research question 6: What feedback do parents have regarding their experiences 
between postworkshop and follow-up? A qualitative research question was also developed to 
further explore parents’ experiences over the three months following the workshop in terms of 
the impact of the workshop on their lives, the most important thing they learned in the workshop, 
changes in their attitudes and behaviours after completing the workshop, how the workshop 
benefitted their children, and any additional feedback they wanted to share. As these workshops 
were original to the present study and, thus, have not been researched before, parents’ qualitative 
responses were elicited through the Follow-up Experiences Survey. Again, no specific research 
hypotheses were formulated as these workshops had yet to be studied. Parents’ qualitative 
responses to these questions, as well as whether differences emerged between workshop 
conditions, were believed to be valuable for informing future workshops. 
  




Participants in the present study were parents of children with ASD from the Windsor 
and Toronto areas. After receiving clearance from the University of Windsor Research Ethics 
Board and relevant community organizations, participants in Windsor were recruited in person, 
over the telephone, and over the Internet through various ASD, disability, and parenting-related 
groups, organizations, and events in the community.  The researcher attended several community 
workshops and events held by three local organizations (i.e., Autism Ontario, Autism Services 
Incorporated, and The Summit Centre for Preschool Children with Autism) to distribute study 
flyers and present parents with a brief description of the study and what would be asked of 
participants. As the researcher and supervisor for the present study are employed in ASD-related 
organizations in the Windsor and Toronto areas, participants were assured during recruitment 
that participation in the study would not affect the services their children received at these 
organizations. As well, the supervisor for the study, Clinical Director of the Summit Centre for 
Preschool Children with Autism, was not directly involved in study recruitment. 
If participants were recruited in-person, they were asked to provide their telephone 
number or email address to be contacted by the researcher at a later date with more details about 
the study. If participants were recruited through emailed flyers, they were asked to contact the 
researcher by telephone or email for more details about the study. The researcher made three 
attempts to reach participants who provided their contact information. Despite these recruitment 
efforts, only 23 participants were recruited from the Windsor area. Therefore, a decision was 
made to expand recruitment to the Toronto area in an effort to achieve the desired sample size 
for the present study.   
TREATMENT SELECTION                                                                                        46 
 
Recruitment in the Toronto area consisted of two large community organizations (i.e., 
Autism Ontario – Toronto Chapter and Extend-A-Family) emailing study flyers to their 
membership, along with word of mouth recruiting and snowball sampling (Atkinson & Flint, 
2001). Interested participants were asked to contact the researcher by telephone or email, at 
which time they were provided with additional information about the study and what would be 
required of participants. Following these expanded recruitment efforts, an additional 34 parents 
were recruited from the Toronto area. Refer to Figure 1 to see the participant flow through each 
phase of the study.   
To be included in the study, interested individuals had to meet several criteria: they had to 
be (a) the biological, step, adoptive, foster parent or legal guardian of a child with ASD; (b) able 
to speak, read, and write in English; (c) able to attend a one-day (6.5-hour) workshop and 
complete pre, post, and follow-up questionnaires; and (d) they had to agree to be randomly 
assigned to either of the two workshops. In an effort to maximize the potential pool of 
participants, there were no exclusion criteria for child age or time since diagnosis. Research has 
demonstrated that child age and time since diagnosis are not correlated with parents’ ASD-
related acceptance, as parents’ levels of acceptance fluctuate at various stages of their children’s 
development (Milshtein, Yirmiya, Oppenheim, Koren-Karie, & Levi, 2010). Furthermore, 
treatment selection is an ongoing and evolving process throughout the lifespan. Thus, including 
parents with children of various ages and time since diagnosis was of interest in the present 
study. These inclusion and exclusion criteria were deemed appropriate given that the current
































Figure 1.  CONSORT diagram of participant flow through each phase of the study
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study aimed to prioritize external validity in this community-based pilot feasibility trial.  
Participants were offered a $5.00 Tim Horton’s gift card at postworkshop as a token of 
thanks for participating in the present study. Participants were also offered a $10.00 Tim 
Horton’s gift card upon completion of the online questionnaires at three-month follow-up (i.e., 
each participant who completed the study was offered $15 Tim Horton’s credit in total).  This 
value was thought to demonstrate recognition and gratitude for parents’ participation in the 
study, while not coercing participation.  
The final sample for the present study consisted of 23 parents of children with ASD. 
Windsor data collection consisted of 8 participants (5 in the ACT workshop and 3 in the Support 
workshop), while Toronto data collection consisted of 15 participants (8 in the ACT workshop 
and 7 in the Support workshop).  Participants were predominantly married mothers, representing 
a diverse sample of ethnic backgrounds. Most participants had college, university, or post-
graduate degrees, and most were either unemployed or working part-time. Refer to Table 2 for 
additional information regarding participants’ gender, ethnic background, marital status, and 
educational status. Participants ranged in age from 27 to 65 years (M = 43.74, SD = 11.64). Their 
reported annual household incomes ranged from $12,000 to $400,000 CDN (M = $60,931.82, SD 
= 80 153.76).  
The children of the participants ranged in age from 4 to 26 years (M = 10.65, SD = 6.73) 
and their time since diagnosis ranged from 1 year to 18 years (M = 5.78 years, SD = 5.34). They 
were predominantly males, and diverse ethnic backgrounds were represented. Participants were 
also asked to bring a copy of their children’s diagnostic reports to the workshop in order to allow   
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Table 2                             
Participant Demographics 
Characteristic N % 
Gender   
     Female 18 78.30 
     Male   5 21.70 
Ethnic Background   
     White   9 39.10 
     Filipino   3 13.00 
     South Asian   3 13.00 
     Arab   2   8.70 
     Black   2   8.70 
     Chinese   3 10.34 
     Aboriginal    1   4.30 
     Other   1   4.30 
Marital Status   
     Married 16 69.60 
     Single   5 21.70 
     Separated/Divorced   2   8.70 
Level of Education   
     College/University/Post-Graduate                           16 69.60 
     Some College/University   6 26.10 
     High School or Less   1   4.30 
Employment Status   
     Unemployed   9 39.10 
     Part Time   8 34.80 
     Full Time   4 17.40 
     Retired   2   8.70 
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for verification of diagnoses and recording of children’s diagnostic information. Of the 29 
parents who participated in the workshops, 3 did not bring a diagnostic letter or report for their 
children. In these cases, parents were asked to report the name of the diagnosing clinician and the 
diagnosis received by the child. Children had predominantly received diagnoses of Autism 
Spectrum Disorder (ASD). See Table 3 for additional information regarding the children’s 
gender, ethnic background, and official diagnoses. 
Measures 
 The study involved the use of ten measures designed to assess demographic variables, 
process-level variables, and outcome variables. See Appendix A for permissions to use and 
modify measures for the purposes of the present study.     
Demographic Questionnaire.  This 14-item questionnaire was designed specifically for 
the present study and contained items regarding demographic variables of the parent and relevant 
child (i.e., age, annual income, gender, education, employment status, marital status, 
race/ethnicity, year of child diagnosis; see Appendix B for a copy of the Demographic 
Questionnaire.   
Evidence-based Practice Attitudes Scale (Parent; Aarons, 2004).  The Evidence-
Based Practice Attitude Scale (Parent) (EBPAS-P) was used in the present study as a measure of 
parents’ willingness to use evidence-based interventions with their children with ASD.  For the 
purposes of the present study, the 15 original items were modified to relate specifically to 
parents’ willingness to use evidence-based treatments with their children (e.g., “I am willing to 
try new types of therapy/interventions even if they require me to follow a manual” was changed 
to “I am willing to try new types of therapy/interventions with my child even if they require me   
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Table 3                     
Children Demographic Information 
Characteristic N % 
Gender   
     Male 17 73.90 
     Female   6 26.10 
Ethnic Background   
     White   9 39.10 
     Filipino   3 13.00 
     South Asian   3 13.00 
     Arab   2   8.70 
     Black   2   8.70 
     Chinese   2   8.70 
     Other   2   8.70 
Diagnosis   
     Autism Spectrum Disorder 21 91.30 
     Autistic Disorder   1   4.35 
     PDD-NOS   1   4.35 
*Note. PDD-NOS = Pervasive Developmental Disorder Not Otherwise Specified. 
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or the treatment provider to follow a manual”). Similar modifications have been used in order to 
assess willingness to adopt evidence-based practices among teachers (Monahan, McDaniel, 
George, & Weist, 2014).   
The EBPAS-P is a 15-item self-report measure on which participants are asked to rate the 
extent to which they agree with statements regarding the use of evidence-based practices.  Each 
item (e.g., “I am willing to use new and different types of therapy/interventions developed by 
researchers”) is rated on a Likert-type scale ranging from 0 (i.e., “not at all”) to 4 (i.e., “to a very 
great extent”).  The EBPAS-P yields an overall score representing parents’ overall willingness to 
use evidence-based practices with their children, as well as scores on each of the four subscales 
(i.e., Appeal, Requirements, Openness, and Divergence). For the purposes of this study, 
participants’ total scores on this measure were used to measure their willingness to select 
evidence-based treatments. Within the present study, the EBPAS-P demonstrated adequate 
internal reliability at preworkshop (α = .82), postworkshop (α = .73), and follow-up time points 
(α = .73).  
The original EBPAS was developed by Aarons (2004) to explore community mental 
health service providers’ attitudes toward the use of evidence-based practices.  The EBPAS is 
comprised of four subscales which are said to represent four distinct aspects of professionals’ 
attitudes toward the use of evidence-based practices: (a) the Appeal subscale, measuring “the 
extent to which the service provider would adopt a new practice if it is intuitively appealing, 
makes sense, could be used correctly, or is being used by colleagues who are happy with it” (pp. 
67); (b) the Requirements subscale, measuring “the extent to which the provider would adopt a 
new practice if it is required by an agency, supervisor, or state” (pp. 67); (c) the Openness 
subscale, measuring “the extent to which the provider is generally open to trying new 
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interventions and would be willing to try or use new types of therapy” (pp. 67); and (d) the 
Divergence subscale, measuring “the extent to which the provider perceives research-based 
interventions as not clinically-useful and less important than clinical experience” (pp. 67). 
The EBPAS was developed on the basis of a thorough review of the literature on 
evidence-based practice adoption, as well as consultation with mental health service providers 
with experience implementing evidence-based practice protocols.  Participants in the initial 
validation study were 322 mental health professionals (i.e., marriage and family therapists, social 
workers, psychologists, psychiatrists) working in publicly funded community mental health 
settings for children, adolescents, and their families in San Diego.   
The initial validation study provided evidence for good internal consistency of the overall 
EBPAS (Cronbach’s alpha = .77), as well as for the Appeal subscale (α = .80), Requirements 
subscale (α = .90), Openness subscale (α = .78), and Divergence subscale (α = .59).  
Additionally, preliminary support for the ecological validity of the EBPAS was provided by this 
initial validation study, as participants were ‘real world’ mental health service providers from 
diverse educational backgrounds and fields of specialization working in publicly funded 
organizations.  In an additional validation study (Aarons, Glisson, Hoagwood, Kelleher, 
Landsverk, & Cafri, 2010), content validity of the EBPAS was assessed by asking an expert 
panel of six mental health service providers to rate the relevance, importance, and 
representativeness of the specific construct (i.e., appeal, requirements, openness, divergence) 
each item seeks to assess on a scale from 1 (i.e., “not at all relevant”) to 5 (“relevant to a very 
great extent”).  Across all items, mean expert ratings of relevance ranged from 3.33 to 4.67, 
mean expert ratings of importance ranged from 3.17 to 4.67, and mean expert ratings of 
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representativeness ranged from 3.17 to 4.67, demonstrating content validity of the EBPAS as 
rated by experts.    
Acceptance and Action Questionnaire-II (Autism; Bond et al., 2011).  The 
Acceptance and Action Questionnaire-II (Autism) was also used as a measure in the study.  For 
the purposes of the present study, the seven original AAQ-II items were modified to relate 
specifically to parents’ acceptance with respect to their children having ASD (e.g., “I’m afraid of 
my feelings” was rephrased as “I’m afraid of my feelings toward my child having Autism”).  
Similar modifications have been utilized in order to study psychological flexibility with regard to 
children with ASD (Weiss, Cappadocia, MacMullin, Vieceli, & Lunsky, 2012), children with 
intellectual disabilities (MacDonald, Hastings & Fitzsimons, 2010), diabetes (Gregg, Callaghan, 
Hayes, & Glenn-Lawson, 2007), substance abuse (Luoma, Drake, Hayes, & Kohlenberg, 2011), 
body image (Timko, Juarascioc, Martina, Faherty, & Kalodner, 2014), chronic pain (McCracken, 
Vowles, & Eccleston, 2004), and social anxiety (MacKenzie & Kocovski, 2010).    
The AAQ-II-A consists of 7 items designed to measure parents’ acceptance with respect 
to their children’s ASD (e.g., “My emotions about my child having Autism cause problems in 
my life”), which are rated on a 7-point Likert scale ranging from 1 (i.e., “never true”) to 7 (i.e., 
“always true”).  Scores on the AAQ-II-A are established by summing individuals’ responses 
across the seven items in order to generate a total score ranging from 7 to 49, with higher scores 
representing lower levels of acceptance.  Due to the confusion which can occur as a result of this 
reverse scoring of acceptance, the directionality of each result will be explicitly stated in the 
present study. As this questionnaire is not intended for use as a psychodiagnostic measure, 
‘cutoff’ scores indicating pathological patterns of response have not been identified (Bond et al., 
2011).  For practical purposes, however, the authors noted the range of AAQ-II scores associated 
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with ‘clinically significant’ scores on the Beck Depression Inventory-II, the General Health 
Questionnaire (12 item version), and the Global Severity Index of the Symptom Checklist – 
Revised (90 item version), and found that AAQ-II scores above 24-28 are associated with 
clinically significant scores on these three measures (Bond et al., 2011). Within the present 
study, the AAQ-II-A demonstrated high internal reliability at preworkshop (α = .93), 
postworkshop (α = .96), and follow-up time points (α = .89).  
 The AAQ-II is a commonly used measure of acceptance in ACT research which was 
developed by Bond and colleagues (2011) in response to psychometric limitations within the 
original AAQ, previously the most widely used measure of experiential avoidance (Hayes et al., 
2004).  The AAQ-II is said to measure psychological flexibility (i.e., “the ability to fully contact 
the present moment and the thoughts and feelings it contains without needless defense, and, 
depending upon what the situation affords, persisting in or changing behaviour in the pursuit of 
goals and values” [Bond et al., 2011, pp. 678]).  Although the AAQ-II was originally a 10-item 
measure, the authors have since concluded that the 7-item version of the measure, representing a 
single factor solution, is optimal (Bond et al., 2011).   
This revised AAQ-II was developed on the basis of three studies performed using six 
distinct sample groups with a total of 2816 participants (Bond et al., 2011).  Importantly, the 
AAQ-II was found to correlate highly with the original AAQ (r = .97), but with improved 
psychometric properties.  Across the six samples tested, the AAQ-II had good internal reliability, 
with Cronbach’s alpha coefficients ranging between .78 and .88 (Bond et al., 2011).  Test-retest 
reliability was also evaluated at three-month and twelve-month intervals and was found to be 
good, with correlations of .81 and .79, respectively (Bond et al., 2011), supporting the sensitivity 
of this measure to changes in parents’ acceptance at three-month follow-up.   Scores on the 
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AAQ-II were significantly correlated in expected directions with scores on the White Bear 
Suppression Inventory (r = .63), the Beck Depression Inventory-II (r = .71), and the Beck 
Anxiety Inventory (r = .61), demonstrating good convergent validity (Bond et al., 2011).  
Conversely, scores on the AAQ-II were not associated with scores on the Marlowe-Crowne 
Social Desirability Scale (r = -.09, ns), demonstrating good divergent validity between these two 
constructs (Bond et al., 2011).  
Cognitive Fusion Questionnaire (Autism; Gillanders et al., 2014).  The Cognitive 
Fusion Questionnaire (Autism) (CFQ-A) was used as an additional process measure in the 
present study.  For the purposes of the present study, the seven original CFQ items were 
modified to relate specifically to parents’ fusion with their thoughts about their children having 
ASD (e.g., “I struggle with my thoughts” was rephrased as “I struggle with my thoughts about 
my child having Autism”).  Similar modifications have been utilized in order to study cognitive 
fusion in adolescent populations (Solé, Racine, Castarlenas, Vega, Tomé-Pires, Jensen, & Miro, 
2015).  The CFQ-A consists of 7 items designed to measure parents’ fusion with their thoughts 
about their children with ASD (e.g., “I get upset with myself for having certain thoughts about 
my child having Autism”), which are rated on a 7-point Likert scale ranging from 1 (i.e., “never 
true”) to 7 (i.e., “always true”).  Scores on the CFQ are established by summing individuals’ 
responses across the seven items in order to generate a total score ranging from 7 to 49, with 
higher scores representing greater cognitive fusion. Within the present study, the CFQ-A 
demonstrated high internal reliability at preworkshop (α = .95), postworkshop (α = .97), and 
follow-up time points (α = .93).  
 The original CFQ (Gillanders et al., 2014) was developed to address limitations of the 
widely used Automatic Thoughts Questionnaire (ATQ; Hollon & Kendall, 1980), which has 
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been said to capture only one aspect of cognitive fusion: believability of automatic thoughts 
(Gillanders et al., 2014).  In contrast, the CFQ captures additional aspects of cognitive fusion, 
such as attempted thought control, rumination, emotional arousal in response to thoughts, 
perspective taking difficulties, and thought-dictated behaviour (Gillanders et al., 2014).  
Additionally, the ATQ was originally developed to measure cognitive fusion in individuals with 
depression (Hollon & Kendall, 1980), whereas the CFQ is intended for use with many 
populations in a variety of settings (Gillanders et al., 2014).  CFQ items were clinically derived 
by a group of expert ACT practitioners based on their knowledge and experience.       
 Construct validity of the CFQ has been demonstrated through a large, multisite validation 
study in which individuals’ scores on the CFQ were highly correlated in expected directions with 
their scores on measures of mindfulness, distress, burnout, psychological flexibility, rumination, 
and automatic thought frequency (Gillanders et al., 2014).  In this same study, individuals’ scores 
on the CFQ were also found to be moderately correlated with measures of life satisfaction and 
quality of life (Gillanders et al., 2014).  The CFQ has demonstrated good internal reliability, with 
a Cronbach’s alpha coefficient of .87 (McCracken, DaSilva, Skillicorn, & Doherty, 2014). Test-
retest reliability was also evaluated at a one-month interval and was found to be good, with a 
significant correlation of .81 (Gillanders et al., 2014). 
 The CFQ has also been demonstrated to be sensitive to treatment effects in a community 
sample, with scores on the CFQ at pre-intervention and 3-month follow-up significantly 
impacted by participation in an ACT training group (partial η² = .150), representing a large effect 
(Gillanders et al., 2014).  Furthermore, changes in scores on the CFQ were demonstrated to 
statistically mediate the impact of the ACT training program on individuals’ mental health 
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ratings (Gillanders et al., 2014), demonstrating that the CFQ is appropriate for use as a process 
measure within a community intervention study. 
Mindful Attention Awareness Scale (Brown & Ryan, 2003). The Mindful Attention 
Awareness Scale (MAAS) served as a measure of parents’ trait mindfulness before completing 
workshops in the present study. This measure was included in the present study in order to 
control for possible effects of trait mindfulness, if found to be significantly correlated with any 
variables of interest. The MAAS (Brown & Ryan, 2003) is comprised of 15 statements (e.g., “I 
tend to walk quickly to get where I’m going without paying attention to what I experience along 
the way”) which individuals are asked to rate on a Likert-type scale ranging from 1 (i.e., “almost 
always”) to 6 (i.e., “almost never”) with respect to how often each statement is true for them. 
Higher MAAS scores denote greater awareness of internal experiences and external behaviours 
(i.e., greater levels of mindfulness). The MAAS demonstrated good internal reliability (i.e., α = 
.89; MacKillop & Anderson, 2007). Construct validity is supported by significant positive 
correlations between MAAS scores and measures of positive affect and life satisfaction (Brown 
& Ryan, 2003), as well as direct participant rating of their levels of mindfulness (Brown & Ryan, 
2003).  MAAS scores have also been demonstrated to correlate negatively with stress, anxiety, 
and depression and to correlate positively with quality of life in a sample of parents of children 
with ASD (Rayan & Ahmad, 2018). Within the present study, the MAAS demonstrated good 
internal reliability (α = .87).  
Marlowe-Crowne Social Desirability Scale- Short Form (Strahan & Gerbasi, 1972).  
The Marlowe-Crowne Social Desirability Scale- Short Form (MCSDS-SF) was included in the 
present study in order to control for possible social desirability effects, if found to be 
significantly correlated with any variables of interest. The MCSDS-SF (Strahan & Gerbasi, 
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1972) is comprised of 10 statements which individuals are asked to rate as “true” or “false” with 
respect to themselves (e.g., “I’m always willing to admit when I make a mistake”).  This measure 
has demonstrated good convergent validity with the full 33-item MCSDS (Crowne & Marlowe, 
1960), r = .80 (Strahan & Gerbasi, 1972).  The MCSDS-SF also has adequate internal reliability, 
with reliability coefficients ranging from .59 to .70 when used with differing populations 
(Strahan & Gerbasi, 1972). Within the present study, the MCSDS-SF had adequate internal 
reliability (α = .65).  
Treatment Selection Knowledge Quiz.  The Treatment Selection Knowledge Quiz 
(TSKQ) was developed by the researcher, Parent Advisor, and study supervisor specifically for 
the purposes of the current study to serve as a pre/post assessment of parents’ retention of the 
information outlined in the workshops (see Appendix C for a copy of this measure). The TSKQ 
consists of ten multiple choice items assessing parents’ achievement of learning objectives set 
for the treatment selection education portion of the workshops, including:  (a) recognition of 
widespread misinformation about ASD and ASD treatments, (b) understanding the term 
‘evidence-based treatment’ as it relates to ASD, (c) understanding the benefits and drawbacks of 
evidence-based treatments, (d) understanding the current evidence behind popular ASD 
treatment approaches, (e) knowledge of how to find quality information about evidence-based 
ASD treatments, (f) knowledge of how to critique/identify quality of ASD information in popular 
media, (g) knowledge of what to ask ASD treatment providers when selecting treatments, and (h) 
knowledge of parents’ rights in relation to their children’s treatment. This quiz was scored in 
terms of the total number of correct responses out of a possible 10 correct responses. Within the 
present study, the TSKQ demonstrated acceptable internal reliability at preworkshop (α = .75), 
postworkshop (α = .76), and follow-up (α = .71) time points.   
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Workshop Satisfaction Survey (Kowalkowski, 2013).  This brief questionnaire is 
comprised of eight items designed to assess participants’ overall satisfaction with the workshop 
they attended.  The original Workshop Satisfaction Survey (WSS; Kowalkowski, 2013) was 
modified for use in the present study to assess the satisfaction of parents of children with ASD 
who had participated in either the ACT workshop or the Support workshop. Specifically, the 
WSS asks participants to rate five aspects of their experiences: (a) the usefulness of the 
workshop, (b) the helpfulness of the facilitators, (c) the helpfulness of the topics discussed, (d) 
the likelihood that they would recommend the workshop to others, and (e) their overall 
satisfaction with the workshop, on a Likert-type scale ranging from 1 (i.e., “not at all”) to 5 (i.e., 
“very much”).  Participants’ responses to these items are summed to yield a total score for 
workshop satisfaction. Within the present study, the WSS demonstrated high internal reliability 
(α = .93).  
For the purposes of the present study, three additional open-ended items were embedded 
within the WSS in order to ascertain feedback about participants’ experiences during the 
workshop. Specifically, participants are asked to describe what they liked most about the 
workshop, what they liked least about the workshop, and their recommendations for improving 
the workshop in the future.  At the end of the survey, participants are also provided with space to 
add any additional comments about the workshop. 
Group Cohesiveness Scale (Wongpakaran et al., 2013). The Group Cohesiveness 
Scale (GCS) served as a measure of parents’ perceived connection and rapport with other parents 
in their workshop group. This measure was included in the present study in order to control for 
possible effects of group cohesion, if found to be significantly correlated with any variables of 
interest. The GCS (Wongpakaran et al., 2013) is comprised of 7 statements (e.g., “In my group, 
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we trust each other”) which individuals are asked to rate on a Likert-type scale ranging from 1 
(i.e., “strongly disagree”) to 5 (i.e., “strongly agree”). Participants’ ratings of each item are 
summed to yield a total score, with higher GCS total scores indicating higher levels of group 
cohesiveness. The GCS demonstrated good internal reliability in the initial validation study (α= 
.87; Wongpakaran et al., 2013). Evidence of concurrent validity was provided by significant 
positive correlations between GSC total scores and participants’ ratings of group benefit (r = .71) 
and cohesion to therapist (r = .71; Wongpakaran et al., 2013). Within the present study, the 
Group Cohesiveness Scale demonstrated good internal reliability (α = .89).  
Follow-up Experiences Survey. The Follow-up Experiences Survey (FES) was 
developed by the researcher, Parent Advisor, and study supervisor specifically for the purposes 
of the present study. The FES is comprised of five open-ended qualitative items to which 
participants were invited to respond at three-month follow-up. Specifically, participants were 
asked how the workshop impacted their lives in the three months since the workshop, what they 
viewed as the most important thing they learned in the workshop, how their attitudes and 
behaviours changed as a result of participating in the workshop, how their children benefitted 
from their participation in the workshop, and what they would most like researchers to know 
about their experiences following the workshop. See Appendix D for a copy of the FES.  
ACT Workshop Fidelity Measure. The ACT Workshop Fidelity Measure was 
developed specifically for the purposes of the present study by the researcher, Parent Advisor, 
and supervisor. This measure is comprised of 14 items denoting ACT workshop learning 
objectives (e.g., “development of concrete goals and commitment to engaging in values-
consistent behaviours”) which the assessor was asked to rate on a 7-point Likert scale ranging 
from 1 (i.e., “not at all covered”) to 7 (i.e., “extremely thoroughly covered”) in terms of how 
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well each topic was covered in the workshop. Fidelity scores are calculated as the ratio of total 
fidelity score to the total possible score (Moncher & Prinz, 1991). See Appendix E for a copy of 
this measure.  
Support Workshop Fidelity Measure. The Support Workshop Fidelity Measure was 
developed specifically for the purposes of the present study by the researcher, Parent Advisor, 
and supervisor. This measure is comprised of 11 items denoting Support workshop learning 
objectives (e.g., “sharing of experiences with other workshop participants”) which the assessor 
was asked to rate on a 7-point Likert scale ranging from 1 (i.e., “not at all covered”) to 7 (i.e., 
“extremely thoroughly covered”) in terms of how well each topic was covered in the workshop. 
Fidelity scores are calculated as the ratio of total fidelity score to the total possible score 
(Moncher & Prinz, 1991). See Appendix F for a copy of this measure.  
Procedure 
 The aim of this randomized pilot feasibility trial was to evaluate the potential benefits of 
the ACT workshop (comprised of treatment-related information and ACT content) for increasing 
acceptance, decreasing cognitive fusion, and increasing willingness to use evidence-based 
practices in a community sample of parents of children with ASD. The ACT workshop was 
evaluated against the Support workshop (comprised of treatment-related information and general 
parent support) which acted as the control group. Participants were randomly assigned to one of 
these two groups and completed study measures at three time points (i.e., preworkshop, 
postworkshop, and 3-month follow-up).     
Overview of procedure.  Parents who provided their email or telephone number during 
recruitment were contacted through their preferred means (i.e., email or telephone), screened for 
inclusion criteria, and presented with information about the study.  This information included an 
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overview of what participation in the study entailed, with special attention to the participant 
randomization process, as well as facilitator qualifications and incentives for participation.  After 
receiving this information, interested parents were randomly assigned a workshop to attend.  A 
computerized random number generator was used to complete a modified simple randomization 
procedure which resulted in participants being randomly assigned to two groups of equal size 
(Altman & Bland, 1999; Suresh, 2011).  Specifically, each participant was assigned a number 
using a computerized random number generator.  The participant list was then re-ordered in 
ascending numerical order by these assigned numbers. Afterwards, the half of the participants 
who were randomly assigned the lowest numbers were allocated to the ACT workshop and the 
half of the participants who were randomly assigned the highest numbers were allocated to the 
Support workshop. As the ACT workshop and the Support workshop were each run once in 
Windsor and in Toronto, the randomization procedure was carried out separately in each 
location. 
 Informed consent process.  On the day of the assigned workshop, parents were presented 
with the letter of information and consent form for the study (see Appendix G) in the group 
setting. They were given time to individually review the document as the researcher walked 
around the room to answer any individual questions. The letter of information and consent form 
contained information on procedures which the researcher was aware could influence 
participants’ willingness to participate in the study, including details on what participation in the 
study entailed, the purpose and process of randomization to groups and blinding, and possible 
risks and benefits associated with participation.  The empirical support behind both types of 
workshop was also communicated, although participants were not explicitly told the names or 
identifying details of each workshop in order to reduce potential expectancy effects.  Participants 
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were reminded that they could choose to participate in the other type of workshop at a later time 
if they wished, although no participants elected to participate in the alternative workshop type in 
the present study. After receiving this information and having their questions answered, 
consenting participants signed the form and returned it to the researcher.  At this time, 
participants were also asked to show their children’s diagnostic reports or letters to the 
researcher, who recorded the children’s official diagnoses, dates of the reports/letters, diagnosing 
clinicians, and assessment measures.  The researcher did not keep a copy of any diagnostic 
reports and only used the reports to verify children’s specific diagnoses.  This procedure helped 
to ensure the security of participants’ personal health information. 
Common workshop components.  With the exception of ‘active’ workshop components 
(i.e., ACT elements, parent support elements), the two types of parent workshops were consistent 
in all aspects.  These common details are described below. 
Common educational components of workshops.  The educational aspects of the 
workshop were developed based on a thorough review of the literature on the topics targeted for 
intervention.  Specifically, the information included in the workshops was developed by 
synthesizing information from several large-scale reviews, published studies, and best practice 
guidelines related to ASD treatments (i.e., National Autism Center [NAC], 2011; NAC 2015; 
National Alliance on Mental Illness [NAMI], 2007; National Institute of Mental Health [NIMH], 
2011; Organization for Autism Research [OAR], 2003; Reichow & Volkmar, 2011). As the 
workshop information was based on published sources, the complete workshop outlines cannot 
be included here. However, copies of the workshop manual and slides can be obtained from the 
author upon request. The following specific topics were covered in educational portion of the 
workshops: (a) introduction to ASD, (b) is there a cure for ASD?, (c) what are evidence-based 
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treatments?, (d) importance of evidence-based treatments, (c) cautions about evidence-based 
treatments, (d) research support for popular ASD treatments, (e) findings of the National 
Standards Report (NAC, 2015), (f) how to find evidence-based treatments, (g) evaluating the 
quality of treatment information from different sources, (h) tips for talking to treatment 
providers, and (i) knowing your rights in relation to your child’s treatment.  
Learning objectives for the educational portion of the workshop included: (a) recognition 
of widespread misinformation about ASD and ASD treatments, (b) understanding the term 
‘evidence-based treatment’ as it relates to ASD, (c) understanding the benefits and drawbacks of 
evidence-based treatments, (d) understanding the current evidence behind popular ASD 
treatment approaches, (e) knowledge of how to find quality information about evidence-based 
ASD treatments, (f) knowledge of how to critique and identify the quality of ASD information in 
popular media, (g) knowledge of what to ask ASD treatment providers when selecting 
treatments, and (h) knowledge of parents’ rights in relation to their children’s treatment.  The 
general format of the workshop included direct instruction and group exercises designed to 
increase knowledge of best practices in selecting treatments for children with ASD.  From the 
information gathered through this literature review, an initial outline of the workshop was 
created by the researcher and reviewed by the Parent Advisor for the study, who gave input on 
which topics would be of most interest to parents, how to best communicate the information to 
parents, and how to encourage retention of the information by parents.  
 Setting characteristics.  Workshops were held at local community organizations for 
children with ASD and their families, in locations that were readily accessible by public transit 
and likely familiar to many parents who participated in the study.  Specifically, Windsor 
workshops took place at the main office of the Windsor branch of Autism Ontario, while Toronto 
TREATMENT SELECTION  66 
 
workshops took place at the main office of Extend-A-Family. Use of these locations for the 
purposes of the study was given clearance by the University of Windsor Research Ethics Board, 
as well as by Autism Ontario and Extend-A-Family. All workshops took place in large 
multipurpose rooms which are often used to host community workshops. Rooms were equipped 
with tables and chairs as well as audiovisual equipment.  Refreshments such as coffee, snacks, 
and lunch were provided to participants at the workshop locations.    
 Facilitator characteristics.   The author of this study was a facilitator for all four 
workshops (i.e., both the ACT workshop and the Support workshop in Windsor and Toronto). 
This researcher was a Ph.D.-level Clinical Psychology student from the University of Windsor 
who had experience facilitating groups, had completed an intensive 2-day ACT training 
workshop, and had completed ACT-specific readings (e.g., Hayes & Smith, 2005; Hayes & 
Strosahl, 2004; Hayes, Strosahl, & Wilson, 2003; Torneke, Barnes-Holmes, & Hayes, 2010). The 
2-day ACT training workshop was led by Dr. Steven Hayes, one of the originators of ACT, and 
involved both didactic components and partnered role plays to rehearse techniques and receive 
feedback. Learning objectives included: (a) gaining exposure to the ACT model, (b) practicing 
clinical techniques based on the ACT model, and (c) gaining comfort in using ACT techniques in 
clinical practice (S. Hayes, personal communication, April 9, 2014).  
The co-facilitator for both types of workshop in Windsor was also a Ph.D.-level Clinical 
Psychology student from the University of Windsor who had experience facilitating ACT groups 
and had also completed ACT-specific didactic training and readings (e.g., Hayes, Strosahl, & 
Wilson, 2003; Twohig, 2008). The co-facilitator for both types of workshop in Toronto was a 
mother of an adult with ASD who works as a resource consultant for parents of children with 
disabilities in the Toronto area. She had also completed a 12-week ACT training course at 
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McMaster University and had experience facilitating ACT groups with parents of children with 
ASD. ACT workshops in Windsor and Toronto were supervised by a registered Psychologist 
with experience providing individual ACT and supervising ACT groups in a community setting, 
while the Support groups were supervised by a registered Psychologist with experience 
facilitating educational and support-based groups for children with ASD in a community setting. 
These facilitators and supervisors were deemed appropriate for this study by a Psychologist with 
experience and training in ACT (A. Dufresne, personal communication, March 25, 2015) and a 
Psychologist with experience and training in ACT and working with parents of children with 
ASD (L. Warner, personal communication, February 27, 2015).   
 Workshop timeline.  Each workshop took place over the course of 6.5 hours, including a 
thirty-minute lunch break and two fifteen-minute breaks (one in the morning and one in the 
afternoon).  That is, each workshop involved 5.5 hours of direct instructional and interactive 
contact with participants, including approximately 20 minutes dedicated to data collection.  This 
length of workshop was deemed appropriate for use in the present study as it was comparable to 
that used in similar studies of psychoeducation with ACT (Gregg et al., 2007; Varra et al., 2007) 
and was consistent with the length of other parent workshops commonly held in the community.      
 Data collection.  Data collection for the present study took place at three time points: (a) 
pre-intervention, (b) post-intervention, and (c) follow-up. 
 Preworkshop.  The letter of information/consent form was emailed to participants before 
the day of the workshop in order to allow participants to review study procedures in advance of 
attending the workshop. On the day of the workshop, participants were presented with an 
additional hard copy of the letter of information/consent form, as well as the other preworkshop 
measures, in order to provide detailed instructions and allow participants to ask questions to 
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ensure their understanding of the materials.  It was believed that completing the pre and post 
workshop batteries onsite on the day of the workshop would also be most convenient for study 
participants and help to reduce attrition rates in the present study (Kazdin, 2013).  Initial data 
collection began immediately after participants gave their consent to participate in the study.  
That is, upon handing their signed consent form to the researcher on the day of the workshop, 
participants were given the preworkshop questionnaire battery, consisting of: the demographic 
questionnaire, EBPAS-P, AAQ-II-A, CFQ-A, TSKQ, MAAS, and MCSDS-SF (78 items in 
total).  Questionnaire packages were completed in the workshop room, although participants 
were instructed to complete their packages individually without speaking to each other. 
Questionnaires were also counterbalanaced such that each participant was presented with 
questionnaires in varying orders to reduce group members’ potential influence on one another. 
Participants were instructed to raise their hands if they had any questions, at which time the 
researcher approached them and quietly answered the question. Preliminary pilot testing by the 
Parent Advisor for the study, from which data was not included in this study, indicated that the 
approximate time to complete this questionnaire package was 13 minutes.  Each workshop began 
after all participants had completed and submitted this initial battery.    
Postworkshop.  Upon completion of the workshop, participants were given the 
postworkshop questionnaire battery at the workshop site, consisting of: the EBPAS-P, AAQ-II-
A, CFQ-A, TSKQ, GCS, and WSS (54 items in total), presented in counterbalanced order for 
each participant.  These questionnaires were also completed individually within the large 
workshop room; however, participants were reminded to not speak to each other while 
completing the questionnaires and to raise their hand if they had any questions. Pilot testing by 
the Parent Advisor indicated that the approximate time required to complete this questionnaire 
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package was 14 minutes.  Participants were then asked whether they preferred to participate in a 
‘booster session’ group and complete follow-up questionnaires in paper-and-pencil format 
onsite, or whether they would prefer to complete follow-up questionnaires online from their own 
homes for the three-month follow-up data collection.  
 Follow-up.  In reviewing participant preferences for follow-up data collection, it was 
noted that only two participants from Windsor and three participants from Toronto were 
interested in attending a booster session. Due to this limited interest, it was decided that follow-
up data collection would be offered through an online survey which participants could complete 
from home at their convenience. However, parents were also provided with information 
regarding where to seek appropriate supports (e.g., Canadian Mental Health Association, 
Distress Centre of Windsor and Essex County) if required within the post-study letter of 
information and debriefing page (Appendix H).  
 Three months after participating in the workshop, participants were contacted by email 
with the link to complete the online follow-up questionnaire package. For all participants, the 
follow-up measures included: the EBPAS-P, AAQ-II-A, CFQ-A, TSKQ, and FES (44 items in 
total).  Pilot testing indicated that the approximate time required to complete this questionnaire 
package was 14 minutes. Participant submissions for the online follow-up questionnaire package 
were screened for the time taken to complete each measure in order to ensure validity of online 
responses. Using this method, the completion time for each participant (M = 19.03 minutes, 
range = 8.21 – 37.07 minutes) was deemed to be acceptable. Furthermore, internal reliability 
statistics for data collected online at follow-up were largely consistent with internal reliability 
statistics for data collected on the same measures at preworkshop and postworkshop. 
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 Debriefing.  Participants were automatically redirected to the debriefing page (Appendix 
H) after completing the follow-up measures online.  The debriefing form contained the contact 
information of the researcher, research supervisor, and Research Ethics Board Chairperson, in 
order for participants to direct any questions or concerns.  In the debriefing page, participants 
were informed of which type of workshop they participated in. The debriefing page also 
contained more detailed information about the purpose of the study and study hypotheses, the 
rationale for randomization to groups and blinding participants to which workshop condition 
they were assigned to, as well as a list of resources for further information and support. 
 Measures taken to minimize attrition.  Although the one-day workshop design of the 
study was expected to minimize participant attrition between preworkshop and postworkshop 
data collection (Kazdin, 2013), several measures were also taken to reduce the likelihood of 
participant attrition between postworkshop and follow-up data collection.  Specifically, 
participant incentives were delivered both at postworkshop and follow-up time points, with a 
larger incentive at follow-up.  Participants also received thank you cards in person after 
completing postworkshop questionnaires and by mail after completing online follow-up 
questionnaires.  Finally, convenience for study participants was considered in designing the 
study, allowing participants to complete follow-up questionnaires online from the comfort of 
their homes.    
 Measures taken to minimize experimenter bias.  Several measures were taken to reduce 
experimenter bias in the present study.  As previously mentioned, participants were blind to their 
particular group assignment and all outcome measures were based on participant self-report.  
These measures helped to ensure that outcome data were not directly influenced by facilitators, 
who could not be blind to the type of workshop they were facilitating. Additionally, workshop 
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co-facilitators were not made aware of study hypotheses at any point during data collection. 
Workshop outlines were also intentionally designed to contain a high level of detail in an effort 
to uphold experimenter consistency both between and within workshops.  This method has also 
been used to minimize experimenter bias in similar studies in which community-based 
psychoeducational workshops were compared to psychoeducational workshops supplemented 
with ACT (Gregg, Callaghan, Hayes, & Glenn-Lawson, 2007; Varra, Hayes, Roget, & Fisher, 
2008). 
Measures taken to ensure workshop adherence.  Adherence was assured in each type of 
workshop with the use of detailed workshop manuals both in the training of facilitators and while 
conducting each type of workshop, as has been done in similar studies of psychoeducational 
workshops supplemented with ACT (Gregg, Callaghan, Hayes, & Glenn-Lawson, 2007; Luoma 
et al., 2007; Varra, Hayes, Roget, & Fisher, 2008).  Furthermore, detailed PowerPoint slides for 
each type of workshop were created based on the workshop manuals. These slides included the 
necessary information for all major and minor content areas of the workshops in sequence with 
breaks and lunch indicated, and facilitators were instructed to strictly adhere to the slides 
throughout the workshops.  This workshop adherence strategy was also used by Varra, Hayes, 
Roget, and Fisher (2008) in a similar study, and was deemed appropriate for use in the present 
investigation. Additionally, observers or co-facilitators who were blind to study hypotheses were 
asked to complete either the ACT Workshop Fidelity Measure (see Appendix E) or the Support 
Workshop Fidelity Measure (see Appendix F) following completion of each workshop, which 
measured facilitator adherence to the workshop objectives. 
ACT workshop components.  For the purposes of the current study, the ACT workshop 
consisted of elements of ACT integrated throughout the common treatment-related information 
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described earlier. The ACT exercises selected for inclusion in the ACT were largely based on 
those used by Blackledge (2004) in his ACT workshop for parents of children with ASD, as well 
as those used by Gregg, Callaghan, Hayes, and Glenn-Lawson (2007) in their psychoeducation 
with ACT workshop for individuals learning to self-manage type-II diabetes.  For the purposes 
of the present study, all ACT metaphors and activities were modified to refer directly to the 
experience of parenting a child with ASD, with particular attention to the process of treatment 
selection.  Additionally, the core concepts of ACT (i.e., acceptance, present moment awareness, 
cognitive defusion, self-as-context, values, and committed action) were discussed in detail, with 
examples tailored to the educational components of the workshop and integrated throughout. For 
example, after discussing how there are many different proposed interventions for ASD with 
widely varying goals, parents in the ACT group were presented with an ACT-based values and 
goals worksheet. On this worksheet, parents were asked to identify the overarching values which 
they would like to guide their treatment goals for their children with ASD (e.g., friendship, 
knowledge). Based on their identified values, parents were asked to set goals for themselves with 
respect to their children’s treatment (e.g., to be actively involved in my child’s treatment) and 
committed actions they would perform which were in keeping with these goals (e.g., I will 
schedule an appointment to observe my child’s treatment).   
 Overall, ACT components of the ACT workshop targeted the following areas: (a) 
parents’ acceptance of distressing thoughts and emotions related to their children having ASD 
and parenting children with ASD; (b) contact and engagement with themselves and their children 
in the present moment, rather than focusing on past difficulties or future worries; (c) separation 
from the influence of distressing thoughts about their children or aspects of their parenting 
through acknowledging distressing thoughts as simply thoughts rather than real or true barriers to 
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their values; (d) awareness of their stable, continuous, and holistic senses of self which exist 
outside of and separate from their parenting-related distress and encompass other aspects of their 
personal identities; (e) identification of life values and current barriers to value-consistent living; 
and (f) development of concrete goals and commitment to engaging in values-consistent 
behaviour, particularly within the context of their roles as parents of children with ASD.   
Support workshop components.  The Support workshop consisted of the same 
treatment-related information covered in the ACT workshop; however, parent support group-
style group discussions related to information-based topics covered in common workshop 
elements were included in place of ACT content throughout the workshop. For example, after 
learning about how there are many different proposed interventions for ASD with widely varying 
goals, parents in the Support workshop were asked to discuss what had made the treatments they 
were currently using with their children appealing to them. These open-ended questions were 
designed to stimulate discussion and facilitate the sharing of experiences among workshop 
participants.   
This type of workshop was deemed appropriate to serve as a relevant comparison group 
in the present study as parent support groups are a commonly accessed service by parents of 
children with ASD, with research demonstrating that approximately 65% of parents of children 
with ASD have accessed ASD-specific parent support groups at some point and more than 50% 
continue to attend on a regular basis (Mandell & Salzer, 2007).  Studies have demonstrated 
multiple benefits of attending parent support groups, including decreased stress and increased 
empowerment (e.g., Banach, Iudice, Conway, & Couse, 2010; McConnell, Savage, & 
Breitkreuz, 2014).  Furthermore, this type of educational workshop with parent-to-parent support 
and discussion is commonly used in the local Windsor community by organizations such as The 
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Summit Centre for Preschool Children with Autism (2019), Connections Early Years Family 
Centre (2019), and Autism Services Incorporated (2019).     
The Support workshop was also designed to control for empirically-derived common 
factors affecting efficacy of therapeutic interventions, including: (a) time, (b) client expectancy, 
(c) therapeutic alliance, and (d) therapist factors (e.g., Arean et al., 2010; Cuijpers, Driessen, 
Hollon, vanOppen, Barth, & Andersson, 2012; Lenhart, Wells, & Lochman, 2008).  Time and 
therapist factors were controlled for by employing parent support group-style discussion of 
workshop topics for the same amount of time as the ACT elements in the ACT workshop, and by 
having the same facilitators administer both types of workshop in each location.  Client 
expectancy was controlled for by explaining the empirical support for parent support groups in 
the same manner in which the empirical support for ACT was explained.  Finally, therapeutic 
alliance was controlled by prioritizing the development and maintenance of mutual positive 
feelings and shared goals between the facilitators and workshop participants, as well as among 
workshop participants.    
Qualitative Data Analyses 
Qualitative data preparation. Parents’ qualitative responses to open-ended items on the 
Workshop Satisfaction Survey and Follow-Up Experiences Survey were transferred to a 
Microsoft Excel spreadsheet. With the exception of removing any identifying information, each 
participant’s response to each qualitative item was transferred verbatim to the Excel spreadsheet.  
As parents gave short written responses to open-ended survey items rather than more in-
depth interviews, content analysis was judged to be the most appropriate qualitative method for 
analyzing the responses (Hsieh & Shannon, 2005). According to Hsieh and Shannon (2005), 
content analysis is defined as “a research method for the subjective interpretation of the content 
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of text data through the systemic classification process of coding and identifying themes or 
patterns” (p. 1278). Thus, qualitative responses were analyzed using content analysis in order to 
summarize parents’ ideas into content categories for each question, rather than reporting each 
individual response (Hsieh & Shannon, 2005; Neuendorf, 2017; Stemler, 2001). It should be 
noted that participants sometimes offered multiple responses to the same question and, so the 
total number of responses varied slightly from question-to-question. 
Content analysis in the present study was conducted collaboratively by the researcher and 
the Parent Advisor. In qualitative data analysis, researcher subjectivity is understood to be an 
asset in interpretation (Braun & Clarke, 2013). As such, potential sources of bias are 
acknowledged and embraced in the process of making meaning of participant responses. In this 
study, the researcher acknowledges biases associated with her experience working with children 
with ASD and their families; providing ASD treatment-related services; and studying and 
reviewing the literature on ACT, parents’ acceptance of their children’s ASD, and their treatment 
selection for their children. Similarly, the Parent Advisor acknowledges biases associated with 
her background as a parent of an adult with ASD, her experiences as a community service 
coordinator for parents of children with ASD, and her training and experience with ACT.  
In preparation for analyzing participant responses, both investigators familiarized 
themselves with the process of content analysis outlined by Elo and Kyngas (2008). As the 
workshop itself was newly designed for this study and there were no previous studies on which 
to base a priori hypotheses with respect to qualitative data, the inductive content analysis method 
was judged to be best suited for analyzing these results (Elo & Kyngas, 2008). In inductive 
content analysis, categories are derived directly from the dataset, as opposed to the deductive 
content analysis method in which data are categorized on the basis of previous knowledge and 
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theory (Elo & Kyngas, 2008). Inductive content analysis is recommended when knowledge about 
the phenomenon of interest is limited (Elo & Kyngas, 2008). The content analysis process was 
carried out using the steps outlined by Elo and Kyngas (2008): open coding, creating categories, 
and abstraction. 
Open coding. After responses from the paper-and-pencil Workshop Satisfaction Survey 
and the online Follow-up Experiences Survey were transcribed and collated into a Microsoft 
Excel spreadsheet, the researcher and Parent Advisor read through all responses to each question 
and noted keywords or headings which reflected the content. Efforts were made to preserve the 
intended meaning of parents’ responses by giving consideration to the context of parents’ 
comments in addition to their words (Elo & Kyngas, 2008). This approach was also thought to 
assist with accurately interpreting data from participants for whom English was not their primary 
language.  
Creating categories. After keywords and headings were identified for each participant’s 
responses to each open-ended question, the researcher and Parent Advisor reviewed these units 
and generated labels under which each heading was then categorized (Elo & Kyngas, 2008). As 
this stage involved perhaps the greatest level of subjective interpretation of parents’ responses, 
the Parent Advisor was particularly important to help ensure that responses were interpreted as 
more reflective of the participants’ ideas than those of the researcher.  
Abstraction. Finally, the researcher and Parent Advisor reviewed the content of the 
responses categorized under each label (i.e., theme) and generated broadly descriptive labels for 
each (Elo & Kyngas, 2008). Throughout this process, efforts were made to label each content 
category using concise language which accurately reflected the participants’ voices. Illustrative 
excerpts from participants’ responses were selected at this stage to reflect and convey themes. 
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For the purposes of reporting qualitative results, “most” parents was defined as >50% of 
participants, “some” parents was defined as 25-50% of participants, and “a few” parents was 
defined as <25% of participants. 
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RESULTS 
Overview of Results 
 In the sections that follow, results from the present study are described. Preliminary 
quantitative analyses are outlined, including data screening and preparation, tests of assumptions, 
descriptive statistics, and correlations among study variables, as well as assessment of baseline 
group equivalence, workshop fidelity, group cohesiveness, and group satisfaction. Next, results 
of the main quantitative and qualitative analyses are reviewed, with a focus on addressing the 
guiding research questions.  
Preliminary Quantitative Analyses 
Data screening and preparation. Statistical analyses were conducted using the 
Statistical Package for the Social Sciences (SPSS) Version 25.0 for Windows (IBM, 2017).  
Accuracy of data file. Prior to conducting any tests of assumptions or examining study 
hypotheses, univariate descriptive statistics for each study variable were examined (Tabachnick 
& Fidell, 2013). Item-level and total scores for each continuous variable were confirmed to be 
within range and means and standard deviations were judged to be plausible.  
Missing data. The dataset was then examined for the presence and pattern of missing 
data. Little’s Missing Completely at Random (MCAR) test was used to determine whether data 
were missing completely at random (Tabachnick & Fidell, 2013). Little’s MCAR chi-square 
statistic was found to be significant, χ² (665) = 7338157201382.453, p < .001, indicating that 
data were not missing completely at random. This conclusion was further substantiated by 
examination of the dataset which revealed that missing data were due to 6 participants who were 
lost to follow-up. That is, 6 participants did not complete any follow-up measures.   
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Although multiple imputation is often considered the optimal approach for estimating 
missing data points within a given dataset (e.g., Enders, 2017; van Ginkel & Kroonenberg, 
2014), this method is known to provide unreliable estimates of missing data in small sample 
datasets (Von Hippel, 2016). Listwise deletion of cases with missing data is also problematic as 
results may be favourably biased when incomplete cases are excluded (van Ginkel & 
Kroonenberg, 2014). The limitations of both methods of addressing missing data were 
considered and a decision was made to exclude incomplete cases listwise when conducting 
analyses. Nonetheless, the multiple imputation procedure was carried out and analyses were also 
conducted on the dataset with missing values estimated using multiple imputation. In order to be 
transparent, these results are reported in footnotes where applicable.  
Meaningful statistical analyses of differences between follow-up completers and non-
completers in each type of workshop was not possible given the small number of participants lost 
to follow-up in each group (i.e., n = 2 for the ACT workshop, n = 4 for the Support workshop). 
However, the question of how follow-up completers and non-completers differed within each 
workshop group was examined by dummy coding follow-up completion to produce two nominal 
variables (i.e., 0 = non-complete, 1 = complete), and comparing means for demographic and 
study variables for follow-up completers and non-completers within each group.  
Using this procedure, follow-up completers and non-completers within the ACT group 
and the Support group were similar in terms of their age, child age, time since diagnosis, social 
desirability, trait mindfulness, willingness to select evidence-based treatments, treatment 
selection knowledge, workshop satisfaction, and ratings of group cohesiveness.  
Despite these similarities, however, there were some observed differences between 
follow-up completers and non-completers within each group which should be acknowledged. 
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Follow-up completers in the ACT group were found to have higher levels of acceptance 
(represented by lower AAQ-II-A scores; M = 16.83, SD = 10.30) and lower levels of cognitive 
fusion (M = 20.25, SD = 11.92) at preworkshop than non-completers (Macceptance = 23.00, SD = 
14.14; Mcognitive fusion = 33.50, SD = 4.95); as well as higher levels of acceptance (M = 15.67, SD = 
11.59) and lower levels of cognitive fusion (M = 17.67, SD = 11.63) at postworkshop than non-
completers (Macceptance = 29.00, SD = 2.83; Mcognitive fusion = 24.50, SD = 10.61).   
Similarly, follow-up completers in the Support group were found to have higher levels of 
acceptance (i.e., lower AAQ-II-A scores, M = 15.45, SD = 8.44) and lower levels of cognitive 
fusion (M = 16.27, SD = 10.49) at preworkshop than non-completers (Macceptance = 26.25, SD = 
7.81; Mcognitive fusion = 22.00, SD = 8.12). At postworkshop, follow-up completers also had higher 
levels of acceptance (i.e., lower AAQ-II-A scores, M = 15.91, SD = 8.48) and lower levels of 
cognitive fusion (M = 16.18, SD = 9.04) than non-completers (Macceptance = 28.25, SD = 9.54; 
Mcognitive fusion = 26.50, SD = 8.89). These differences are important to keep in mind when 
considering results of main analyses conducted without including participants who were lost to 
follow-up from each group.   
Outliers. In order to assess for the presence of outliers, z -scores were computed for each 
continuous variable to determine the deviation of each score from the mean (Tabachnick & 
Fidell, 2013). Using a cut-off value of ±3.29 (Tabachnick & Fidell, 2013), no outliers were 
identified in the present dataset.   
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Tests of assumptions. The extent to which the assumptions of split-plot repeated 
measures analysis of variance (ANOVA) were met within the current dataset was examined prior 
to conducting tests of hypotheses. Assumptions of split-plot repeated measures ANOVA include: 
(a) continuous and normally distributed dependent variables, (b) correlations of measurements at 
each time point, and (c) sphericity (i.e., equal variances between groups and equal covariances 
between pairs of conditions; Field, 2013).  
In order to evaluate whether dependent variables were normally distributed within each 
group, Shapiro-Wilk’s test of normality was conducted for each dependent variable within each 
group. Within the ACT group, Shapiro-Wilk’s test of normality was significant for: acceptance 
at preworkshop, W(14) = .831, p = .012; acceptance at postworkshop, W(14) = .825, p = .010; 
cognitive fusion at postworkshop, W(14) = .858, p = .029; workshop satisfaction, W(14) = .711, 
p = .000; and group cohesiveness, W(14) = .854, p = .025, indicating potential deviations from 
normality. Within the Support group, Shapiro-Wilk’s test of normality was significant for: 
acceptance at preworkshop, W(15) = .876, p = .041; workshop satisfaction, W(15) = .879, p = 
.045; and group cohesiveness, W(15) = .850, p = .017, indicating potential deviations from 
normality. To further investigate the assumption of normality, skewness and kurtosis values for 
each dependent variable within each group were examined, with skewness values lower than ±2 
and kurtosis values lower than ±3 considered acceptable deviations from normality (Tabachnick 
& Fidell, 2013). Using this procedure, distributions of scores for each dependent variable within 
each group were considered normal. As a final normality check, histograms for each dependent 
variable within each group were visually inspected to determine how closely they approximated 
the normal curve. These histograms provided further evidence of acceptable normality of 
dependent variables in the present dataset. Additionally, all dependent variables were measured 
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on Likert or Likert-type rating scales, yielding continuous, interval-level data. Overall, the 
assumption of continuous and normally distributed dependent variables was said to have been 
satisfied within the present dataset. 
The assumption that measurements of the dependent variable would be correlated at each 
time point was considered to have been satisfied in the present dataset due to the nature of the 
repeated measures design. That is, scores on each dependent variable between preworkshop, 
postworkshop, and follow-up time points were assumed to be correlated as the same participants 
completed each measure at each time point (Field, 2013).  
The assumption of sphericity (i.e., that the variances of differences between groups are 
equal; Field, 2013) was evaluated by examining Mauchly’s test of sphericity for the split-plot 
repeated measures ANOVA for each dependent variable. Mauchly’s test indicated that the 
assumption of sphericity was satisfied in the present dataset for cognitive fusion, χ² (2) = .066, p 
= .066; willingness to select evidence-based treatments, χ² (2) = .942, p = .552; and treatment 
selection knowledge, χ² (2) = .934, p = .506; however, this assumption was violated in the 
present dataset for acceptance, χ² (2) = .668, p = .022. As such, the F statistic for the ANOVA 
examining group differences in acceptance over time was interpreted with the Greenhouse-
Geisser correction (Tabachnick & Fidell, 2013).  
Descriptive statistics. Descriptive statistics for each study variable by group were 
calculated prior to conducting any tests of hypotheses. Results of this analysis are reported in 
Table 4, including mean scores, standard deviations, and observed score ranges at each time 
point. 
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Table 4              
Means, Standard Deviations, and Ranges for Study Variables by Group 
Note. EBTs = evidence-based treatments; Acceptance measured using the AAQ-II-A, lower scores represent greater levels of 
acceptance; Cognitive fusion measured using the CFQ-A; Treatment selection knowledge measured using the TSKQ; 
Willingness to select evidence-based treatments measured using the EBPAS-P; Trait mindfulness measured using the MAAS, 
higher scores represent higher levels of trait mindfulness; Social desirability measured using the MCSDS-SF. 
 
Variable M SD Observed Range 
ACT Workshop Group    
Acceptance 
     Preworkshop 
     Postworkshop 








  4.44 
 
  7 - 36 
  7 - 41 
  7 – 22 
Cognitive Fusion 
     Preworkshop 
     Postworkshop 








  8.33 
 
  7 - 41 
  7 - 44 
  7 – 34 
Treatment Selection Knowledge 
     Preworkshop 
     Postworkshop 
     Follow-up 
 
  6.07 
  7.29 
  7.08 
 
  2.23 
  2.20 
  2.43 
 
  3 - 10 
  3 - 10 
  2 – 10 
Willingness to Select EBTs 
     Preworkshop 
     Postworkshop 






  6.80 
  8.44 
  7.03 
 
28 - 56 
58 - 57 




  7.07 
  7.83 
  2.16 
49 - 78 
  3 – 10 
Support Workshop Group    
Acceptance 
     Preworkshop 
     Postworkshop 






  9.40 
10.14 
  7.95 
 
  7 - 33 
  7 - 41 
  7 – 30 
Cognitive Fusion 
     Preworkshop 
     Postworkshop 






  9.78 
  9.88 
  8.70 
 
  7 - 37 
  7 - 38 
  7 – 34 
Treatment Selection Knowledge 
     Preworkshop 
     Postworkshop 
             Follow-up 
 
  4.87 
  6.67 
  6.82 
 
  2.64 
  2.26 
  2.23 
 
  0 - 9 
  3 - 10 
  3 – 9 
Willingness to Select EBTs 
     Preworkshop 
     Postworkshop 






  9.21 
  7.85 
  7.15 
 
22 - 55 
27 - 55 
17 – 43 
Trait Mindfulness 63.80 14.55 30 – 81 
Social Desirability   5.13   1.85   1 – 8 
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Correlations among variables. Zero-order correlations between study variables are 
reported in Table 5. As expected, participants’ levels of acceptance at each time point were 
significantly positively correlated with one another, as were participants’ levels of cognitive 
fusion at each time point and participants’ treatment selection knowledge at each time point. 
Participants’ willingness to select evidence-based treatments at preworkshop and postworkshop 
were significantly positively correlated, but not at follow-up. Furthermore, as expected based on 
previous ACT studies and the ACT model, acceptance and cognitive fusion were significantly 
positively correlated at preworkshop, postworkshop, and follow-up.  
Zero-order correlations between dependent variables and participants’ background 
characteristics and ratings of workshop experiences were also conducted in order to screen for 
potential covariates (see Table 6). Variables screened as covariates included: child age, time 
since diagnosis, social desirability, and trait mindfulness, as well as participants’ ratings of group 
cohesiveness and workshop satisfaction.  Time since diagnosis was the only covariate identified, 
as it was significantly positively correlated with acceptance at preworkshop and postworkshop, 
as well as with cognitive fusion at postworkshop. Therefore, time since diagnosis was included 
as a covariate in the main analyses.  
Baseline group equivalence. Participants in each group were compared based on key 
participant characteristics (i.e., parent age, family income, child age, time since diagnosis, trait 
mindfulness, and social desirability) and study variables (i.e., acceptance, cognitive fusion, 
willingness to select evidence-based treatments, treatment selection knowledge) using 
independent samples t-tests in order to confirm that random assignment to groups successfully  
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Table 5                        

























Preworkshop             
1. Acceptance -            
2. Cognitive Fusion      .84** -           
3. Willingness to Select 
   EBTs 
-.03 -.01 - 
  
 
      
4. Treatment Selection 





      
Postworkshop             
5. Acceptance      .89**      .81** -.10    -.45*   -        
6. Cognitive Fusion      .92**      .83** -.06    -.44*      .96** -       
7. Willingness to Select 





     
     .62** 
 







     
8. Treatment Selection 







    
 .81** 
    







    
 
Follow-up 
   
  
  
     
9. Acceptance      .56** .51 .31    -.19      .62**     .61** .14 -.05 -    
10. Cognitive Fusion      .68**     .64** .17    -.30      .81**    .80** .19 -.25       .88** -   
11. Willingness to Select 








    .07 
   














12. Treatment Selection 
   Knowledge 
 
-.36 
   
    -.30 
  
    -.07 
    
 .75** 
 
    -.41 
    
   -.39 
 
.00 
     









Note. EBTs = Evidence-based treatments. *p < .05. **p < .01. Acceptance measured using AAQ-II-A; lower scores represent higher levels of acceptance. 
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Table 6                         
Zero-Order Correlations between Covariates and Dependent Variables 
  Child Age Time Since 
Diagnosis 
Social Desirability  Trait Mindfulness  Group Cohesiveness Workshop Satisfaction 
Preworkshop       
   Acceptance      .17            .41*           .01         .01 -.10   .02 
   Cognitive Fusion      .03           .36           .06        .04 -.06 -.01 
   Willingness to Select 
        EBTs 
           -.11           .07         -.17        .07 .13  .17 
   Treatment Selection    
        Knowledge  
           -.14          -.28         -.03      -.34 .30 -.23 
Postworkshop       
   Acceptance            -.10             .42*        -.00      .03 -.20  .08 
   Cognitive Fusion     .14             .47*         .02     .07 -.17  .08 
   Willingness to Select 
        EBTs 
   -.07          -.02       -.13     .02 .07 -.16 
   Treatment Selection 
        Knowledge 
   -.26          -.19       -.10    -.30 .34 -.24 
Follow-up       
   Acceptance     .19           .11      -.25    -.03 -.17 -.03 
   Cognitive Fusion     .13           .30      -.22    -.06 -.29 -.05 
   Willingness to Select 
        EBTs 
  -.18          -.10      -.13     .19 .36  .15 
   Treatment Selection 
        Knowledge 
   -.23          -.39      -.15    -.38 .26 -.32 
Note. EBTs = Evidence-based treatments. Acceptance measured using AAQ-II-A; lower scores represent higher levels of acceptance. 
*p <.05
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resulted in no meaningful differences between groups at preworkshop. Results of these analyses 
revealed no significant differences between groups at preworkshop (Table 7).  
Comparisons of key participant characteristics and study variables using independent 
samples t-tests were also conducted to identify any differences in sample characteristics between 
participants from the Windsor data collection and participants from the Toronto data collection. 
Results of these analyses revealed that there were no significant differences between locations at 
preworkshop (Table 8). 
Workshop fidelity. Fidelity for each workshop group was assessed in several ways. 
First, scores on either the ACT Workshop Fidelity Measure or the Support Workshop Fidelity 
Measure were calculated. These scores represent the extent to which workshop facilitators 
adequately covered each learning objective of the respective workshop. Scores were calculated 
as the ratio of total achieved fidelity score to the total possible fidelity score (Moncher & Prinz, 
1991). That is, fidelity scores were calculated by summing the scores for each item to establish 
an achieved fidelity score and then dividing this value by the highest possible score (i.e., perfect 
fidelity). Using this method, fidelity for the Acceptance workshop was .857 in Windsor and .847 
in Toronto, reflecting high levels of treatment integrity in both locations (Perepletchikova & 
Kazdin, 2006). Similarly, fidelity for the Support workshop was .896 in both Windsor and 
Toronto, reflecting high levels of treatment integrity (Perepletchikova & Kazdin, 2005). 
Additionally, t-tests were used to compare fidelity ratings of the Acceptance workshop 
with fidelity ratings of the Support workshop to determine whether fidelity ratings differed 
between workshop types. Using this method, Acceptance workshop fidelity ratings (M = .852, 
SD = .007) and Support workshop fidelity ratings (M = .896, SD = .000) were not found to differ, 
t(1) = -8.800, p  = .662.   
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Table 7               
Results of t-tests demonstrating Preworkshop Equivalence between Groups 
Variable ACT Workshop Group 
M(SD) 
Support Workshop Group 
M(SD) 
t P 
Parent age          41.43(7.68)          46.40(12.65) -1.27 .22 
Family income $49,692.31(31414.92) $31,414.92(8712.932)   -.91 .37 
Child age            8.29(4.98)          12.11(6.96) -1.70 .10 
Time since diagnosis            3.76(3.36)            6.67(5.92) -1.59 .12 
Acceptance          17.71(10.49)          18.33(9.40) -1.68 .87 
Cognitive fusion          21.50(12.85)          19.27(9.78)    .53 .60 
Willingness to select 
   EBTs 
 
         40.14(6.80) 
 
         39.87(9.21) 
 




   knowledge 
 
           6.07(2.23) 
 





Note. EBTs = evidence-based treatments; time since diagnosis is reported in years. 
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Table 8             






Parent age          41.11(11.31)          45.30(10.40)   -.98 .34 
Family income $63,285.00(125,697.77) $49,868.42(36,413.46)  1.47 .16 
Child age            9.33(8.15)          10.70(5.45)   -.53 .60 
Time since diagnosis            3.11(2.85)            6.25(5.49) -1.61 .12 
Acceptance          16.78(7.28)          18.60(10.83)   -.46 .65 
Cognitive fusion          23.44(7.60)          18.95(12.42)  1.00 .33 
Willingness to 
   select EBTs 
 
         45.44(6.54) 
 






   knowledge 
 
           5.67(2.00) 
 
           5.35(2.72) 
 
   .31 
 
.76 
Note. EBTs = evidence-based treatments; time since diagnosis is reported in years. 
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Group cohesiveness. In order to examine whether group cohesiveness differed between 
workshop groups, a t-test comparing ratings of group cohesiveness (i.e., participants’ total scores 
on the Group Cohesiveness Scale) between ACT group participants and Support group 
participants was conducted. Results revealed that ratings of group cohesiveness for the ACT 
group (M = 29.71, SD = 2.585) and Support group participants (M = 28.27, SD = 3.918) did not 
differ, t(27) = 1.165, p = .254. Similarly, a t-test comparing ratings of groups cohesiveness 
between participants in Windsor and Toronto was conducted. Results revealed that ratings of 
group cohesiveness for Windsor (M = 28.33, SD = 3.50) and Toronto (M = 29.25, SD = 7.28) did 
not differ, t(27) = -.672, p = .811.       
 Workshop satisfaction. In order to examine whether participant workshop satisfaction 
differed between groups, a t-test comparing ratings of workshop satisfaction (i.e., participants’ 
total scores on the Workshop Satisfaction Scale) between ACT group participants and Support 
Group participants was conducted. Results revealed that ratings of participant satisfaction with 
the ACT workshop (M = 23.14, SD = 2.770) and the Support workshop (M = 20.93, SD = 3.845) 
did not differ, t(27) = 1.764, p = .089. Similarly, a t-test comparing ratings of workshop 
satisfaction between participants in Windsor and Toronto was conducted. Results revealed that 
ratings of participant satisfaction in the Windsor groups (M = 21.78, SD = 3.49) and the Toronto 
groups (M = 22.10, SD = 3.58) did not differ, t(27) = -.226, p = .946.       
Main Quantitative Analyses       
 Overview. Quantitative analyses included split-plot repeated measures analyses of 
variance (ANOVAs) (Hypotheses 1a, 1b, 1c, 3a, and 3b), trend analyses (Hypotheses 2a and 2c), 
paired samples t-tests (Hypotheses 2b and 2d), and moderation models (Hypotheses 4a, 4b, 4c, 
and 4d). The Bonferroni correction was not applied for multiple analyses, as this procedure is 
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known to inflate type II error rate and was not necessary given that each ANOVA was performed 
on a different dependent variable and hypotheses were informed by previous research (Field, 
2013).            
 Research question 1: Changes over time between groups. To determine how 
acceptance, cognitive fusion, and willingness to select evidence-based treatments changed 
between groups over time, three split-plot repeated measures analyses of variance (ANOVAs), 
including significant covariates where appropriate, were conducted to assess changes between 
groups over time in: (a) acceptance, (b) cognitive fusion, and (c) willingness to select evidence-
based treatments. Significant main effects were followed up with trend analyses and significant 
interactions were followed up with either simple effects analyses or trend analyses.   
 Testing Hypothesis 1a. It was hypothesized that acceptance would differ significantly 
between workshop groups over time, with ACT group participants showing greater increases in 
acceptance over time than Support group participants. A split-plot repeated measures ANOVA 
controlling for time since diagnosis was conducted to test this hypothesis. Mauchly’s test 
indicated that the assumption of sphericity had been violated, χ² (2) = .668, p = .0221. Degrees of 
freedom were therefore corrected using Greenhouse-Geisser estimates of sphericity. There was 
no significant main effect for time irrespective of group, F(1.502, 30.037) = .766, p = .439, ηp2 = 
0.0372, and no significant main effect for group irrespective of time F(1, 20) = .179, p = .677, 
ηp2 = .0093. However, there was a significant group x time interaction, F(1.502, 30.037) = 3.862, 
p = .043, ηp2 = .1624, such that group and time accounted for 16.2% of the variance in 
 
1 χ² (2) = .668, p = .003 in dataset with multiple imputed values 
2 F(1.465, 38.084) = .261, p = .702, ηp2 = .010 in dataset with multiple imputed values 
3 F(1, 26) = .55, p = .447, ηp2 = .022 in dataset with multiple imputed values 
4 F(1.465, 38.084) = 1.601, p = .217, ηp2 = .058 in dataset with multiple imputed values 
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participants’ acceptance scores. Post hoc simple effects analyses were conducted to determine at 
which time points acceptance scores varied significantly by groups. These analyses revealed that 
acceptance scores were not significantly different between the ACT workshop group and the 
Support workshop group at postworkshop, t(21) = .055, p = .955, ηp2 = .006. However, the 
difference in acceptance scores between the ACT workshop and the Support workshop at follow-
up approached significance, t(21) = 1.835, p = .081, ηp2 = .138, with ACT workshop participants 
showing higher acceptance than Support workshop participants at follow-up (Figure 2). Taken 
together, these findings reveal that Hypothesis 1a was partially supported. Changes in acceptance 
differed significantly over time by workshop group; however, although ACT group participants 
showed trends toward greater increases in acceptance from postworkshop to follow-up than 
Support group participants, the difference in acceptance between groups at follow-up failed to 
reach statistical significance. In other words, although the trajectories of change in participants’ 
acceptance were significantly different between groups over time, the differences in levels of 
acceptance between groups at postworkshop and follow-up failed to reach statistical significance.  
Testing Hypothesis 1b. It was hypothesized that cognitive fusion would differ 
significantly between workshop groups over time, with ACT group participants showing greater 
decreases in cognitive fusion over time than Support group participants. A split-plot repeated 
measures ANOVA controlling for time since diagnosis was conducted to test this hypothesis. 
Mauchly’s test of sphericity was not significant, χ² (2) = .751, p = .0665, indicating that the 
assumption of sphericity was satisfied. Results showed that there was no significant main effect   
 
5 χ² (2) = .871, p = .179 in dataset with multiple imputed values  




Figure 2. Changes in acceptance over time by group,  



























ACT Group Support Group
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for time irrespective of group, F(2, 40) = 1.253, p = .297, ηp2 = .0596, and no significant main 
effect for group irrespective of time F(1, 20) = .038, p = .847, ηp2 = .0027. However, there was a 
significant group x time interaction, F(2, 40) = 4.888, p = .013, ηp2 = .1968. Post hoc simple 
effects analyses revealed no significant difference in cognitive fusion between groups at 
postworkshop, t(21) = .339, p = .738, ηp2 = .005. The difference in cognitive fusion between 
groups at follow-up failed to reach significance, t(21) = 1.188, p = .248, although ACT workshop 
participants demonstrated lower cognitive fusion at follow-up (Figure 3) and workshop type 
accounted for 6.3% of the variance in participants’ cognitive fusion at follow-up, ηp2 = .063. 
Taken together, these findings reveal that Hypothesis 1b was partially supported. Although 
changes in cognitive fusion differed significantly by workshop group over time, the differences 
in cognitive fusion between ACT workshop participants and Support workshop participants at 
postworkshop and follow-up failed to reach statistical significance. In other words, although the 
trajectories of change in participants’ cognitive fusion over time were significantly different 
between groups, the differences in cognitive fusion between groups at postworkshop and follow-
up failed to reach statistical significance.  
Testing Hypothesis 1c. It was hypothesized that willingness to select evidence-based 
treatments would differ significantly between groups over time, with ACT group participants 
showing greater increases in willingness to select evidence-based treatments over time than 
Support group participants. A split-plot repeated measures ANOVA was conducted to test this 
hypothesis. 
 
6 F(2, 52) = .464, p = .631, ηp2 = .018 in dataset with multiple imputed values 
7 F(1, 26) = .031, p = .861, ηp2 = .001 in dataset with multiple imputed values 
8 F(2, 52) = 5.300, p = .008, ηp2 = .169 in dataset with multiple imputed values 
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Mauchly’s test of sphericity was not significant, χ² (2) = .942, p = .5529, indicating that the 
assumption of sphericity was satisfied. Results showed that there was no significant main effect 
for group irrespective of time, F(1, 21) = .001, p = .977, ηp2 = .00010, and no significant group x 
time interaction, F(2, 42) = .501, p = .609, ηp2 = .02311. However, there was a significant main 
effect for time irrespective of group, F(2, 42) = 11.492, p < .001, ηp2 = .35412. Trend analyses 
revealed that there was a significant linear trend in the pattern of means, F(1, 21) = 21.785, p < 
.001, ηp2 = .50913, such that willingness to select evidence-based treatments varied as a function 
of time irrespective of group membership, with steady decreases in willingness to select 
evidence-based treatments observed over time among participants in both workshop groups (see 
Figure 4). Taken together, these findings reveal that Hypothesis 1c was not supported in the 
present study; ACT group participants did not show greater increases in their willingness to 
select evidence-based treatments than did Support group participants. To the contrary, decreases 
in participants’ willingness to select evidence-based treatments were observed over time in both 
groups. 
Research question 2: Postworkshop to follow-up changes in ACT process variables. 
To determine how participants’ levels of acceptance and cognitive fusion changed between 
postworkshop and follow-up time points, trend analyses investigating the patterns of change over 
time were examined for acceptance and cognitive fusion.  
  
 
9 χ² (2) = .899, p = .250 in dataset with multiple imputed values 
10 F(1, 27) = .115, p = .737, ηp2 = .004 in dataset with multiple imputed values 
11 F(2, 54) = .056, p = .946, ηp2 = .002 in dataset with multiple imputed values 
12 F(2, 54) = 10.048, p < .001, ηp2 = .271 in dataset with multiple imputed values 
13 F(1, 27) = 15.880, p < .001, ηp2 = .370 in dataset with multiple imputed values 
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Figure 4. Changes in willingness to select evidence-based treatments over time by group, with 
lower EBPAS-P scores representing lower willingness to select evidence-based treatments. 
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Testing Hypothesis 2a. It was hypothesized that increases in acceptance would continue 
between postworkshop and follow-up within the ACT workshop group. As previously described, 
following the detection of a significant group x time interaction for acceptance, F(1.502, 30.037) 
= 3.862, p = .043, ηp2 = 0.162, a trend analysis examining changes in acceptance within the ACT 
workshop group over time, controlling for time since diagnosis, was conducted. This analysis 
revealed a significant linear trend, F(1, 10) = 5.982, p = .035, ηp2 = .374, with steady increases in 
acceptance observed over time among ACT group participants. Taken together, these findings 
reveal that Hypothesis 2a was supported in the present study; participants in the ACT group 
displayed stable increases in their acceptance from preworkshop to postworkshop and from 
postworkshop to follow-up.    
Testing Hypothesis 2b. It was hypothesized that there would be no significant change in 
acceptance within the Support workshop group over time. As previously described, following the 
detection of a significant group x time interaction for acceptance, paired samples t-tests 
comparing acceptance scores within the Support workshop group at preworkshop and 
postworkshop, as well as at postworkshop and follow-up, were conducted. These analyses 
revealed no significant change in acceptance from preworkshop to postworkshop, t(10) = -.345, p 
= .737, or from postworkshop to follow-up, t(10) = -1.255, p = .238. Taken together, these 
findings reveal that Hypothesis 2b was supported in the present study; participants in the Support 
group did not show significant change in their acceptance over time.  
Testing Hypothesis 2c. It was hypothesized that decreases in cognitive fusion would 
continue from postworkshop to follow-up within the ACT workshop group. As previously 
described, following the detection of a significant group x time interaction, F(2, 40) = 4.888, p = 
.013, ηp2 = 0.196, a trend analysis examining changes in cognitive fusion within the ACT 
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workshop group over time, controlling for time since diagnosis, was conducted. This analysis 
revealed a quadratic trend which approached statistical significance, F(1, 10) = 4.155, p = .069, 
ηp2 = .294, with cognitive fusion decreasing in the ACT workshop group between preworkshop 
and postworkshop, then continuing to decrease from postworkshop to follow-up. As such, these 
findings reveal that Hypothesis 2b was not supported in the present study; although participants 
in the ACT group displayed decreases in their cognitive fusion from preworkshop to 
postworkshop and from postworkshop to follow-up, this trend failed to reach statistical 
significance.  
Testing Hypothesis 2d. It was hypothesized that there would be no significant change in 
cognitive fusion within the Support workshop group over time. As previously described, 
following the detection of a significant group x time interaction for cognitive fusion, paired 
samples t-tests comparing cognitive fusion scores within the Support workshop group at 
preworkshop and postworkshop, as well as at postworkshop and follow-up, were conducted. 
These analyses revealed no significant change in cognitive fusion from preworkshop to 
postworkshop, t(10) = 1.281, p = .229, or from postworkshop to follow-up, t(10) = -.269, p = 
.793. Taken together, these findings reveal that Hypothesis 2d was supported in the present 
study; participants in the Support group did not show significant change in their cognitive fusion 
over time.  
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Research question 3: Knowledge of ASD treatment selection. To determine how 
knowledge of ASD treatment selection changed between groups over time, a split-plot analysis 
of variance (ANOVA) was conducted. Significant main effects were followed up with post hoc 
trend analyses.   
 Testing Hypothesis 3a. It was hypothesized that treatment selection knowledge would 
increase significantly from preworkshop to postworkshop in both the ACT group and the 
Support group. A split-plot repeated measures ANOVA was conducted to test this hypothesis. 
Mauchly’s test of sphericity was not significant, χ² (2) = .934, p = .50614, indicating that the 
assumption of sphericity was satisfied. Results showed that there was no significant main effect 
of group irrespective of time, F(1, 21) = .100, p = .755, ηp2 = .00515, and no significant group x 
time interaction, F(2, 42) = .124, p = .884, ηp2 = .00616. However, there was a significant main 
effect of time irrespective of group, F(2, 42) = 13.180, p < .001, ηp2 = .38617. These findings 
reveal that Hypothesis 3a was supported in the present study; significant increases in treatment 
selection knowledge were observed over time for participants in both the ACT group and the 
Support group (Figure 5).  
  
 
14 χ² (2) = .895, p = .237 in dataset with multiple imputed values 
15 F(1, 27) = .721, p = .403, ηp2 = .026 in dataset with multiple imputed values 
16 F(2, 54) = 1.539, p = .224, ηp2 = .313 in dataset with multiple imputed values 
17 F(2, 54) = 14.236, p < .001, ηp2 = .345 in dataset with multiple imputed values 
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Figure 5. Changes in treatment selection knowledge over time by group, with higher TSKQ 
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Testing Hypothesis 3b. It was hypothesized that increases in treatment selection 
knowledge would be maintained from postworkshop to follow-up in both the ACT group and the 
Support group. Following the detection of a significant main effect for time irrespective of group 
as previously described, F(2, 42) = 13.180, p < .001, ηp2 = .386, a post hoc trend analysis was 
conducted to determine the shape of the pattern of means. This analysis revealed a significant 
quadratic trend, F(1, 21) = 19.197, p < .001, ηp2 = .47818, with participants in both groups 
showing a steep increase in their treatment selection knowledge from preworkshop to 
postworkshop, followed by relatively stable treatment selection knowledge from postworkshop 
to follow-up. Taken together, these findings reveal that Hypothesis 3b was supported in the 
present study; gains in treatment selection knowledge were maintained from postworkshop to 
follow-up in both the ACT group and the Support group (Figure 5).  
Research question 4: Acceptance and cognitive fusion as moderators. To determine 
whether acceptance and cognitive fusion moderated the relation between parents’ treatment 
selection knowledge and their willingness to select evidence-based treatments, change scores 
were computed for acceptance and cognitive fusion from preworkshop to postworkshop and 
from postworkshop to follow-up. Using the PROCESS macro plug-in for SPSS (Hayes, 2013), 
preworkshop to postworkshop change scores for acceptance and cognitive fusion were included 
as moderators between treatment selection knowledge and willingness to select evidence-based 
treatments at postworkshop in separate analyses. Similarly, postworkshop to follow-up change 
scores for acceptance and cognitive fusion were included as moderators between treatment 
 
18 F(1, 27) = 14.648, p = .001, ηp2 = .352 in dataset with multiple imputed values 
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selection knowledge and willingness to select evidence-based treatments at follow-up in separate 
analyses.  
Testing hypothesis 4a. The relation between parents’ treatment selection knowledge and 
their willingness to select evidence-based treatments at postworkshop was hypothesized to be 
moderated by parents’ changes in acceptance from preworkshop to postworkshop. In step 1, 
postworkshop treatment selection knowledge and change in acceptance from preworkshop to 
postworkshop were entered at predictors of willingness to select evidence-based treatments at 
postworkshop. Results indicated that parents’ treatment selection knowledge and changes in 
acceptance from preworkshop to postworkshop did not significantly predict their willingness to 
select evidence-based treatments at postworkshop, R2 = .014, F (3, 25) = .115, p = .950. Parents’ 
treatment selection knowledge was not a significant predictor of their willingness to select 
evidence-based treatments at postworkshop, b = .416, SE = .778, 95% CI [-1.186, 2.019]. 
Similarly, changes in parents’ acceptance from preworkshop to postworkshop was not a 
significant predictor of postworkshop willingness to select evidence-based treatments, b = .142, 
SE = .356, 95% CI [-.592, .876]. Finally, the interaction between parents’ treatment selection 
knowledge and their changes in acceptance from preworkshop to postworkshop did not 
significantly predict their willingness to select evidence-based treatments at postworkshop, b = 
.028, SE = .161, 95% CI [-.304, .360]. The R2 change between the two predictors and the 
interaction was .001, F (1, 25) = 0.031, p = .862. Taken together, these findings indicate that 
Hypothesis 4a was not supported in the present study; changes in parents’ acceptance from 
preworkshop to postworkshop did not moderate the relation between their treatment selection 
knowledge and their willingness to select evidence-based treatments at postworkshop. 
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Testing hypothesis 4b. The relation between parents’ treatment selection knowledge and 
their willingness to select evidence-based treatments at follow-up was hypothesized to be 
moderated by changes in parents’ acceptance from postworkshop to follow-up. In step 1, follow-
up treatment selection knowledge and change in acceptance from postworkshop to follow-up 
were entered at predictors of willingness to select evidence-based treatments at follow-up. 
Results indicated that parents’ treatment selection knowledge and changes in acceptance from 
postworkshop to follow-up did not significantly predict their willingness to select evidence-
based treatments at follow-up, R2 = .265, F (3, 19) = 2.289, p = .111. Parents’ treatment selection 
knowledge did not predict their willingness to select evidence-based treatments at follow-up, b = 
-.421, SE = .704, 95% CI [-1.896, 1.053]; however, changes in acceptance from postworkshop to 
follow-up predicted parents’ willingness to select evidence-based treatments at follow-up, b = 
.442, SE = .195, 95% CI [.033, .851]. The interaction between parents’ treatment selection 
knowledge and their changes in acceptance from postworkshop to follow-up did not significantly 
predict their willingness to select evidence-based treatments at follow-up, b = -.055, SE = .079, 
95% CI [-.221, .110]. The R2 change between the two predictors and the interaction was 
.019, F (1, 19) = 0.491, p = .492. Taken together, these findings indicate that Hypothesis 4b was 
not supported in the present study; changes in parents’ acceptance from postworkshop to follow-
up did not moderate the relation between their treatment selection knowledge and their 
willingness to select evidence-based treatments at follow-up. 
The significant association between changes in acceptance from postworkshop to follow-
up and willingness to select evidence-based treatments at follow-up is nonetheless important to 
note, despite that acceptance failed to reach statistical significance as a moderator between 
parents’ treatment selection and their willingness to select evidence-based treatments. This 
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finding indicates that parents with greater change in acceptance from postworkshop to follow-up 
had higher levels of willingness to select evidence-based treatments at follow-up.  
Testing hypothesis 4c. The relation between parents’ treatment selection knowledge and 
their willingness to select evidence-based treatments at postworkshop was hypothesized to be 
moderated by parents’ changes in cognitive fusion from preworkshop to postworkshop. In step 1, 
postworkshop treatment selection knowledge and change in cognitive fusion from preworkshop 
to postworkshop were entered at predictors of willingness to select evidence-based treatments at 
postworkshop. Results indicated that parents’ treatment selection knowledge and changes in 
cognitive fusion from preworkshop to postworkshop did not significantly predict their 
willingness to select evidence-based treatments at postworkshop, R2 = .039, F (3, 25) = .342, p = 
.795. Treatment selection knowledge did not predict willingness to select evidence-based 
treatments at postworkshop, b = .449, SE = .772, 95% CI [-1.141, 2.039]. Changes in cognitive 
fusion from preworkshop to postworkshop also did not predict willingness to select evidence-
based treatments at postworkshop, b = .520, SE = .845, 95% CI [-1.220, 2.260]. The interaction 
between parents’ treatment selection knowledge and their changes in cognitive fusion from 
preworkshop to postworkshop did not significantly predict their willingness to select evidence-
based treatments at postworkshop, b = -.044, SE = .123, 95% CI [-.298, .210]. The R2 change 
between the two predictors and the interaction was .005, F (1, 25) = .126, p = .726. Taken 
together, these findings indicate that Hypothesis 4c was not supported in the present study; 
changes in parents’ cognitive fusion from preworkshop to postworkshop did not moderate the 
relation between their treatment selection knowledge and their willingness to select evidence-
based treatments at postworkshop. 
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Testing hypothesis 4d. The relation between parents’ treatment selection knowledge and 
their willingness to select evidence-based treatments at follow-up was hypothesized to be 
moderated by changes in parents’ cognitive fusion from postworkshop to follow-up. In step 1, 
treatment selection knowledge and change in cognitive fusion from postworkshop to follow-up 
were entered at predictors of willingness to select evidence-based treatments at follow-up. 
Results indicated that parents’ treatment selection knowledge and changes in cognitive fusion 
from postworkshop to follow-up did not significantly predict their willingness to select evidence-
based treatments at follow-up, R2 = .065, F (3, 19) = .442, p = .726. Treatment selection 
knowledge did not predict willingness to select evidence-based treatments at follow-up, b = .273, 
SE = .701, 95% CI [-1.195, 1.741]. Changes in cognitive fusion from postworkshop to follow-up 
also did not predict willingness to select evidence-based treatments at follow-up, b = .256, SE = 
.266, 95% CI [-.403, .363]. The interaction between parents’ treatment selection knowledge and 
their changes in cognitive fusion from postworkshop to follow-up did not significantly predict 
their willingness to select evidence-based treatments at follow-up, b = -.020, SE = .183, 95% CI 
[-.403, .363]. The R2 change between the two predictors and the interaction was .001, F (1, 19) = 
.012, p = .914. Taken together, these findings indicate that Hypothesis 4d was not supported in 
the present study; changes in parents’ cognitive fusion from postworkshop to follow-up did not 
moderate the relation between their treatment selection knowledge and their willingness to select 
evidence-based treatments at follow-up. 
Qualitative Results 
Content categories for research question 5: Parents’ feedback regarding their 
experiences during the workshop. Participants in both the ACT workshop and the Support 
workshop shared predominantly positive experiences in the Workshop Satisfaction Survey. The 
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content categories derived from participants’ responses are discussed below (see Appendix I for 
tables outlining the number of participants who endorsed each content category). Most 
participants in the ACT group identified that they liked the ACT elements of the workshop such 
as mindfulness and values, while some participants identified most liking the information 
provided and the opportunity to share their experiences with one another. Similarly, most 
participants in the Support group identified that they most liked the information they gained from 
the workshop, while some parents identified most liking the opportunity to share their 
experiences with other parents.  
Most ACT group participants reported that there was nothing they liked least about the 
workshop, although a few participants indicated that they least liked particular aspects of the 
content and presentation style. A few Support group participants also reported that there was 
nothing they liked least about the workshop, although others reported least liking that the 
workshop was too long, had anxiety-provoking content (e.g., learning about “the treatment 
options that could be harmful”), and had too few participants. 
When asked about ‘things you would change or do differently’, some participants in the 
ACT group indicated personal changes they pledged to make as a result of participating in the 
workshop rather than their suggested changes to the workshop, which was the intended meaning 
of the question. For instance, parents made comments such as “I will do things mindfully [and] 
look for evidence-based treatments for my child” and “I would stop being guilty for the past and 
focus on what I can do now for the future”. A few ACT group participants also indicated that 
they would have liked the workshop to include more interactive exercises and specific 
information about programs, and some of these parents made suggestions about logistical 
changes. Some participants in the Support group suggested making no changes to the workshop, 
TREATMENT SELECTION  108 
 
while others suggested making the workshop discussions more structured or changing the 
workshop length, location, content, and group size. 
When asked whether they had additional feedback about their experiences in the 
workshop, most participants in the ACT workshop did not respond, while some shared that the 
workshop was a positive experience for them. As one parent shared, “What a great experience as 
a parent to discover more tools and connect with other parents”. ACT participants described the 
workshop as helpful, practical, and enjoyable. Participants in the Support group expressed 
gratitude for the information provided, as well as for the parent support elements of the 
workshop. They noted an appreciation for the diversity of the parents in attendance, as well as 
the limitations of current research in the field of ASD treatments. Finally, as one parent stated, 
“We need more sessions like these”. 
Content categories for research question 6: Parents’ feedback regarding their 
experiences between postworkshop and follow-up. Participants in the ACT workshop and the 
Support workshop shared their experiences in the three months following participating in the 
workshop on the Follow-up Experiences Survey. The content categories derived from their 
responses are discussed below (see Appendix J for tables outlining the number of participants 
who endorsed each content category). Some parents in the ACT group reported a lasting impact 
of the knowledge about evidence-based treatments that they gained from the workshop, while 
others reported that the workshop encouraged them to independently investigate available 
treatment options, that they are now more mindful in their everyday lives, and that they now feel 
less alone. In contrast, three parents in the ACT group reported that the workshop did not 
significantly impact their lives over the past three months.  
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Some parents who participated in the Support group reported that the workshop left them 
with increased feelings of empowerment and confidence in their ability to advocate for their 
children, as well as helped them come to a greater understanding of ASD and their children and 
develop a more positive attitude. In contrast, three parents in the Support group reported that the 
workshop did not have a lasting impact on their lives. For example, one parent stated, “I came 
out knowing the same as when I went in”. 
Most participants in both the ACT and Support groups reported that the most important 
thing they learned in the workshop was treatment-related information. A few ACT group 
participants also discussed the importance of social support and noted the lasting significance of 
the more holistic view of their child which they learned through the workshop. As one parent 
shared, “Take time to look at all aspects of your child, not just the 'the Disabilities'. Take care of 
the whole individual just like the exercise we did. Take time to look and taste the 'raspberry'. 
You will be surprised what can be discovered”.  In addition to the treatment-related information, 
a few Support group participants also that the most important lesson they learned was to trust 
their instincts and knowledge of their children, noting that “every individual with autism is 
different”. One Support group participant shared that the sense of social support and learning that 
they are “not alone on this journey” was the most important thing they learned in the workshop.   
Three months following completion of the workshop, some participants in the ACT 
group reported feeling more hopeful and less stressed than they had before completing the 
workshop. Some parents noted that their attitudes and behaviours did not significantly change as 
a result of participating in the workshop. Other parents reported feeling more knowledgeable, 
hopeful, and supported with respect to selecting treatments. One parent described frustration, 
noting “I am more frustrated by the lack of services for our adult ASD community and for my 
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son”. In comparison, three parents in the Support group noted that their attitudes and behaviours 
had not significantly changed as a result of participating in the workshop. Some other parents 
reported that the workshop helped them to become more knowledgeable and open minded 
regarding available treatments and information.   
Some ACT group participants reported improved overall quality of life for themselves 
and their families in the three months following the workshop. Parents also reported that their 
children have benefitted from parents’ increased mindfulness, improved capacity to advocate on 
behalf of their children, and spending more time together. Some Support group participants 
reported that their children benefitted from their increased confidence in making treatment-
related decisions, as well as improved strategies and specific intervention approaches, and 
decreased parental stress.   
Half of the participants in the ACT workshop shared having realized the importance of 
parents of children with ASD having adequate treatment selection knowledge. They also 
mentioned the importance of giving parents the opportunity to connect with each other. Further, 
parents noted the importance of an open but cautious approach to investigating treatments, the 
benefits of mindfulness, and the importance of the parental role. These parents also advocated for 
increased access to individualized services and supports for their children. Some participants in 
the Support workshop also discussed the importance of parents of children with ASD having 
adequate treatment selection knowledge. Others discussed the importance of including parent 
perspectives, outlined their future plans for their children, or did not respond.  
Summary of Quantitative Results 
 The trajectories of change in participants’ acceptance were found to differ significantly 
between groups over time. Although increases in acceptance were observed over time among 
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participants in the ACT workshop group, the differences in acceptance between groups at 
postworkshop and follow-up failed to reach significance. Similarly, trajectories of change in 
participants’ cognitive fusion also varied significantly by group and time. Although decreases in 
cognitive fusion were observed over time among participants in the ACT workshop group, the 
differences in cognitive fusion between groups at postworkshop and follow-up failed to reach 
significance. Surprisingly, willingness to select evidence-based treatments was not influenced by 
workshop type. Instead, willingness to select evidence-based treatments was observed to 
decrease over time for participants in both the ACT group and the Support group. Treatment 
selection knowledge was also not influenced by workshop type, as participants in both the ACT 
group and the Support group displayed significant increases in their treatment selection 
knowledge from preworkshop to postworkshop. These gains were maintained at 3-month follow-
up. Finally, although neither acceptance nor cognitive fusion were found to significantly 
moderate the relation between participants’ treatment selection knowledge and their willingness 
to select evidence-based treatments, a positive association was identified between parents’ 
changes in acceptance from postworkshop to follow-up and their willingness to select evidence-
based treatments at follow-up. At this time point, parents displaying greater change in acceptance 
from postworkshop to follow-up had higher levels of willingness to select evidence-based 
treatments.   
Summary of Qualitative Results 
At postworkshop, parents in both groups reported that the workshop was useful and 
enjoyable. They appreciated the information they received and the opportunity to connect with 
other parents of children with ASD. Participants in both groups recommended some logistical 
changes to the workshop, such as increasing the group size, adding more interactive components, 
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and changing the location or duration. Parent responses differed between groups in terms of the 
aspect of the workshop they most liked, with ACT workshop participants identifying ACT-
specific content (e.g., mindfulness, cognitive defusion exercises) and Support workshop 
participants identifying treatment-related information.  
At three-month follow-up, parents in both workshop groups reported increased 
knowledge about ASD treatment selection, as well as increased openness and enhanced 
confidence in their ability to select treatments for their children. Participants in both groups 
identified that the most important thing they learned in the workshop was tips and strategies for 
selecting treatments and highlighted the importance of parents of children with ASD having 
access to treatment-related information. Parent responses differed between groups in that ACT 
workshop participants reported feeling more positive and hopeful three-months after completing 
the workshop, while Support workshop participants reported feeling more open-minded and 
knowledgeable. ACT workshop participants also commented that their children’s quality of life 
had improved in the three-months since the workshop, while Support group participants noted 
increased understanding of their children.   
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DISCUSSION  
The present randomized pilot feasibility trial examined the potential benefits of 
incorporating ACT components into a standard one-day educational workshop on selecting 
treatments for children with ASD. In the study, a new group workshop aimed at enhancing both 
knowledge and psychological flexibility in parents of children with ASD was developed. The 
outcomes of this workshop were evaluated against a similar workshop aimed at enhancing 
knowledge while providing general parent support. A repeated measures design in which open-
ended items were embedded within quantitative questionnaires was used to explore differences 
in effects between groups over time, as well as participants’ experiences during the workshops 
and at three-month follow-up. In the sections that follow, a review of the study findings, as well 
as discussion of how they fit into the existing body of literature are presented. Clinical 
implications are also discussed, as well as study strengths, limitations, and directions for future 
research.  
Review of Study Findings 
ACT workshop participants were expected to show greater increases in acceptance (i.e., 
greater openness to experiencing thoughts and emotions related to their children’s ASD), greater 
decreases in cognitive fusion (i.e., reduced tendency to buy into and get stuck on particular 
thoughts about their children’s ASD), and greater increases in willingness to select evidence-
based treatments than Support workshop participants over time.  
Acceptance.  Although the differences in participants’ acceptance between groups failed 
to reach statistical significance at both postworkshop and follow-up, the trajectories of change in 
participants’ levels of acceptance were found to vary significantly between groups over time. 
Specifically, linear increases in acceptance were observed over time within the ACT workshop 
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group, while no change in acceptance was observed over time within the Support workshop 
group. This finding is consistent with results from similar group ACT studies which have found 
significant increases in acceptance over time following participation in ACT workshops or 
groups (e.g., Blackledge & Hayes, 2006; Fung et al., 2018; Gregg et al., 2007). In the present 
study, participation in the ACT workshop was associated with increases in parents’ acceptance of 
their thoughts and emotions related to parenting a child with ASD over time. 
Parents’ qualitative responses at three-month follow-up may further enrich the 
interpretation of the finding of continued increases in parents’ acceptance from postworkshop to 
follow-up in addition to between preworkshop and postworkshop. Three months after completing 
the workshop, some ACT workshop participants reported feeling more positive and hopeful. It 
may be that practicing acceptance (i.e., fully and actively embracing both pleasant and 
unpleasant thoughts, emotions, and bodily sensations; Luoma, Hayes, & Walser, 2007) led 
parents in the ACT group to more fully connect with positive experiences with their children in 
their day-to-day lives over time (e.g., sharing enjoyment while playing together). Greater 
openness to experiencing the positive thoughts and emotions associated with these actions could 
be connected to parents’ reported increased positivity and hopefulness over time. Furthermore, 
parents who are more willing to experience both the positive and negative thoughts and feelings 
associated with interacting with their children may also be more willing to spend quality time 
engaging with their children. This could explain the improved quality of life for their children 
reported by some ACT group participants three-months after participating in the workshop.  
One possible explanation of the failure to detect differences in acceptance between 
groups at postworkshop may be the relatively short duration of exposure to ACT content in the 
present study. Workshops in the present study took place over only one session (6.5 hours), 
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unlike in the study by Luoma and colleagues (2007) in which the 12-hour ACT component of the 
intervention was delivered to participants over 8 weekly sessions. As such, participants in Luoma 
and colleagues’ (2007) study had the opportunity to benefit from continued reflection and 
experiencing between each session, as well as longer duration of exposure to ACT content, likely 
contributing to greater increases in acceptance immediately following completion of the final 
session.  
The group format of the ACT Swamp and Mountain Metaphor used to introduce 
the concept of acceptance in the ACT workshop (Hayes & Strosahl, 2004) may have also 
contributed to finding that participants’ levels of acceptance were not significantly 
different between the two groups at postworkshop or follow-up. In this metaphor, 
parents’ values with respect to their children’s lives (e.g., happiness, contribution to 
society, belongingness) were represented by a beautiful mountain.  A swamp was said to 
represent parents’ unpleasant, distressing, or uncomfortable thoughts and emotions which 
could interfere with their ability to reach the mountain (e.g., thoughts that the child may 
never fully ‘recover’, fears about missing out on a treatment that may have had a 
miraculous effect). Acceptance was explained as a willingness to wade through the 
swamp in order to continue travelling toward the mountain.  
Although this exercise was helpful in introducing the concept of acceptance 
within the ACT framework, the group format used to introduce acceptance may not have 
created sufficient activation of emotion within individual participants to actually teach 
acceptance in practice, rather than merely in theory. Acceptance work in ACT typically 
involves individuals intentionally seeking out uncomfortable or distressing thoughts and 
emotions through in vivo experiential exercises in order to practice actively accepting 
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them (e.g., Luoma, Hayes, & Walser, 2007). In the present study, however, the group exercise 
used to introduce acceptance may not have been the optimal method of creating emotional 
arousal and practicing acceptance ‘in the moment’. It should be noted, though, that seeking to 
intentionally activate participants’ distressing thoughts and emotions could potentially have had 
harmful effects within this group format in which they could not be sufficiently processed (e.g., 
leaving participants in emotional distress and without proper support following the workshop). 
As such, acceptance may be an ACT process which is better targeted through ongoing, 
individualized Acceptance and Commitment Therapy, or a combination of individualized 
Acceptance and Commitment Therapy and group Acceptance and Commitment Training, rather 
than through a one-day group Acceptance and Commitment Training workshop.  
Although the greatest difference in acceptance between groups in the present study was 
observed at follow-up, this difference failed to reach statistical significance. The failure to detect 
significant differences in acceptance between groups, particularly at follow-up, is best explained 
by the small sample size and resulting low statistical power in the present study. This will be 
further discussed in limitations and directions for future research.  
Cognitive fusion. Although the differences in participants’ cognitive fusion between 
groups failed to reach statistical significance at both postworkshop and follow-up, the trajectories 
of change in participants’ levels of cognitive fusion were found to vary significantly between 
groups over time. Specifically, ACT group participants displayed reductions in cognitive fusion 
at each time point, while Support group participants’ levels of cognitive fusion remained 
relatively unchanged over time. This finding is partially consistent with results of similar studies 
comparing education with ACT groups to education-only or general support groups. These 
studies have demonstrated long-lasting decreases in cognitive fusion after participating in even 
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brief ACT interventions, compared with no change in control conditions (Gregg, Callaghan, 
Hayes, and Glenn-Lawson 2007; Varra, Hayes, Roget, and Fischer, 2008). 
This quantitative finding was further substantiated in the present study by qualitative 
responses from parents in the ACT workshop group. Most ACT workshop participants identified 
the mindfulness and defusion exercises as their most-liked workshop component, whereas most 
Support workshop participants identified information as their most-liked workshop component. 
The increased hopefulness and positivity reported by some ACT workshop participants at 
follow-up add additional support to the finding of their decreasing levels of cognitive fusion over 
time. With decreased cognitive fusion, ACT group participants may have been better able to 
separate themselves from their thoughts and less likely to become “stuck” in their focus on 
distressing topics (e.g., fears about their children’s futures). In combination with additional 
practice of mindfulness and acceptance, the increased hopefulness and positivity reported by 
some ACT workshop participants at follow-up may be an anticipated finding.    
Relational Frame Theory may provide further insight into the finding of decreasing levels 
of cognitive fusion among ACT workshop participants and consistent levels of cognitive fusion 
among Support workshop participants. Relational Frame Theory posits that individuals 
automatically form internal associations between various events and particular thoughts and 
emotions (e.g., Hayes, 2004). Research has demonstrated that, as these relational frames are 
often automatic and implicit, directly challenging the associations between events and particular 
thoughts and emotions serves to increase the size and power of the relational network by 
incorporating new events which become associated with the distressing thoughts and emotions 
(Barnes-Holmes, Barnes-Holmes, McHugh, & Hayes, 2004). Hayes, Fox, Gifford, Wilson, 
Barnes-Holmes, and Healy (2001) proposed that forming new, more useful associations to 
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individuals’ relational networks may be more effective in creating lasting change than trying to 
directly disrupt existing distressing relational frames.  
In the present study, parents’ cognitive fusion was targeted through teaching and 
rehearsing strategies for separating oneself from thoughts, as well as through presenting parents 
with new information. The validity of their thoughts was not directly challenged, as is often done 
in Cognitive-Behavioural Therapy (CBT). In doing so, parents were able to form new, perhaps 
more helpful relational frames which persisted following the completion of the workshop. For 
example, parents commonly report thoughts such as “all treatments are helpful in some way”, 
from which it can be difficult to separate themselves. Within the ACT workshop, experiential 
activities such as the Leaves on a Stream Exercise were introduced to help participants learn to 
separate themselves from these types of thoughts (i.e., to decrease cognitive fusion). In addition, 
parents were also presented with new information about ASD treatments and their empirical 
support. It is believed that the combination of these strategies promoted development of more 
helpful relational frames with respect to ASD treatments, which persisted following completion 
of the workshop. These results demonstrate the importance of active, in-the-moment 
experiencing and processing in ACT, rather than psychoeducation alone. 
Willingness to select evidence-based treatments. Contrary to expectations, participants’ 
willingness to select evidence-based treatments was found to vary by time but not by group, such 
that willingness to select evidence-based treatments steadily decreased in both workshop groups 
over time. This finding was initially puzzling. However, it may be better understood within the 
context of Relational Frame Theory. Relational Frame Theory posits that attempting to disrupt or 
disprove relations that individuals have formed between particular events and distressing 
thoughts and emotions typically serves to expand these negative relational frame networks 
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(Blackledge, 2003; Hayes, 2004). In the present study, both the ACT workshop and the 
Support workshop exposed parents to a great deal of group discussion. Participants in 
both groups therefore had the opportunity to hear other parents’ diverse opinions on ASD 
treatment selection (e.g., negative experiences with government-funded agencies, 
perceived improvement in children’s behaviours following non-evidence-based 
treatments such as a gluten-free diet, unfounded beliefs in vaccine injury, and perceived 
medical biases of the academic community). It may be, then, that participants’ existing 
relational frame networks were expanded through exposure to the opinions of other group 
members. Researchers have demonstrated that even being exposed to information or 
opinions which are contrary to one’s previously held beliefs can often result in 
strengthening existing beliefs (Paynter et al., 2019). Additionally, as relational frames are 
constantly being formed as individuals are exposed to different stimuli (Hayes, 2004), 
these expanded unhelpful relational frame networks may have continued to expand over 
time, leading to negative cascading effects which could explain the decreases in 
willingness to select evidence-based treatments found in participants in both workshop 
groups at three-month follow-up.  
In one study, Varra and colleagues (2008) noticed that professional counsellors who 
completed an educational workshop on current research findings in preventative care and 
strength-based leadership skills prior to exposure to information about evidence-based treatments 
showed decreases in their willingness to select evidence-based treatments from preworkshop to 
postworkshop, although this trend did not reach statistical significance. It may be that being 
presented with alternative information serves to further expand individuals’ existing relational 
frame networks, leading their opinions to become more entrenched. Although this explanation is 
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consistent with Relational Frame Theory, it does not account for the decreases in willingness to 
select evidence-based treatments observed in ACT workshop participants over time. In contrast, 
Varra and colleagues (2008) found increased willingness to use evidence-based treatments at 
postworkshop and follow-up in participants who completed an ACT workshop prior to being 
exposed to information about evidence-based treatments.  
Participants’ qualitative responses on the Follow-up Experiences Survey may offer 
additional insight into the observed decreases in participants’ willingness to select evidence-
based treatments at follow-up. At three-month follow-up, participants in both workshop groups 
reported increased treatment selection knowledge, as well as increased openness and enhanced 
confidence in their ability to select appropriate treatments for their children. It is possible that 
these changes may have led parents to be more open-minded to non-evidence-based treatment 
approaches, and more confident in these treatment selection choices rather than relying on 
recommendations from researchers and clinicians. This is consistent with previous research 
demonstrating a positive relation between openness and use of non-evidence-based treatments in 
health professionals (Paynter, Sulek, Luskin-Saxby, Trembath, & Keen, 2018). This effect may 
have been further exacerbated in the present study due to the use of the Evidence-Based Practice 
Attitude Scale (Parent) to measure willingness to select evidence-based treatments. For example, 
parents with higher levels of openness and self-efficacy may have been more likely to strongly 
endorse items such as “I know better than academic researchers how to care for my child”, which 
would have resulted in lower scores on this measure.   
Although the potential negative impact of both types of workshop on parents’ willingness 
to select evidence-based treatments is important to acknowledge, other and perhaps more likely 
explanations for the reported decreases in willingness to select evidence-based treatments over 
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time in both workshop groups include the measure used to assess the construct and the 
operationalization of the construct itself. First, the Evidence-Based Practice Attitudes Scale 
(EBPAS; Aarons, 2004) used in the current study was originally developed for the purpose of 
investigating mental health practitioners’ attitudes toward using evidence-based practices with 
their clients. Although there is a precedent for modifying this measure to assess attitudes toward 
evidence-based practice among other populations such as teachers (Monahan, McDaniel, 
George, & Weist, 2014), it is possible that even with modifications, the EBPAS-P was not the 
most sensitive measure to assess parents’ attitudes toward evidence-based treatments for their 
children with ASD. For example, for the purposes of the present study, items from the original 
EBPAS such as “I am willing to try new types of therapy/interventions even if I have to follow a 
treatment manual” and “how likely would you be to adopt a treatment/intervention if it was 
required by your state?” were modified. In an attempt to increase their relevance to parents’ 
treatment decision-making for their children, those items became “I am willing to try new types 
of therapy/interventions even if they require me or the treatment provider to follow a treatment 
manual” and “how likely would you be to adopt a treatment/intervention if it was required to 
qualify for government funding?”. As such, the items included in this measure may not have 
accurately reflected the most salient considerations parents make when selecting treatments for 
their children with ASD. 
The appropriateness of the construct of willingness to select evidence-based 
treatments as a primary outcome of the present study should also be considered. Use of 
non-evidence-based treatments is common among parents of children with ASD (e.g., 
Green, Pituch, Itchon, Choi, O’Reilly, & Sigafoos, 2006; Paynter, Trembath, & Lane, 
2018; Wong & Smith, 2006); however, parents most commonly employ several different 
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treatment approaches (some which are evidence-based and some which are not) simultaneously 
with their children (e.g., Drouillard, 2012; Goin-Kochel, Myers, & Mackintosh, 2007). As such, 
the concern is more that parents’ inclusion of non-evidence-based treatments in their children’s 
treatment plans may lead to opportunity cost (i.e., missing out on evidence-based treatments) or 
cause direct harm. Thus, it may have been more appropriate in the present study to have 
investigated how increased psychological flexibility affects parents’ selection of non-evidence-
based treatments for their children with ASD, rather than merely their willingness to select 
evidence-based treatments.   
Patterns of change in ACT process variables. It was predicted that participants in the 
ACT group would continue to demonstrate changes in acceptance and cognitive fusion from 
postworkshop to follow-up, while participants in the Support group would show no differences 
in acceptance and cognitive fusion over time. That is, ACT group participants were expected to 
show additional increases in acceptance and additional decreases in cognitive fusion from 
postworkshop to follow-up, while no change was expected in the Support group. 
Acceptance. Acceptance (i.e., openness to experiencing thoughts and emotions related to 
their children’s ASD) was found to increase over time for ACT workshop participants, with the 
highest levels of acceptance observed at three-month follow-up. This finding indicates that ACT 
group participants continued to show increases in their acceptance after completing the ACT 
workshop, while Support group participants’ acceptance did not change over time. These results 
are consistent with findings indicating further improvement on ACT-specific process measures 
in the months following completion of ACT workshops or groups (e.g., Fung, Lake, Steel, 
Bryce, Gould, Tarbox, & Coyne, 2018; & Lunsky, 2018; Varra, Hayes, Roget, & Fischer, 2008).  
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This finding is particularly important given that the ACT workshop provided participants 
with only a few hours of ACT-specific content, delivered in group format. As such, the 
substantial benefits observed as a result of this intervention with minimal time and financial 
demands make it particularly well suited for public health institutions or community 
organizations to provide at a low cost to parents. This one-time intervention with the potential for 
positive cascading effects is also particularly well suited for parents of children with ASD, as 
their substantial time spent caring for and supporting their children often leaves little time for 
interventions aimed at supporting themselves.  
Furthermore, the finding of increasing acceptance in ACT group participants but not in 
Support group participants suggests that these improvements were related to ACT-specific 
workshop content, rather than simply to common factors known to affect the efficacy of 
therapeutic interventions such as duration of intervention and therapist factors (e.g., Arean et al., 
2010; Cuijpers, Driessen, Hollon, vanOppen, Barth, & Andersson, 2012; Lenhart, Wells, & 
Lochman, 2008). As these common factors were consistent between workshop groups and 
participants’ levels of acceptance did not differ between groups at preworkshop assessment, it is 
reasonable to conclude that the observed increases in ACT workshop participants’ acceptance 
over time were related to their participation in the ACT workshop.  
Cognitive fusion. ACT group participants demonstrated reductions in cognitive fusion at 
each time point, while Support group participants’ levels of cognitive fusion did not change over 
time. Relational frame theory states that one of the goals of ACT is expanding relational frame 
networks to include more helpful associations between particular events and particular thoughts 
and emotions (Blackledge, 2003). As individuals implicitly form associations during their day-
to-day lives (Hayes, 2004), the expanded, more helpful relational frame networks developed 
TREATMENT SELECTION  124 
 
through participation in the ACT workshop may, through time, lead to additional positive 
relational frames being formed. Participation in the ACT workshop therefore may have resulted 
in cascading positive effects for parents, such that greater reductions in cognitive fusion were 
seen at three-month follow-up than immediately following completion of the workshop.  
Treatment selection knowledge. It was predicted that treatment selection knowledge 
would increase in both workshop groups from preworkshop to postworkshop. Treatment 
selection knowledge was also expected to be maintained in both workshop groups at three-month 
follow-up.  
Treatment selection knowledge at postworkshop. Treatment selection knowledge was 
found to vary over time but not by group, with participants in both groups demonstrating 
significantly increased knowledge from preworkshop to postworkshop. Previous research has 
similarly demonstrated that adding ACT as a supplement to education-based workshops did not 
result in decreased retention of information compared to education-only workshops in a sample 
of healthcare professionals (Gregg, Callaghan, Hayes, and Glenn-Lawson, 2007). Thus, 
participants in the ACT group had the opportunity to benefit from ACT-specific content (e.g., 
increased acceptance, decreased cognitive fusion), while still retaining the same knowledge 
about ASD and treatment selection as participants in the Support group. This is particularly 
important, given that participation in ACT groups has been associated with mental health 
benefits such as reduced stress and social isolation for parents of children with ASD (Lunsky, 
Fung, Lake, Lee, & Bryce, 2018).  
Participants in both groups shared that the most important things they learned in the 
workshop were tips and strategies for selecting treatments for children with ASD. This 
qualitative information corroborates observed increases in participants’ knowledge of ASD 
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treatment selection from preworkshop to postworkshop in both the ACT workshop and 
the Support workshop.  
Treatment selection knowledge at follow-up. Treatment selection knowledge was 
found to remain stable between postworkshop and follow-up time points for participants 
in both the ACT and Support workshops. In other words, the gains in treatment selection 
knowledge made by parents in both the ACT and the Support workshops were 
maintained three months after completing the workshops. It is possible that this 
information was retained because parents spent additional time reflecting on the content 
or putting the information into practice in their day-to-day lives following workshop 
completion. The finding that parents in both workshop groups reported increased 
confidence in their abilities to select treatments for their children with ASD at follow-up 
lends further support to this hypothesis. Finally, participants in both groups highlighted 
the importance of parents of children with ASD having access to treatment-related 
information. They appreciated the knowledge gained through the workshop and reported 
that other parents would benefit from this additional information when making treatment-
related decisions on behalf of their children.  
ACT process variables as moderators. It was predicted that the relation between 
parents’ treatment selection knowledge and their willingness to select evidence-based 
treatments would be moderated by acceptance and cognitive fusion both at postworkshop 
and follow-up time points.   
Acceptance and cognitive fusion were not found to significantly moderate the 
relation between parents’ treatment selection knowledge and their willingness to select 
evidence-based treatments at either postworkshop or follow-up time points, possibly due 
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to the insufficient power afforded by the small sample size in the present study. However, a 
significant association was found between parents’ increases in acceptance from postworkshop 
to follow-up and their willingness to select evidence-based treatments at follow-up. Specifically, 
parents who showed the greatest increases in their acceptance in the three months following 
workshop completion reported the highest levels of willingness to select evidence-based 
treatments at follow-up. This positive relation between acceptance and willingness to select 
evidence-based treatments is consistent with findings from Varra and colleagues (2008), who 
demonstrated increased willingness to use evidence-based treatments among professional 
counselors who completed an ACT workshop prior to completing a workshop about evidence-
based treatments.  
Clinical Implications  
Incorporating elements of ACT into standard community educational workshops and 
support groups has many potential benefits for parents of children with ASD. This intervention 
was shown to be as effective as the Support workshop (comprised of education and general 
parent support) for increasing parents’ treatment selection knowledge, while offering the added 
benefits of increased acceptance and decreased cognitive fusion. Previous research has 
demonstrated associations between changes in these ACT processes variables (i.e., acceptance 
and cognitive fusion) and mental health benefits including: decreased depressive symptoms 
(Blackledge & Hayes, 2006; Lunsky, Fung, Lake, Steel, & Bryce, 2018; Poddar et al., 2015) and 
parenting-related stress (Kowalkowski, 2013; Lunsky, Fung, Lake, Steel, & Bryce, 2018), as 
well as increased participation in self-care activities (Fung, Lake, Steel, Bryce, & Lunsky, 2018) 
and enhanced coping skills (Clarke, Kingston, Wilson, Bolderston, & Remington, 2012). 
Increased acceptance in a general sample of parents has also been shown to be associated with 
TREATMENT SELECTION  127 
 
decreased internalizing and externalizing behaviours in children (e.g., Brassell, 
Rosenberg, Parent, Rough, Fondacaro, & Seehus, 2016). The relatively low cost and low 
resource demand aspects of incorporating ACT components into existing community 
education and support groups for parents of children with ASD makes this a feasible 
method of supporting parents of children with ASD. Furthermore, ACT exercises can be 
readily tailored to suit a wide range of topics relevant to parents of children with ASD 
(e.g., managing challenging behaviours, the importance of self-care, strategies for 
enhancing play and interactions, navigating the school system).  
Parent feedback was overwhelmingly positive for both types of workshop in the 
present study. Participants in both the ACT workshop and the Support workshop reported 
high levels of satisfaction with the workshop they participated in, and these ratings did 
not differ significantly between groups. This is consistent with results from a related 
study in which parents of children with ASD in an education and support group reported 
similar satisfaction levels to participants in a mindfulness group (Lunsky, Hastings, 
Weiss, Palucka, Hutton, & White, 2017). In the present study, parents in both groups 
reported feeling more knowledgeable and confident in their abilities to make treatment 
decisions on behalf of their children at three-month follow-up. They noted the importance 
of parents of children with ASD having access to both information and support in order to 
best serve their children.    
Interventions aimed at supporting parents in selecting effective treatments for their 
children with ASD are particularly important at this time, given the recently announced 
changes to the Ontario Autism Program (Ministry of Children, Community, and Social 
Services, 2019). Under this revised program, families are allotted childhood budgets 
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which are provided to them directly and which they may use to access interventions and supports 
for their children. Specifically, children under the age of six are eligible to receive $20,000 
annually, while children aged six and over are eligible to receive $5,000 annually. Although the 
Ministry of Children, Community, and Social Services (2019) has recently announced that it 
plans to develop a needs-based model of funding, few details are currently known. In this new 
direct funding model, parents are faced with the challenge of navigating through the myriad 
treatments available, many of which may be non-evidence-based or provided with little-to-no 
quality oversight from regulatory bodies. This places enormous responsibility on parents for 
evaluating the quality of empirical support for various interventions and their ability to meet the 
individual needs of their children. Although the Ministry of Children, Community, and Social 
Services has stated that it will develop an independent intake agency in the next year to assist 
parents throughout this process, families who begin receiving their childhood budgets after this 
new program took effect on April 1, 2019 are now tasked with selecting treatments for their 
children with minimal support. Given that difficulty completing lengthy paperwork and limited 
understanding of bureaucratic processes have been identified as barriers to immigrant parents 
accessing services for their children with ASD in Canada (Khanloul, Haque, Mustafal, Vazquez, 
Mantini, & Weiss, 2017), parents with learning challenges, parents with lower levels of 
education, and parents for whom English is their second language are likely to be most impacted 
by these changes.  
Additionally, for many families, these new childhood budgets represent a considerable 
reduction in financial support in comparison to what they had previously been eligible for. As 
such, parents may feel forced to make a difficult choice between evidence-based treatments such 
as intensive behaviour analysis (which can cost approximately $80,000/year) and non-evidence-
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based interventions (e.g., technology aids), which are often less expensive. Interventions 
aimed at increasing parents’ knowledge of ASD treatments and their varying levels of 
empirical support while simultaneously addressing the emotional factors which often 
affect treatment-related decisions may be of particular value in addressing these concerns.  
Strengths of the Present Study 
The present study contributes to and builds upon the existing literature in several 
ways. This was the first study to the author’s knowledge to investigate the potential 
benefits of adding elements of acceptance and commitment training to standard 
educational workshops to increase parents’ willingness to select evidence-based 
treatments for their children with ASD. Furthermore, in this investigation, the ACT 
workshop (comprised of education and ACT) was evaluated against the Support 
workshop (comprised of education and general parent support), which represented a high-
quality service commonly accessed by parents of children with ASD (Mandell & Salzer, 
2007). This design allowed the researcher to assess whether the ACT workshop was more 
effective in promoting willingness to select evidence-based treatments in parents of 
children with ASD than the most common workshops currently available. Random 
assignment of participants to workshop groups increased the likelihood that groups would 
be equivalent in terms of variables of interest before the workshop. Utilizing the same 
two facilitators for both the ACT workshop and the Support workshop in each location 
also helped to ensure that between-groups differences in treatment effects could not be 
attributed to facilitator characteristics.  
Additionally, variables of interest were measured at three time points (i.e., 
preworkshop, postworkshop, and follow-up). This allowed for analyses of change in 
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which participants acted as their own controls. The repeated measures design of the present study 
also allowed the researcher to conduct trend analyses to better understand the pattern of change 
over time for participants in each group.  
The present study also contributed to the literature by incorporating measures to assess 
the proposed process-level variables which were hypothesized based on theory and previous 
research to act as the mechanisms of change in the ACT workshop group. Including measures of 
acceptance and cognitive defusion allowed for examination of the extent to which changes in 
these core ACT processes were responsible for changes in parents’ willingness to select 
evidence-based treatments, although no significant moderation effects were found in the present 
study. It was also possible to measure whether participation in the ACT workshop was associated 
with increased acceptance and decreased cognitive fusion at postworkshop and follow-up. 
An additional strength of the present study was that a measure of parents’ understanding 
and retention of workshop information (i.e., the Treatment Selection Knowledge Quiz) was 
incorporated at each time point. This allowed the researcher to confirm that both the ACT and 
Support groups demonstrated significant increases in their treatment selection knowledge from 
preworkshop to postworkshop and that these gains were maintained at three-month follow-up in 
both groups.  
The present study also incorporated a process for assessing workshop fidelity in each 
condition. The inclusion of these workshop fidelity measures allowed the investigator to confirm 
that there were high levels of integrity for the ACT workshop and the Support workshop in both 
locations (Perepletchikova & Kazdin, 2006), indicating that the learning objectives identified for 
each workshop were sufficiently covered by workshop facilitators. The inclusion of these 
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measures also allowed the investigator to confirm that treatment fidelity did not differ 
significantly between ACT and Support workshop conditions in the present study.  
Finally, two parents of children with ASD served as Parent Advisors throughout 
the research process in order to ensure that the study design and results were suitable, 
meaningful, and useful to parents of children with ASD. These two parents of children 
with ASD were key collaborators throughout all stages of the research process, including 
designing the study, collecting data, and interpreting results. This approach to conducting 
research recognizes that all studies are influenced to some degree by the implicit biases 
held by researchers (Fletcher-Watson et al., 2018). Collaborating with stakeholders from 
the population of interest in research helps to ensure that information gained from the 
study reflects the beliefs and experiences of the participant group, rather than only the 
researchers. In the present study, Parent Advisors were instrumental in terms of helping 
to select which information to include in the psychoeducation component of the 
workshops, pilot testing study measures, advising on recruitment practices, and assisting 
with interpretation of data.  
Limitations and Future Directions 
A number of factors should be taken into consideration when reviewing the 
findings of this study and planning for future studies. A small sample size was the most 
significant limitation of the present study. Although efforts to expand recruitment and 
promote participation were made, the final sample size of 23 participants was far below 
the size needed to conduct analyses with adequate power (e.g., at least 50 participants 
required for moderation analyses). Therefore, the sample size in the present study likely 
resulted in under-detection of effects due to insufficient power. For example, between-
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group differences in acceptance and cognitive fusion which approached statistical significance at 
follow-up may have achieved significance with a larger participant sample, given their medium 
effect sizes. Although a sample size of 23 participants is comparable to or larger than the sample 
sizes in many published studies of group ACT interventions and group interventions for parents 
of children with ASD (e.g., Banach, Iudice, Conway, & Couse, 2010; Blackledge & Hayes, 
2006; Chiang, 2014; Fung, Lake, Steel, Bryce, & Lunsky, 2018; Lunsky, Fung, Lake, Steel, & 
Bryce, 2018; Luoma et al., 2007), a larger sample size in future studies would allow for 
conducting statistical analyses with increased power, particularly to detect moderating effects 
and differences between groups at various time points.  
Recruiting participants from a clinical community population poses special challenges 
not found when recruiting participants from University undergraduate participant pools. The pool 
of potential participants is smaller and requires a more focused recruitment approach in these 
clinical samples. Recruitment in the present study targeted distributing materials through ASD-
related community organization email lists and various ASD-related community events. 
However, this approach introduced a sampling bias in that parents of children with ASD who 
were not actively involved in the ASD community were unlikely to be recruited for the study. 
Parents who participated were therefore likely to be already relatively well supported, informed, 
and thus less in need of the intervention. Thus, participants in both groups in the present study 
were found to have relatively high levels of acceptance at the preworkshop time point (i.e., no 
scores in the clinically significant range [24-28; Bond et al., 2011] were observed at any time 
point), which may have contributed to a ceiling effect in which there was less room for 
improvement as a result of participating in the workshop. Future studies could benefit from 
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recruiting parents through more universally experienced touch points (e.g., upon 
receiving the initial diagnosis or at a follow-up appointment). 
In an attempt to maximize recruitment, restrictions were not placed on the age of 
participants’ children in the present study. As a result, participants’ children ranged in age 
from 4 to 26 years and their time since diagnosis ranged from 1 year to 18 years. Child 
age was not found to be correlated with participants’ levels of acceptance, cognitive 
fusion, treatment selection knowledge, or willingness to select evidence-based treatments 
at any time point. However, time since diagnosis was found to be associated with parents’ 
acceptance at preworkshop and postworkshop, as well as with parents’ cognitive fusion at 
postworkshop. These results highlighted the greater impact of parents’ internal processes, 
rather than child-related factors, in influencing parents’ psychological flexibility and 
treatment decision-making. As such, the present study focused on parent-related factors 
without directly assessing the impact of child-related factors (e.g., child age, 
developmental level), which poses an additional limitation. These factors would be 
interesting to explore in future studies of ACT workshops for parents of children with 
ASD.  
The nature of the sample of parents of children with ASD in the present study 
represents another limitation to the generalizability of findings. The sample of parents of 
children with ASD who participated in the present study were all English-speaking and 
were predominantly mothers, most of whom were married and had at least some College 
or University education. As recruitment primarily took place through ASD-related 
organizations, participants in the present study also may have had higher levels of 
acceptance of their children’s diagnoses and were more active participants in the ASD 
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community than many parents of children with ASD.  Thus, generalization of findings to parents 
outside this very specific population should be made with caution. Future research on this topic 
would benefit from recruitment of larger and more diverse samples of parents of children with 
ASD, particularly those who are not already connected to the ASD community. This could be 
achieved through specifically addressing barriers to participation (e.g., childcare, travel, length of 
time) in the design of studies, being clear about study procedures and potential benefits during 
recruitment, encouraging ‘word of mouth’ recruitment, and finding creative solutions for 
reducing demands on participants (e.g., incorporating online components to remove travel 
requirements).  
For parents of children with ASD, lack of appropriate childcare is a significant barrier to 
research participation. During recruitment for the present study, many parents cited lack of 
childcare as the reason they were unable to participate. As the present study involved only 
parents and not their children, participants were required to provide their own childcare for the 
full 6.5-hour time frame of the weekend workshop. Finding qualified individuals to provide 
childcare for children with ASD is known to be especially challenging (e.g., Houser, McCarthy, 
Lawer, & Mandell, 2014). Despite the researcher’s attempts to organize childcare through the 
community organization hosting the workshop, this was ultimately not possible due to concerns 
regarding cost and liability. As a result, many participants had to rely on their partners to care for 
their children while they attended the workshop, which would not have been possible for single 
parents or families in which one parent works during weekends. Offering childcare would 
significantly reduce barriers to parents’ participation in future community-based interventions for 
parents of children with ASD. 
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In terms of measurement limitations, self-report questionnaires were used in the 
present study to measure all variables of interest. As such, accuracy of data obtained is 
dependent on participants’ understanding of items, capacity for self-reflection, and 
willingness to accurately report their internal experiences (Austin, Gibson, Deary, 
McGregor, & Dent, 1998). Although participants’ scores on each study measure were not 
significantly correlated with their scores on a measure of social desirability, the capacity 
for potential bias remains.  
An additional measurement limitation in the present study was the use of the 
Evidence-Based Practice Attitudes Scale – Parent (EBPAS-P; Aarons, 2004) as a measure 
of willingness to select evidence-based treatments in parents of children with ASD. This 
measure was adapted for use in the current study from the original form developed to 
assess professionals’ willingness to adopt evidence-based practices in their clinical care 
(Aarons, 2004). The extent to which the EBPAS-P truly captured parents’ willingness to 
select evidence-based treatments for their children in the present study is unknown. 
Furthermore, parents’ responses on a questionnaire designed to measure willingness to 
select evidence-based treatments may fail to accurately reflect the real-world treatment-
related decisions they make on behalf of their children with ASD, which are often 
influenced by practical considerations (e.g., availability, cost). That is, a parent may be 
willing to select an evidence-based treatment for his/her child but may not be able to 
access this treatment due to limited resources, long wait times, or limited availability. 
Given that the researcher was one of the workshop facilitators in the present study, 
it was not possible for all workshop facilitators to be blind to research hypotheses. This 
introduced the potential for the researcher to intentionally or unintentionally lead 
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workshops in such a way as to bias results in favour of supporting the hypotheses. In order to 
protect against this potential experimenter bias, workshop co-facilitators were blinded to study 
hypotheses, and treatment fidelity measures were incorporated to allow for analyses to confirm 
that workshops were facilitated as intended.   
The type of fidelity measure used in the present study also represents a limitation. 
Although the ‘gold standard’ practice for ensuring program fidelity in behavioural health 
research involves audio or videotaping sessions and conducting random reviews of recordings to 
assess fidelity (Bellg et al., 2004), the Parent Advisor and researcher believed that doing so in the 
present study would have placed undue stress on workshop participants. As such, efforts were 
made to ensure workshop fidelity through facilitators following detailed PowerPoint slides and a 
facilitator manual, as has been done in similar published studies (e.g., Fung, Lake, Steel, Bryce, 
& Lunsky, 2018; Varra, Hayes, Roget, & Fisher, 2008). Workshop fidelity in each condition was 
then assessed using a paper-and-pencil fidelity measure designed specifically for use in the 
present study. Although these measures were completed by observers or cofacilitators without 
direct knowledge of study hypotheses, results may nonetheless have been biased in favour of 
desirability. Future studies would benefit from addressing these limitations by using less 
intrusive recording methods (e.g., audio recording followed by transcription of sessions and 
coding) to avoid undue stress while allowing for more direct and systematic assessment of 
workshop fidelity (Breitenstein, Gross, Garvey, Hill, Fogg, & Resnick, 2010).  
The design of the study may have also introduced several limitations. For instance, 
workshop participants may have influenced each other, given that workshops involved 
participants interacting with one another through group discussions and exercises for 6.5 hours. 
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Although workshops were heavily structured in an attempt to reduce this likelihood, 
group influence was informally observed within both the ACT workshop and the Support 
workshop.  
As discussed earlier, the phrasing of open-ended items in the Workshop 
Satisfaction Survey (Kowalkowski, 2013) and Follow-up Experiences Survey may 
represent another measurement limitation within the present study. Specifically, unclear 
item phrasing may have led participants to interpret some items differently at times than 
the researcher had intended. For example, when asked what they would change about the 
workshop, several participants identified changes they had seen in themselves as a result 
of participating in the workshop, rather than offering their feedback on how the workshop 
could be improved. Pilot testing these qualitative items with a sample of parents would 
have likely been helpful in ensuring clarity of phrasing. Furthermore, adding a semi-
structured interview component in addition to open-ended survey items would have also 
helped to ensure participants’ understanding of the questions. Semi-structured interviews 
would have also allowed parents to provide more detailed feedback, likely yielding richer 
data and strengthening the qualitative component of the study.  
In terms of limitations related to external validity of the ACT workshop, it is 
important to note that although many mental health professionals could facilitate 
workshops comprised of education and general parent support, fewer mental health 
professionals have sufficient training in ACT to facilitate workshops incorporating ACT 
exercises and teaching. In the present study, ACT workshop facilitators completed 
specific ACT readings and trainings (e.g., attending a 2-day intensive ACT workshop, 
completing a 12-week ACT course at McMaster University) to prepare, had previous 
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experience facilitating ACT groups, and were supervised by a registered psychologist with 
experience in ACT. This additional training may reflect a barrier for some professionals. 
However, it should be noted that ACT groups can also be led by lay facilitators with appropriate 
training and support. For example, several parents of children with ASD in the Toronto area have 
been trained to effectively facilitate ACT workshops and support groups for other parents of 
children with ASD and participant feedback from these parent-facilitated groups has been quite 
positive (Fung, Lake, Steel, Bryce, & Lunsky, 2018; Lunsky, Fung, Lake, Steel, & Bryce, 2018). 
Finally, the present study was largely exploratory as it was one of the first to specifically 
investigate the topic. As such, any significant effects of the ACT workshop should be replicated 
in additional studies using a larger sample size and multivariate statistics to more 
comprehensively address the relevant research questions.   
Conclusion  
The present randomized pilot feasibility trial sought to examine the benefits of 
incorporating elements of Acceptance and Commitment Training (ACT) into a standard one-day 
educational workshop for parents of children with ASD. Although the trajectories of change in 
participants’ acceptance and cognitive fusion differed significantly between workshop groups 
over time with ACT workshop participants showing increases in acceptance and decreases in 
cognitive fusion, differences in acceptance and cognitive fusion between groups failed to reach 
significance. Unexpectedly, willingness to select evidence-based treatments decreased over time 
for participants in both groups. ASD treatment selection knowledge increased from preworkshop 
to postworkshop for parents in both groups and these gains were maintained at three-month 
follow-up. Acceptance and cognitive fusion were not found to moderate the relation between 
participants’ treatment selection knowledge and their willingness to select evidence-based 
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treatments, possibly due to insufficient statistical power. However, increases in parents’ 
acceptance from postworkshop to follow-up were found to be positively correlated with 
parents’ willingness to select evidence-based treatments at follow-up. Although ACT 
group participants reported that the ACT components were their most liked aspect of the 
workshop, participants in both groups reported that the treatment selection information 
was the most important thing they learned in the workshop. Participants in both groups 
were highly satisfied with the workshops and reported feeling more knowledge and 
confident in their ability to effectively select treatments for their children at follow-up.  
Overall, results of the present study demonstrate the feasibility of incorporating 
ACT into educational community workshops for parents of children with ASD. Although 
the ACT workshop was not associated with increased willingness to select evidence-
based treatments, both workshops were associated with increases in parents’ treatment 
selection knowledge, with preliminary support for additional benefits of the ACT 
workshop in terms of increased acceptance and decreased cognitive fusion. Replication of 
these findings with larger samples should be prioritized in future research, as well as 
further investigation into additional benefits of these types of ‘hybrid’ community 
interventions for parents of children with ASD.    
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APPENDICES 
Appendix A: Permissions for Study Measures 
Measure Permission Obtained From 
EBPAS-P* Gregory Aarons, Professor, Department of Psychiatry, UC San 
Diego School of Medicine (email communication; March 12, 
2015) 
AAQ-II-A Frank Bond, Director, Institute of Management Studies, 
Goldsmiths College, London, UK (website for the Association 
of Contextual Behavioral Science) 
CFQ-II-A David Gillanders, Professor, University of Edinburgh (website 
for the Association of Contextual Behavioral Science) 
MAAS This measure is in the public domain and does not require 
author permission for its use (Brown & Ryan, 2003) 
MCSDS-SF This measure is in the public domain and does not require 
author permission for its use (Strahan & Gerbasi, 1972) 
WSS* Jennifer Kowalkowski, Psychologist, Beaumont Hospital, 
Grosse Pointe, MI (email communication; May 13, 2015) 
GCS This measure is in the public domain and does not require 
author permission for its use (Wongpakaran et al., 2013) 
*Note. Permission granted to use and modify the measure.  
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Appendix B: Demographic Questionnaire 
Please let us know a bit about yourself. 
 
1. Your Gender: _________________ 
 
2. Your Age: _____ years   
 
3. Your Marital Status:  _____________     
 
4. Your Annual Household Income: $___________  
 
5. Your Education:  
a)  High School or Less   
b)  Some College/University   
c)  College/University or Post-Graduate   
   
6. Your Employment Status: 
        a)  Full-Time 
 b)  Part-Time 
 c)  Unemployed 
 d)  Retired 
 
7. Your Spouse/Partner’s Employment Status: 
a)  Full-Time 
b)  Part-Time 
c)  Unemployed 
d)  Retired 
e)   Not applicable 
 
8. Child’s birthday: month (a) ________________ & year (b): _________    
 
9. Child’s gender: _________________ 
 
10. Child’s birthplace: city (a) ___________, province (b) ____________, country (c): _____________ 
 
11. Your relationship to your child:   
 
 a)  birth parent    b)  other parent/caregiver (please specify): ______________________________  
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 Which race or ethnicity do you identify with the most for yourself and for your child?  





Race or Ethnicity 
  a) Aboriginal 
  b) Arab 
  c) Black 
  d) Chinese 
  e) Filipino  
  f) Japanese 
  g) Korean 
  h) Latin American 
  i) South Asian (East Indian, Pakistani, Sri Lankan, etc.) 
  j) Southeast Asian (Cambodian, Indonesian, Laotian, 
Vietnamese, etc.) 
  k) West Asian (Afghan, Iranian, etc.) 
  l) White 
  m) Other (please specify): ___________________________________ 
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Appendix C: Treatment Selection Knowledge Quiz  
Below you will find several questions about selecting treatments for children with Autism 
Spectrum Disorder (ASD). Please circle the best response for each item.  
1. What is meant by the term ‘evidence-based treatment’? 
a. Following the advice of professionals in order to best support your child with ASD 
b. A treatment that was developed based on findings from research studies 
c. A treatment that has been proven to be effective in multiple high-quality research studies 
d. A treatment that was effective for another child with ASD in the community 
2. Which of the following treatment elements are consistently found in research to have the most 
positive impact on children with ASD? 
a. Treatments involving dietary adjustments and/or vitamin supplements 
b. Treatments administered by trained professionals only 
c. Treatments with high parental involvement  
d. Treatments focused on teaching academic skills  
3. Which of the following is a drawback of many evidence-based treatments? 
a. They may have only been shown to be effective in one study 
b. They have more risks to the child with ASD 
c. They cannot be tailored to the individual child 
d. They may have not been proven to be effective with diverse groups of children with ASD 
4. Which of the following statements about ASD is most generally true? 
a. ASD is caused by the MMR (measles, mumps, and rubella) vaccine 
b. There is no cure for ASD 
c. Most children with ASD never learn to speak 
d. Individuals with ASD cannot live independently 
e. All treatments for ASD are effective 
5. Which of the following ASD treatments is not supported by research? 
a. Gluten-free/casein-free diet 
b. Parent training 
c. Behavioural interventions 
d. Naturalistic teaching strategies 
  
TREATMENT SELECTION  176 
 
6. Which treatment endorsement below is the most trustworthy? 
a. An endorsement from a psychologist or physician, based on their own knowledge 
b. An endorsement from another parent of a child with ASD, based on personal experience and 
‘real life’ events 
c. An endorsement from a national or provincial ASD organization based on stories from many 
parents of children with ASD 
d. An endorsement from yourself, based on your sense of your child, family values, and a 
critical review of the treatment research   
7. To be effective, an ASD treatment must address the cause of ASD 
a. True 
b. False  
8. Parents can be least suspicious about treatments for ASD which involve:  
a. High ‘upfront’ cost 
b. Claims of a cure 
c. Large investment of time and effort 
d. Treating underlying biological processes linked to ASD 
9. Which of the following is most often true of news reports of ASD treatments?  
a. They offer first-hand scientific information about ASD treatments 
b. They are more difficult to access than scientific journal articles 
c. They leave out important details about the quality of research support for the treatment 
d. They are more difficult to understand than scientific journal articles 
10.   Which of the following ASD treatments has the most research support? 
a. Picture exchange communication system (PECS) 
b. Applied behaviour analysis (ABA) 
c. Music therapy  
d. Structured teaching 
 
  
TREATMENT SELECTION  177 
 
Appendix D: Follow-up Experiences Survey  
We would like to know more about your experiences since participating in the workshop.  
Please answer the following questions as honestly as possible. 














3. How have your attitudes and/or behaviours changed (if at all) between when you 














5. What would you most like researchers to know about your experiences between the 
workshop and now? 
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Appendix E: ACT Workshop Fidelity Measure  
Instructions: Please reflect on the workshop you just observed and indicate (by circling one 
number between 1 to 7 as indicated on the scale below) the extent to which each learning 
objective was covered by workshop facilitators. Please be as honest as possible.  
1 2 3 4 5 6 7 



















1. Recognition of widespread misinformation about ASD 
and ASD treatments 
1        2        3        4        5        6        7  
2. Understanding of term ‘evidence-based treatment’ as 
it relates to ASD 
1        2        3        4        5        6        7  
3. Understanding of benefits and drawbacks of 
evidence-based treatments 
1        2        3        4        5        6        7  
4. Understanding of current evidence behind popular 
ASD treatment approaches 
1        2        3        4        5        6        7  
5. Knowledge of how to find quality information about 
evidence-based ASD treatments 
1        2        3        4        5        6        7  
6. Knowledge of how to critique/identify quality of ASD 
information in popular media 
1        2        3        4        5        6        7  
7. Knowledge of what to ask ASD treatment providers 
when selecting treatments 
1        2        3        4        5        6        7  
8. Knowledge of parents’ rights in relation to their 
children’s treatment 
1        2        3        4        5        6        7  
9. Acceptance of distressing thoughts and emotions 
related to their children having ASD and parenting 
children with ASD 
1        2        3        4        5        6        7 
10. Contact and engagement with themselves and their 
children in the present moment 
1        2        3        4        5        6        7 
11. Separation from the influence of distressing thoughts 
about their children or aspects of their parenting  
1        2        3        4        5        6        7 
12. Awareness of their stable senses of self which exist 
outside of and separate from their parenting roles 
1        2        3        4        5        6        7 
13. Identification of life values and current barriers to 
value-consistent living 
1        2        3        4        5        6        7 
14. Development of concrete goals and commitment to 
engaging in values-consistent behaviours 
1        2        3        4        5        6        7 
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Appendix F: Support Workshop Fidelity Measure 
Instructions: Please reflect on the workshop you just observed and indicate (by circling one 
number between 1 to 7 as indicated on the scale below) the extent to which each learning 
objective was covered by workshop facilitators. Please be as honest as possible.  
1 2 3 4 5 6 7 



















1. Recognition of widespread misinformation about ASD 
and ASD treatments 
1        2        3        4        5        6        7  
2. Understanding of term ‘evidence-based treatment’ as 
it relates to ASD 
1        2        3        4        5        6        7  
3. Understanding of benefits and drawbacks of 
evidence-based treatments 
1        2        3        4        5        6        7  
4. Understanding of current evidence behind popular 
ASD treatment approaches 
1        2        3        4        5        6        7  
5. Knowledge of how to find quality information about 
evidence-based ASD treatments 
1        2        3        4        5        6        7  
6. Knowledge of how to critique/identify quality of ASD 
information in popular media 
1        2        3        4        5        6        7  
7. Knowledge of what to ask ASD treatment providers 
when selecting treatments 
1        2        3        4        5        6        7  
8. Knowledge of parents’ rights in relation to their 
children’s treatment 
1       2        3        4        5        6        7  
9. Sharing of experiences with other workshop 
participants 
1       2        3        4        5        6        7  
10. Development of sense of social support with other 
workshop participants 
1       2        3        4        5        6        7  
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Appendix G: Letter of Information and Consent Form 
 
 
Title of Study: Selecting Treatments for Children with Autism Spectrum Disorder  
 
You are asked to participate in a research study conducted by Brianne Drouillard, under the supervision of Dr. Marcia 
Gragg, from the Department of Psychology at the University of Windsor. This study is a Doctoral Dissertation 
research project.  
 
If you have any questions or concerns about the research, please feel to contact Brianne Drouillard 
(drouillb@uwindsor.ca) or Dr. Marcia Gragg (519) 253-3000 Ext. 2227. 
 
PURPOSES OF THE STUDY 
 
• To evaluate the effectiveness of an educational workshop for teaching parents about selecting treatments 
for their children with Autism Spectrum Disorder 





If you volunteer to participate in this study, you will be asked to: 
• Agree to be randomly assigned to one of two types of workshops about selecting treatments for children with 
Autism 
o Both types of workshop have the same information about choosing treatments for children with 
Autism, but include different ways of supporting parents to use the information 
• Attend a workshop about choosing treatments for children with Autism, and complete questionnaires about 
your family, yourself, and your knowledge about selecting treatments before and after the workshop (6.5 
hours in total) 
o Bring a copy of your child’s diagnostic report to the workshop and allow researchers to record 
diagnostic information 
• Complete questionnaires about your family, yourself, and your knowledge about selecting treatments online 
or in-person 3 months after the workshop (10 minutes)  
 
The total time to complete the study is less than 7 hours. 
 
POTENTIAL RISKS AND DISCOMFORTS 
 
Some aspects of the workshop may remind you of some uncomfortable thoughts or feelings about your child, about 
ASD, or about treatment selection experiences.  You can access professional support by calling the Distress Centre 
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POTENTIAL BENEFITS TO PARTICIPANTS AND/OR TO SOCIETY 
 
Learning more about how to choose treatments for your child with Autism may help your child access high quality 
treatments at an earlier age.  You may also feel more supported and empowered as a decision maker for your child.  
Supporting parents in choosing treatments for their children with Autism had not been studied very much yet, so it is 
important to learn more about the best ways to do this.  
 
COMPENSATION FOR PARTICIPATION 
 
As a token of thanks for participating in the study, you will be offered a $5 Tim Horton’s gift card after completing the 





We will keep the paperwork and your answers to questionnaires for this study confidential.  They will be identified 
only by a code number.  The researchers will keep the data from this study locked in a secure location for seven 
years after the study is completed.  All data and forms will be shredded or deleted after seven years.  By law, there 
are exceptions to confidentiality.  Researchers must report any suspicions of child abuse or neglect to the Children’s 
Aid Society, and we may need to inform the supervising Psychologist as well.  If we feel that you are at imminent risk 
of hurting yourself or others, we may need to tell someone without your permission to help keep you or others safe, 
and we may need to inform the supervising Psychologist.   
 
PARTICIPATION AND WITHDRAWAL 
 
You may choose to be in this study or not.  If you volunteer to be in this study, you may withdraw at any time without 
consequence.  You may also refuse to answer any questions you do not want to answer and remain in the study.  
You may contact the researchers at any point prior to completing your follow-up questionnaire to remove your data 
from the study.  
 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE PARTICIPANTS 
 
Research findings will be posted after completion of the study on Dr. Gragg’s website.  
 
Web address: www.uwindsor.ca/autism (click on “student research” and “Brianne Drouillard”) 
 
Results will be made available no later than August 31, 2017. 
 
SUBSEQUENT USE OF DATA 
 
These data may be used in subsequent studies, in publications, and in presentations.  
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RIGHTS OF RESEARCH PARTICIPANTS 
 
If you have questions regarding your rights as a research participant, contact: Research Ethics Coordinator, 
University of Windsor, Windsor, Ontario N9B 3P4; Telephone: 519-253-3000, ext. 3948; e-mail: ethics@uwindsor.ca 
 
 
SIGNATURE OF RESEARCH PARTICIPANT 
 
I understand the information provided for the study Selecting Treatments for Children with Autism Spectrum 
Disorder as described herein.  My questions have been answered to my satisfaction, and I agree to participate in this 




Name of Participant 
 
 
______________________________________  ___________________ 
Signature of Participant       Date 
 
 
SIGNATURE OF INVESTIGATOR 
 
These are the terms under which I will conduct research. 
 
 
_____________________________________  ____________________ 
Signature of Investigator      Date 
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Appendix H: Post-Study Letter of Information and Debriefing Form 
 
 
Title of Study: Supporting Treatment Selection in Parents of Children with Autism Spectrum Disorder:  
                   An Educational Workshop with Acceptance and Commitment Therapy  
 
Thank you for your participation in this study by Brianne Drouillard, M.A. from the Psychology Department at the 
University of Windsor. This study is part of her Doctoral Dissertation in Child Clinical Psychology. Dr. Marcia Gragg, 
Ph.D., C.Psych., is supervising the study. If you would like more information or if you have any questions or concerns, 
please feel free to contact Brianne at drouillb@uwindsor.ca or Dr. Gragg at mgragg@uwindsor.ca.  
 
BACKGROUND OF THE STUDY 
 
• Treatment selection can be a complex and overwhelming process for many parents of children with Autism 
 
• Parents often receive little support when selecting treatments, and their most common sources of 
information often contain misleading or inaccurate information 
 
• Despite widespread availability of high-quality, evidence-based treatments, many parents report using non-
evidence-based treatments with their children with Autism 
 
• Research has shown that information alone often does not lead to changed attitudes toward evidence-based 
treatments 
 
• Parents of children with Autism appear to be less influenced by research evidence for treatments than by 
more emotional factors when selecting treatments 
 
• Acceptance and Commitment Training has been shown, when combined with information, to increase 
willingness to use evidence-based treatments  
 
PURPOSE OF THE STUDY 
 
• To examine the effectiveness of a workshop combining treatment selection information with elements of 
Acceptance and Commitment Training to increase parents’ willingness to select evidence-based treatments 
for their children with Autism 
 
• Results of the study have the potential to improve early access to evidence-based treatments for children 
with Autism and to help parents feel more informed and empowered as decision-makers on behalf of their 
children with Autism 
 
PROCEDURES AND RATIONALE 
 
• Participants in this study were randomly assigned to one of two types of workshop: 
 
1. Education with Acceptance and Commitment Training (ACT) 
• Included elements of ACT with information about treatment selection 
• ACT is an evidence-based approach which has been used to support parents of children with 
ASD by helping them struggle less with difficult thoughts and feelings and take action to do the 
things that are most important to them 
 
2. Education with Support 
• Included parent support group-style discussion with information about treatment selection 
• Parent support groups are an evidence-based approach which has been used to support 
parents of children with ASD by helping them connect with other parents to gain information, 
tips, and form supportive bonds 
 
• Both workshops contained the same information about selecting treatments for children with Autism 
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• It was necessary to compare the Education with ACT workshop with the Education with Support workshop to 
see whether the Education with ACT workshop would lead to greater increases in parents’ willingness to 
select evidence-based treatments for their children with Autism than the Education with Support workshop, 
which is what is typically received by parents in the community 
 
• It was necessary to keep specific study hypotheses and group assignment secret until after you completed 
follow-up questionnaires so that this information would not influence how you answered items on the 
questionnaires 
 
• We ask that you do not tell other participants about the purpose of the study since any pre-knowledge will 
bias the data for that person and thus cannot be used 
 
GROUP ASSIGNMENT DISCLOSURE 
 
In this study, you were randomly assigned to the [insert type of workshop] workshop condition. Please do not 
hesitate to ask the researcher any questions you have about the purpose, rationale, and any procedures used in this 
study. If you wish, you may participate in the workshop to which you were not assigned at a later date. Please contact 
the researcher to arrange this. 
 
PARTICIPATION AND WITHDRAWAL 
 
Now that you are fully informed about the purpose of the study, why it was necessary to blind participants to group 
assignment, and which workshop group you participated in, you may choose to have your data included in this study 
or not. At this point, you may withdraw your information without consequence by contacting the researcher. 
 
FEEDBACK OF THE RESULTS OF THIS STUDY TO PARTICIPANTS 
 
Research findings will be posted no later than August 31, 2017 on Dr. Gragg’s website → www.uwindsor.ca/autism  
(click on “student research” and “Brianne Drouillard”) 
 
PROFESSIONAL SUPPORT RESOURCES 
 
If participating in this study caused you to experience distress, you can access free, confidential, and immediate 
professional support by contacting the Distress Centre of Windsor and Essex County at 519-256-5000. Please 
contact the Canadian Mental Health Association at the Windsor branch (519-255-7440) or the Leamington branch 
(519-326-1620) if you would like to access free, confidential, ongoing therapeutic support in the community. 
 
PARTICIPATION IN FUTURE STUDIES 
 
Would you like to be contacted by a member of the University of Windsor Autism Research Group to learn more 
about participating in future studies? (Please check one box) 
 
◻ Yes, please let me know about future studies  ◻ No, thanks 
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RIGHTS OF RESEARCH PARTICIPANTS 
 
If you have questions regarding your rights as a research participant or the use of deception in this study, contact: 
Research Ethics Coordinator, University of Windsor, Windsor, Ontario N9B 3P4; Telephone: 519-253-3000, ext. 
3948; e-mail: ethics@uwindsor.ca 
 
 
SIGNATURE OF RESEARCH PARTICIPANT 
 
I understand the purpose of the study Supporting Treatment Selection in Parents of Children with Autism 
Spectrum Disorder: An Educational Workshop with Acceptance and Commitment Training as described 
herein.  I understand why participants were not told their group assignments until completing data collection. I was 
informed which type of workshop I participated in. My questions have been answered to my satisfaction, and I agree 
to include my data in this study.  
[click yes or no] 
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Appendix I: Content Categories Derived from Participant Responses at Postworkshop 
Table 9  
Most Liked Aspects of the Workshop 
Content Category n 
ACT Group  
ACT exercises 8 
Information 5 




No response 0 
Support Group  
Information 11 
Sharing experiences 4 
Facilitators 1 
Everything 1 
No response 0 
*Note. NACT = 15, NSupport = 14. Participants may have offered multiple responses to each item. 
 
Table 10 
Least Liked Aspects of the Workshop 
Content Category n 
ACT Group  
Nothing 9 
Content 2 
No response 2 
Presentation style 1 
Support Group  
Nothing 3 
Logistical aspects 3 
Content 2 
No response 4 
*Note. NACT = 15, NSupport = 14. Participants may have offered multiple responses to each item. 
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Table 11  
What Parents Would Change about the Workshop 
Content Category n 
ACT Group  
Personal changes 4 
More interactive elements 3 
Nothing 2 
Content 2 
Logistical changes 2 
No response 1 
Support Group  
Nothing 5 
Logistical changes 3 
More structure 2 
Content 1 
No response 1 
*Note. NACT = 15, NSupport = 14. Participants may have offered multiple responses to each item. 
 
Table 12 
Additional Feedback about the Workshop 
Content Category n 
ACT Group  
Positive experience 4 
Information was useful 2 
Presenters were effective 1 
Enjoyed connecting with other parents 1 
Practical considerations of selecting treatments 1 
No response 7 
Support Group  
Information was useful 2 
Desire to include other family members 2 
Enjoyed connecting with other parents  2 
Limitations of current research/future areas of need  2 
No response 3 
*Note. NACT = 15, NSupport = 14. Participants may have offered multiple responses to each item. 
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Impact from Postworkshop to Follow-up 
Content Category n 
ACT Group  
Increased knowledge of evidence-based treatments 3 
Increased openness and independence in selecting treatments 3 
No real change 3 
Increased support 1 
Increased mindfulness 1 
No response 0 
Support Group  
Increased openness/empowerment/advocacy 3 
No real change 3 
Increased understanding of ASD/my child 2 
More positive attitude 1 
No response 1 




Most Important Lessons Learned 
Content Category n 
ACT Group  
Tips/strategies for selecting treatments 9 
More holistic view of child/ASD 2 
Importance of social support 1 
No response 0 
Support Group  
Tips/strategies for selecting treatments 7 
Trusting instincts/knowledge of child 2 
Importance of social support 1 
No response 0 
*Note. NACT = 13, NSupport = 10. Participants may have offered multiple responses to each item. 
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Table 15 
Changes in Attitudes and Behaviours at Follow-up 
Content Category n 
ACT Group  
More positive, hopeful, less stressed 5 
No real change 3 
More mindful 1 
Increased understanding of treatment selection 1 
More frustrated about lacking services 1 
No response 1 
Support Group  
No real change 3 
More open minded 2 
Increased understanding of treatment selection  2 
More positive 1 
Enhanced support 1 
No response 1 




Benefits to Children 
Content Category n 
ACT Group  
Improved quality of life 4 
Improved interventions/strategies 2 
Enhanced understanding and support 2 
Enhanced advocacy skills 1 
Increased mindfulness 1 
No response 0 
Support Group  
Enhanced confidence in selecting treatments for own child  4 
Improved interventions/strategies 2 
Decreased parental stress 2 
Increased connection with other parents 1 
No real change 1 
No response 1 
*Note. NACT = 13, NSupport = 10. Participants may have offered multiple responses to each item. 
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Table 17 
What Parents Would Like Researchers to Know 
Content Category n 
ACT Group  
Importance of treatment selection knowledge  6 
Importance of parents connecting with each other 2 
Workshop was helpful/positive 2 
Increased services/supports are needed 1 
Benefits of mindfulness for parents 1 
No response 1 
Support Group  
Importance of treatment selection knowledge 4 
Parent plans and next steps 2 
No response 2 
Importance of parent perspectives 1 
Nothing 1 
*Note. NACT = 13, NSupport = 10. Participants may have offered multiple responses to each item. 
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